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3AN OVERVIEW OF THE FRAMEWORK OF CURRENT REGULATION 
AFFECTING THE DEVELOPMENT AND MARKETING OF 
NANOMATERIALS
1.0 EXECUTIVE SUMMARY
This report represents an analysis of the potential gaps in the regulation of the 
development, manufacture, supply, use and end of life of free engineered 
nanoparticles. Alongside the recognised benefits of nanotechnologies are 
prevailing uncertainties regarding health and environmental exposures and 
most reports have called for careful consideration of the marketing of  free, 
engineered nanomaterials, pending further research in the face of such 
uncertainties. This should provide the base for regulatory evaluation in an 
open, inclusive and transparent manner.
In the report current and future foreseeable applications of nanomaterials are 
mapped against existing regulatory frameworks that might govern the lifecycle 
of these materials. These regulations serve a number of purposes including: 
controls on marketing; health and safety, consumer and environmental 
protection; and waste regulation. By subjecting such regulations to careful 
legal scrutiny of their capacity to fulfil basic risk governance functions the 
report draws out gaps in the regulatory provision. 
Reviewing the types of legislation listed above, the Report finds potential for 
gaps where thresholds are set to govern whether materials or products fall 
within regulation. These thresholds might be set in accordance with 
concentrations of particular substances or via percentages or weight of such 
substances. Given that some nanomaterials have different properties to their 
non-nanomaterial counterparts, it is conceivable that these thresholds are 
inappropriately set for the inclusion in products of nanoparticles.   
A similar problem arises where the regulation of substances coming to or 
placed upon the market depends upon their equivalence to substances 
already well regulated and understood. The ability of pre-market authorisation 
to identify potential risks associated with nanomaterials may depend on 
whether products containing nanoparticles are construed as being equivalent 
to authorised products already on the market.  The judgement on questions of 
equivalence is problematic and may depend upon the producer or supplier in 
the first instance. This could lead to a lack of scrutiny of products that are 
apparently similar to existing products on the market but which contain 
nanomaterials with different properties.
In certain areas of regulation such as environmental protection, we may 
regulate processes or restrict the use or escape of prescribed substances. 
Here the problem is whether either the prescribed processes or substances 
are sufficiently exactly defined to prevent, restrict or control harm to the 
environmental due to the presence of nanomaterials either prior to or post 
entry into the environment. A number of the relevant regulations seem too 
narrow in scope and interpretation to ensure this. 
4In relation to the escape or emission of substances to the environment, the 
regulator needs to be able to monitor and sample the relevant media and will 
require technical capacity to undertake appropriate sampling of 
nanomaterials. Moreover, given current uncertainties in relation to the 
potential impacts of nanomaterials on human health and/or the environment, it 
may not be possible to assess the impacts of many nanomaterials. Such 
uncertainties relate both to the potential for adverse effects and to the level at 
which these effects might occur. This is a recurrent problem in our findings.
Often the regulation will govern the generation of further data as part of a 
system of risk governance. For example the classification of a substance as 
hazardous will require a supplier to provide information relating to the hazards 
of the substance supplied.  If not classed as hazardous, no new data would 
be generated on the risks or hazards relating to the identified nanomaterial. 
Nanomaterials might then move through their lifecycle without any further 
assessment of their properties. Such classifications, in areas such as health 
and safety at work operate also as the trigger for effective risk management 
programmes. Limited or imprecise definitions in regulation concerning what 
should be subject to risk assessment may lead in turn to weak risk 
management.
This explanation into how the early identification of hazards may affect the 
substance throughout its lifecycle is a significant part of the report. A 
regulatory framework should ensure that any substance that may cause harm 
to human health and/or the environment is effectively regulated at whatever 
phase in the lifecycle.  Yet we find that decisions made at an early stage may 
influence the later lifecycle of a product. Thus materials not thought harmful to 
humans within a particular product might have the capacity for deleterious
effects bulked up in the domestic waste stream in a landfill. 
An integrated approach is needed, especially since current regulation was 
never designed with nanotechnology in mind and is inevitably piecemeal, 
being contained in various statutory provisions spread over different areas of 
regulatory activity. Nonetheless in the interim the existing framework can be 
adapted generally by ensuring that where appropriate the regulation extends 
to nanomaterials. In this context the work of international standard setting 
bodies is crucial in resolving issues of definition and taxonomy, allowing 
effective standard setting in relation to nanoparticles and opening up the 
prospects of a uniform global response to the marketing and circulation of 
nanomaterials.
Many of the gaps identified in this report arise due to a lack of existing data on 
the potential effects of nanomaterials on human health and the environment. If 
nothing else this report demonstrates how effective regulation will depend on 
moving to a position of greater certainty on such questions. Even where risk 
assessment procedures established under existing regulatory frameworks 
appear robust, their ability to accurately characterise and assess potential 
risks associated with nanotechnologies is limited by fundamental uncertainties 
about the impact of exposure to free, engineered nanomaterials. Better 
research and better regulation ought to move hand in hand. 
52.0 INTRODUCTION – A BRIEF SUMMARY OF THE CONTEXT 
2.1 Nanotechnologies and Nanomaterials – Issues and Perceptions
Nanotechnologies and nanoscale materials bring new and innovative 
opportunities, but at the same time some of them have the potential to pose 
risks to human health and the environment. There is a wide range of 
regulation governing new materials and products coming on to the market and 
throughout their lifecycle in order to protect against these types of risk.  
However, since none of these regulations specifically address the presence of 
nanomaterials, this paper examines whether the existing regulatory regime is 
sufficiently broad to capture any potential risks arising from the use of free, 
engineered nanoparticles.  
This analysis is centred upon existing frameworks of regulation. It attempts to 
conduct a comprehensive review of existing (and foreseeable future) 
regulations building on recent studies carried out by and for a number of UK 
Government departments and publicly sponsored bodies (as referenced in the 
literature review in Annex 1). Most of this work has flagged up the potential 
health and environmental risks of free, engineered nanoscale materials as an 
early topic for consideration. In response, this study looks to locate gaps in the 
framework of regulation such that nanoscale materials evade any scrutiny of 
risk as goods reach and remain on the market. This report is focussed 
primarily on an assessment of the potential risks associated with the 
development, manufacture, supply and use of free, engineered nanoparticles. 
Whilst it is acknowledged that fixed nanoparticles might also pose a threat 
over their lifecycle, evidence (Chaudhry, Q., Boxall, A., Aitken, R. and Hull, 
M., 2005)1 suggests that free nanoparticles2 have the potential to present a 
greater risk to human health and the environment.   Because little is currently 
understood about the nature of these risks, the report presents findings from 
an exhaustive review of feasibly relevant regulation in order to isolate gaps in 
regulatory control. It is hoped that this work can lead to recommendations for 
regulatory development. 
The term ‘nanotechnology’ is used to describe a wide range of enabling 
technologies (ESRC, 2003).  It is widely accepted that ‘nanotechnology’ refers 
to the design, characterisation, production and application of structures, 
devices and systems by controlling shape and size at the nanoscale (BSI, 
2005).  It has been described as ‘technologies of the tiny’ (EU, 2004), 
involving the manufacture of materials with one or more dimension of the 
order of 100nm or less.  
The development of nanotechnologies redefines advances in manufacturing 
processes in a wide range of sectors, including consumer products, 
                                                
1 A scoping study into the manufacture and use of nanomaterials in the UK, Central Science 
Laboratory, Sand Hutton, York; all references included in the text refer to sources fully 
documented in the literature review in Annex 1.
2 Due to their capacity to bioaccumulate and disperse.
6pharmaceuticals, construction, aerospace, energy, defence and transport.  A 
table of current applications is included in section 4 of the report (Table 1).
Nanotechnology is expected to make significant contributions to a number of 
fields (ICON, 2006) and is described as one of the most powerful 
transformative technologies in human history (FoE, 2006). Yet its recognised 
benefits are accompanied by concerns over the potential human and 
environmental exposure to nanoparticles.  Current scientific knowledge about 
the impact of nanomaterials precludes a full assessment of potential risks to 
human health and the environment.  Given the scientific uncertainty 
associated with nanomaterials, nanotechnology is seen to present new 
challenges for regulation (Stirling, 2000).
2.2 Regulation of New Technologies
There are genuine health and safety concerns in relation to human exposure 
to nanomaterials. The extent to which fears over safety are well grounded is 
itself a matter of uncertainty since the potential risks posed by nanomaterials 
are not fully understood. In response to this information deficit, a number of 
regulatory reviews have been conducted. They attempt to ascertain the extent 
to which this uncertainty limits the efficacy of current regulation (Defra, 2006; 
FSA, 2006; HSE, 2006; RS/RAEng, 2004).  Broadly they conclude that, given 
the paucity of current information about the likely impact of nanotechnology, 
the potential risks from free, engineered nanoscale materials need to be 
encompassed within regulatory structures at this stage, and that an analysis 
of those structures is a necessary starting point.
Lessons from biotechnology, particularly in relation to genetically modified 
(GM) products, show that an early evaluation of possible adverse effects 
alongside the balancing of potential risks and benefits is crucial to the 
sustainable and successful development of ‘new technologies’.  By the same 
token, it is imperative that any risk analysis is conducted in an open, inclusive 
and transparent manner, promoting the clear characterisation of hazards, 
stakeholder communication, and the implementation of measures consistent 
with the Government’s commitment to ‘Better Regulation’ (BRTF, 2003).  It is 
essential that structures of risk governance are underpinned by public trust so 
as to enable the successful development and application of innovative 
technologies.
3.0 METHODOLOGY
Initial work on this project was directed at producing an exhaustive literature 
review of academic, policy, and ‘grey’ literature relating to questions that might 
affect the regulation of nanomaterials. This was crucial not only to shape the 
main work on identifying current applications of these materials and the likely 
regulatory instruments to be surveyed but also to avoid replication of existing 
work. This literature review is appended to this report (Annex 1) and that part 
of the review touching upon the framework of regulation is to some degree 
replicated in the main body of this report.
7The next stage of the work was to use existing research to identify current 
nanotechnology applications and materials.3 In one sense, to isolate sectors 
and applications in this way may seem pointless, as over time nanomaterials 
may be prevalent in a huge range of products. On the other hand to review 
current usage does help identify potential risk by reviewing how these 
particular sectors or products are currently regulated thereby informing our 
later gap analysis. 
With Table 1 in mind, a list of existing regulatory provisions applying to current 
and future uses of nanomaterials was produced (Table 2).  The focus of Table 
2 was limited to provisions at EU and UK levels. A worldwide survey of 
regulations within other jurisdictions that might capture nanomaterials was not 
feasible given the duration of this project. Where international agreements 
impose obligations relating to (say) hazardous materials that might impact on 
nanomaterials, these are generally reflected in EU legislation (ordinarily by 
Directives) and these are then transposed into UK law.  In fact, the problem 
with international treaties (e.g. on transhipment of hazardous wastes) is that 
these do not single out nanomaterials. International standard setting may 
prove to be vital in due course if disputes as to the free flow of goods (such as 
that which arose in relation to GM products) are to be avoided. (WTO Dispute 
Panel Report on Complaints by the US, etc., 2006)
The Table of Current Applications of Nanomaterials (Table 1) and the three 
areas of potential impact (consumer protection; health and safety; 
environmental protection) listed in the Table of Current Regulations (Table 2) 
were the subject of specialist consultation using both telephone interviews 
with policy makers and discussions with a focus group drawn from experts 
within our own University setting in Cardiff. 
The framework of EU/UK regulation considered in this study is found in the 
Regulatory Analysis (Templates) in Annex 5. This forms the core of our work.  
Annex 5 contains in-depth analysis of each of the relevant regulations 
identified in Table 2.  Following this analysis, the assessed regulations were 
grouped under the following headings in order to produce the overview 
Regulatory Gaps Table in Annex 4B:
 Regulation of production and introduction to the market;
 Health and safety legislation;
 Product composition, quality and safety provisions;
 Consumer protection measures;
 Environmental controls;
 Waste regulation.
The Regulatory Gaps Table in Annex 4A draws out the main themes identified 
in Annex 5, and considers the scope of the controls in each regulatory 
instrument included. It assesses the ability of each of the legislative provisions 
to handle potential risks by examining how those risks are characterised, 
assessed and managed.  The Regulatory Gaps Table in Annex 4A also 
                                                
3 The Table of Current Applications of Nanomaterials (Table 1) can be found in section 4.0 
below.
8includes a final ‘Information Base’ column, reflecting concerns as to the lack of 
complete information about the potential for risk posed by free, engineered 
nanoparticles. 
This approach allows a consideration of the adequacy and practical limitations 
of current controls applying to nanomaterials.  The Regulatory Gap Analysis 
Table (Annex 4A) identifies a series of potential gaps in the existing 
framework of regulation. These regulatory gaps are considered in detail 
below.  Broadly speaking, gaps tend to arise as a result of legislative 
thresholds and definitions more designed to capture risks associated with bulk 
materials.  
Where appropriate, the individual Regulatory Analysis (the Templates set out 
in Annex 5) considers future applications of nanotechnologies and likely 
regulatory developments in relation to all legislation studied. Because the 
Regulatory Analysis is complex, lengthy and consists of a detailed legal 
interpretation of a large number of regulations from differing fields, it has not 
been included in the main body of this report. Instead, key findings are 
highlighted below.  Annex 5 can be used as a reference resource should 
readers wish to examine in greater detail the regulatory gaps cited in the 
report. 
Having conducted a detailed regulatory gap analysis, an attempt has been 
made to map these in a manner that allows recognition of similarities and 
differences in the types of gaps in different policy areas. This assists in 
determining whether the gap is specific to nanomaterials or whether it is a 
more general regulatory shortfall.  The regulatory gaps identified are mapped 
using a ‘lifecycle’ approach to nanotechnologies.  Annex 3 and the Lifecycle 
Table (Table 3B) identify the following stages of a product’s lifecycle which 
provide a framework for further analysis:
 Research and development, production and introduction to the market;
 Market use and circulation with an emphasis on human health and 
safety, consumer protection, and environmental protection;
 Producer responsibility for goods and issues of waste disposal. 
94.0 NANOTECHNOLOGIES – CURRENT APPLICATIONS
4.1 Table 1: Current Applications of Nanomaterials 
Sector Current applications4 Examples
Automotive and aviation  Advanced materials and coatings
- Low friction and 
wear resistant 
coatings
- Advanced tyres
- Cooling- and ferro-
fluids
 Energy generation
- Hydrogen storage 
fuel cell
- Catalytic 
converters
 Sensors
- Exhaust emission 
detectors
Aerospace, defence 
and transport
Aerospace and defence  Electronics and IT
- Advanced 
simulation
 Advanced materials and coatings
- High strength 
lightweight 
laminates
- Fire retardant 
materials
- Light alloys
 Energy generation
- Liquid jet and 
rocket fuel
 Explosives/weapons technology
Personal care  Skincare products
- Cosmetics 
including
sunscreens
 Dental products
- Composite filling 
materials
Consumer products
Household  Cleaning products
- Detergents
- Self-cleaning 
antiseptic/antifung-
al surfaces
 Appliances
- Air conditioning 
units
- Refrigerators
 Home furnishings
- Fabrics
                                                
4 Covers early stage R&D through to products containing nanoparticles currently on the 
market.
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Food  Food packaging and storage
- Antimicrobial 
materials
- Dirt repellent 
coatings
 Food processing
- Microsieves 
 Food engineering 
- Nutrient 
nanocapsules
 Food safety
- Contaminant 
sensors
- Tagging and 
monitoring
- ‘Smart’ packaging
Other commodities  Clothing
 Sports equipment
 Toys
Pollution prevention and 
remediation
 Biodegradable materials
 Sensors
- Silicon nanowires 
 Filtration media
- Flexible 
membranes
 Catalysis
- Photocatalysts
Environment and 
agriculture
Plant protection products  Fertilisers
 Pesticides
Antimicrobial materials  Clinical textiles
- Wound dressings
 Soaps
Tissue regeneration, 
growth and repair
 Orthopaedic and dental implants
- Tissue engineering
- Bone growth 
promoters and 
replacement 
materials
- Implant coatings
 Endovascular implants
 Active implantable devices
- Pacemakers and 
hearing aids
- Microchip-based 
drug delivery
Medical imaging and 
diagnostic agents
 Luminescent dyes
 ‘Lab-on-a-Chip’ systems
 Biosensors
 Magnetic resonance imaging
 DNA arrays
Pharmaceuticals, 
biotechnology and 
medical devices
Therapeutics and drug 
delivery
 Nanotools
- Surgical blades
- Suture needles
- Optical tweezers
 Targeted drug delivery
 Gene therapy
Energy generation and 
storage
Cells and batteries  Solar cells
 Solid oxide fuel cells
 High performance battery 
materials
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Fuel additives  Catalysts
Electronics and IT  Computing
- Computer 
hardware
- Quantum 
computing
 Displays
- Flat panel displays
- Light Emitting 
Diodes (LEDs)
 Lasers
 Circuits
Optics  Lasers
Electronic and 
magnetic
Magnetic devices  Magnetic tapes
 Magneto-resistive devices
 Ferrofluids
Textiles  Protected fabrics
- Stain resistant 
fabric
- Water repellent 
fabric
- Anti-odour fabric
 Anti-counterfeit fibres
Coatings and pigments  Paints
 Conductive inks
 Stain/water resistant coatings
 UV absorbers
Printing materials  Inks
 Absorbents
 Colloidal silica
Advanced materials
Conductors, 
semiconductors and 
insulators
 Conducting paste
 Heat dissipaters
Physically enhanced 
polymers/composites
 Ceramics
 Cement
 Plastics
 Rubber
 Glass
 Glues
Industrial and 
construction materials
Machinery  Cutting tool bits
 Robotics
4.2 Opinions and Views – Expert Witnesses
4.2.1 Questions Asked of Expert Witnesses
Interviews were conducted with experts and policy makers involved in 
nanotechnology.  To assess key observations and to direct the interviews a 
structured questionnaire was designed (see Annex 2).  Two groups of 
interviews were conducted, one with a select group by telephone and the 
other via a focus group held at Cardiff University.
The aim of the interviews was to gain expert perspectives on current and 
future applications of nanotechnology, thereby ensuring that the resulting 
analysis accurately followed from this initial identification.  A secondary aim 
was to gain an overview of what those involved in this sector considered were 
12
the perceived problems or gaps relating to the regulation of nanotechnology. 
A third area of questioning was the status of the current evidence base.
4.2.2 Summary of Responses
The specific issues identified during the telephone interviews are as follows:
(a) In general the information contained in Table 1 was satisfactory but also 
could include the use of nanomaterials in sport goods and nanosilver 
impregnated socks for first aid materials.  Due to the wide applicability of 
nanomaterial it could almost be used in any process, application or product.
(b) Gaps in producer responsibility regulations were a particular concern as 
they do not extend to the formulation, manufacture, supply and use of 
nanomaterials.  Further issues were raised over the regulation of the 
nanomaterials at the research and development stages with potential gaps 
likely.
(c) Current levels of information are problematic, whilst a lot is known about 
the toxicity of regulated non-nanomaterials, so little is known about 
nanomaterials.  
(d) Due to the scale of nanomaterials, meeting defined concentration 
thresholds based on the risks or hazards of substances at the macro level 
might also be an issue.   Current acceptable concentration thresholds for 
example in regulations dealing with prescribed substances may need to be 
readdressed as they fail to address the risks that may arise due to the 
nanoscale. 
(e) Potential solutions lay with improved definitions to capture nanomateials 
and in setting international standards for definitions and terminology.
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5.0 NANOTECHNOLOGIES AND MATERIALS – CURRENT 
REGULATORY PROVISIONS
Table 2: Current Regulations5
Legislation
Consumer 
Protection
Health 
& 
Safety
Environmental 
Protection
Notification of New Substances Regulations 1993 X
Registration, Evaluation and Authorisation of 
Chemicals (proposed) X
Biocidal Products Regulations 2001 (as amended) X
Chemicals (Hazard Information and Packaging for 
Supply) Regulations 2002 (as amended) X X
Control of Major Accident Hazard Regulations 1999 
(as amended) X X
Control of Substances Hazardous to Health 
Regulations 2002 (as amended) X
Dangerous Substances & Explosions Atmosphere 
Regulations 2002 X
Health & Safety at Work Act 1974 X
Management of Health & Safety at Work 
Regulations X
Ammonium Nitrate Materials (High Nitrogen 
Content) Safety Regulations 2003 X
Batteries and Accumulators (Containing Dangerous 
Substances) Regulations 1994 (as amended) X X
Medical Devices Regulations 2002 (as amended) X X
Medicines Act 1968 X X
Medicines for Human Use (Marketing Authorisations 
etc.) Regulations 1994 (as amended) X
Motor Fuel (Composition and Content) Regulations 
1999 (as amended) X
End-of-Life Vehicles Regulations 2003 X
Restriction of the Use of Certain Hazardous 
Substances in Electrical and Electronic Equipment 
Regulations 2005 X
Directive 2002/96/EC on Waste Electrical and 
Electronic Equipment X
Packaging (Essential Requirements) Regulations 
2003 X
Producer Responsibility Obligations (Packaging 
Waste) Regulations 2005 X
Veterinary Medicines Regulations 2005 X
Building Regulations 2000 (as amended) X
Textile Products (Indications of Fibre Content) 
Regulations 1986 (as amended) X
Electrical Equipment (Safety) Regulations 1994 X
Control of Pesticides Regulations 1986 (as 
amended) X X
Fertilisers Regulations 1991 (as amended X
Plant Protection Products Regulations 2005 (as 
amended) X
Detergents Regulations 2005 X
                                                
5 Order of regulations matches the assignment of regulations to group in Annex 4B and the 
order of analysis in Annex 5.
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Cosmetic Products (Safety) Regulations 2004 (as 
amended) X
General Product Safety Regulations 2005 X
Additives Directive 89/107/EEC (as amended) X
Articles in Contact with Food Regulations 1987 (as 
amended X
Colours in Food Regulations 1995 (as amended X
Contaminants in Food (England) Regulations 2005 X
Food Safety Act 1990 (as amended) X
Materials and Articles in Contact with Food 
(England) Regulations 2005 X
Miscellaneous Food Additives Regulations 1995 (as 
amended X
Novel Foods and Novel Food Ingredients 
Regulations 1997 (as amended X
Plastic Materials and Articles in Contact with Food 
Regulations 1998 (as amended) X
Regulation (EC) No.178/2002 on General Principles 
of Food Law X
Environmental Protection Act 1990 (as amended) X
Pollution Prevention and Control (England and 
Wales) Regulations 2000 (as amended) X
Control of Pollution (Oil Storage) (England) 
Regulations 2001 X
Control of Pollution (Silage, Slurry and Agricultural 
Fuel Oil) Regulations 1991 (as amended) X
Environmental Protection (Prescribed Processes 
and Substances) Regulations 1991 X
Air Quality (England) Regulations 2000 X
Clean Air Act 1993 X
Air Quality Limit Values Regulations 2003 X
Groundwater Regulations 1998 X
Surface Waters (Dangerous Substances) 
(Classification) Regulations 1997 X
Surface Waters (Dangerous Substances) 
(Classification) Regulations 1998 X
Trade Effluents (Prescribed Processed and 
Substances) Regulations 1989 (as amended) X
Urban Waste Water Treatment (England and Wales) 
Regulations 1994 X
Waste Management Licensing Regulations 1994 X
Water Act 2003 X
Water Environment (Water Framework Directive) 
(England and Wales) Regulations 2003 X
Water Industry Act 1991 X X
Water Resources Act 1991 X X
Hazardous Waste (England and Wales) Regulations 
2005 X
Landfill (England and Wales) Regulations 2002 X
List of Wastes (England) Regulations 2005 X
Waste Incineration (England and Wales) 
Regulations 2002 X
Waste Management Licensing Regulations 1994 X
15
6.0 NANOTECHNOLOGIES AND MATERIALS – A GAP ANALYSIS OF 
REGULATION
6.1 Assessment of Regulations and development of the Regulatory 
Gap Analysis Table
Applying the methodology outlined in Section 3 a comprehensive analysis of 
each of the regulations identified in Table 2 above was undertaken.  These 
analyses of the various regulatory provisions can be found at Annex 5 below.  
A summary of the key findings from the assessments in Annex 5 is included 
as a regulatory gap analysis table (‘the Gap Table”). This makes an 
assessment of regulations by reference to a set of criteria measuring the 
ability of the regulation to address potential risks arising from the manufacture, 
formulation, supply and use of nanotechnologies.  
Regulations were grouped according to their scope and purpose, however the 
breadth of the scope of certain regulations meant that they fell into more than 
one category (see for example the Chemicals (Hazard Identification and 
Packaging for Supply) Regulations).  These particular groupings based upon 
potential impacts also allowed for additional lifecycle analysis.  The six groups 
identified are:
 Introduction/Notification – where regulations control the entry 
of a substance onto the market and identify procedures 
demanded by the producer/supplier.
 Health & Safety – including both the obligations on employers 
to meet health and safety standards at the work place and the 
general health and safety standards placed upon suppliers of 
substances.
 Producer Responsibility – Product Quality & Safety –
containing those regulations prohibiting or restricting the use of 
certain prescribed substances or demanding the application of a 
lifecycle approach to the design of a product thereby reducing its 
impact on the environment.
 Consumer Protection – in the form of regulations specifically 
designed to control the entry of products onto the market place 
and which lay down the procedures relating to safety and the 
protection of human health.
 Environmental Protection – regulations designed to reduce the 
impact of harm to the environment and the prevention and 
control of pollution.
 Waste – a wide category of regulation that covers the 
obligations of actors in the waste chain and sets out mwaste 
management options and targets.
The regulations within each of the above groups were assessed according to 
the certain criteria, thought to be essential for effective regulation:
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 Scope – identifying whether particular substances are 
specifically identified, and where so, whether nanomaterials are 
captured under the scope of the prescribed substances.
 Risk Characterisation – whether the regulations set prescribed 
concentration thresholds or emission/discharge levels and 
whether these will capture the production or subsequent use of 
nanomaterials.
 Risk Assessment – whether the regulations demand required 
procedures to assess the risks posed by substances prescribed 
under the regulation or whether (where the regulations are 
general in their nature as with Health & Safety at Work,6 and 
CHIP7), risk assessments are required to identify necessary 
precautions.
 Risk Management – whether, as a result of the risk assessment 
procedures, the appropriate person is made responsible for 
ensuring an appropriate management response (e.g. Health & 
Safety at Work and the need for personal protective equipment8) 
or in more general terms duty of care under environmental law9
on the waste generator to ensure the appropriate management 
of waste.
 Information Base – whether specific information was required 
to be generated under a regulation, e.g. sampling or 
monitoring10 for environmental protection purposes or on a more 
general basis, and whether the potential gap arose because of a 
general lack of current available scientific knowledge.
The Gap Table produced can be found at Annex 4A.
6.2 Key Findings
6.2.1 Consumer Protection
On the whole, the regulatory provisions identified in this area can be 
described as providing a sufficiently broad framework of consumer protection. 
However, there are three clear instances in which measures might fail to 
prevent potentially harmful nanomaterials from being placed on the market.  
Each of these instances described below stem from provisions whose scope 
is restricted to particular substances, concentrations of substances, or 
products.  
(a) Legislation restricting the use of particular substances by 
percentage or weight
                                                
6 Health and Safety at Work Act 1974
7 Chemicals (Hazards Information and Packaging for Supply) Regulations 2002
8 See Part 1 Health and Safety at Work Act 1974 and Regulation 4 of the Personal Protective 
Equipment at Work Regulations 1992.
9 Section 34 Environmental Protection Act 1990
10 Water Environment (Water Framework Directive) (England and Wales) Regulations 2003
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Example:
Regulation 5 of the Cosmetic Product (Safety) Regulations 2004 restricts 
the use of groups of cosmetic ingredients listed in Schedules 4 to 7 to the 
Regulations.  
A potential regulatory gap arises where thresholds are set restricting the use 
of specific substances in cosmetic products.  Thresholds restricting the 
percentage or weight of substance permitted in products establish safety 
levels based on information relating to bulk materials.  Given that 
nanomaterials have different properties to their non-nanomaterial 
counterparts, it is conceivable that these thresholds are inappropriately set to 
capture risks arising from the inclusion in products of a nanoparticulate 
version of a restricted substance.   
(b) Legislation restricting the concentration of particular substances
Examples:
 Regulation 2 of the Contaminants in Food (England) Regulations 2006
makes it an offence, for example, to place on the market certain foods if they 
contain contaminants of any kind specified in the Commission Regulation 
(No.466/2001) at levels exceeding those specified.  
 Regulation 7 of the Restriction of the Use of Certain Hazardous 
Substances in Electrical and Electronic Equipment Regulations 2005 
requires that a producer ensures that new equipment put on the market 
does not contain more than the permissible maximum concentration values 
of hazardous substances.
A potential regulatory gap arises from the setting of thresholds of permitted 
concentrations of substances in consumer products.  Regulatory provisions 
establishing maximum concentration levels are often enacted for substances 
where there exists an extensive body of dose-response and exposure data.  It 
is conceivable that thresholds set on the basis of known toxicity of particular 
substances are inappropriately set for the manufacture of those substances 
using nanomaterials.
(c) Legislation requiring pre-market product authorisation 
Examples:
 Regulation 3 of the Medicines for Human Use (Marketing Authorisations 
etc.) Regulations 1994 provides that no ‘relevant medical product’ shall be 
placed on the market or distributed by way of wholesale dealing unless prior 
authorisation has been granted by the licensing authority (MHRA) or the 
European Commission.
 Regulation 3 of the Novel Foods and Novel Food Ingredients 
Regulations 1997 requires that that the marketing of food or food 
ingredients falling within the scope of the Regulations be authorised. 
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A potential regulatory gap arises in relation to schemes requiring that products 
are authorised before being placed on the market.  The ability of pre-market 
authorisation to identify potential risks associated with nanomaterials depends 
on whether products containing nanoparticles are construed as being 
equivalent to authorised products already on the market.  Safety questions 
arise if a product authorised on the market is subsequently manufactured 
using nanoparticles.  It is conceivable that the insertion of nanoparticles in a 
product after its authorisation as a non-nanoparticle product will lead to the 
marketing of nanoparticles before hazard characterisation or risk assessment 
processes have been conducted.  
6.2.2 Environmental Protection
Current environmental legislation provides a broad framework to prevent, 
restrict or control the impacts of pollution on or harm to the environment.  
However, the scope of some regulations can be restricted to a specific sector 
or activity, to prescribed substances, to a prescribed product or to releases 
into specific media.  These restrictions in scope may lead to gaps in the 
regulation of nanomaterials and in the ability of environmental regulation to 
prevent, restrict or control harm to the environmental due to the presence of 
nanomaterials either prior to or post entry into the environment.
(a) Legislation referring to prescribed substances and processes
(i) New manufacturing process
Such is the innovative nature of nanotechnology production that production 
process may not meet the pollution prevention and control activity 
descriptions. 
Example: 
Pollution Prevention and Control (England and Wales) Regulations 
(PPC) 200011 – Chapter 4, Schedule 1 - chemical industry activities must 
involve the production of chemicals ‘in a chemical plant by chemical 
processing for commercial purposes’ and this would exclude nanomaterials 
produced solely by physical production routes. 
(ii) Hazardous or Dangerous Substances
Regulations refer either to identified lists of substances, which have been 
prescribed at the European level or to specific substances. 
Example 1:
The Groundwater Regulations 1998 prohibit or restrict the release of List I 
or List II substances including regulation 4(1) - An authorisation shall not be 
                                                
11 As amended 2001 (SI 503), 2002 (SI 275 & SI 1702), 2003 (SI 1699 & SI 3296), 2006 (SI 
2311), Pollution Prevention and Control (England and Wales) (Amendment) and Connected 
Provisions Regulations 2004 SI 3276, Pollution Prevention and Control (Unauthorised Part B 
Processes) (England and Wales) Regulations 2004, SI 434 and Pollution Prevention and 
Control (Public Participation)(England and Wales) Regulations 2005 SI 1448
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granted if it would permit the direct discharge of any substance in list I – and 
Regulation 5(1) - An authorisation shall not be granted in relation to … any 
direct discharge of any substance in list II.12
Whether nanomaterials will be covered by the regulations will depend on 
whether they can be classed as a List I or List II substance. If they are classed 
as a List I substance their discharge into groundwater must be prohibited.  A 
regulatory gap may arise depending upon whether nanomaterials are classed 
as an existing substance controlled under the regulations or not.  If the 
nanoscale form is classed as ‘existing’ then any assessments may fail to 
identify the unique properties and potential risks associated with the 
nanoscale form, even though prohibitions on its discharge will apply. The 
problem is the availability of exemptions under the regulations after prior 
investigation. These will be reliant on technical knowledge, which may not be 
currently comprehensive, concerning the impacts of the nanoscale form.  
Conversely, if nanomaterials are not classed as a list I substance, there is a 
danger that nanomaterials will fall outside the scope of the regulations.
Example 2:
List of Wastes (England) Regulations 2005 – A substance is classed as 
dangerous if it falls under regulation 2 of Chemicals (Hazard Information & 
Packaging for Supply) Regulations 2002.13  Schedule 1 of the Regulations 
outlines specific categories of danger.
A potential gap may exist as currently no existing substance in nanosize form 
has been through the EU process with none being available on the UK 
‘Approved Supply List’.  The lack of data available may mean that substances 
in nanosize form will not be classed as a dangerous substance within the List 
of Waste Regulations. This may lead to waste types containing nanomaterials 
being classed as non-hazardous. As a consequence waste management 
options may be less stringent, for example disposal to non-hazardous landfill 
may take place.
In summary, gaps exist in relation to the definition of prescribed processes 
and substances, with many of the relevant regulations being too narrow in 
scope and interpretation.  An important question is whether the change in 
form is such that it might constitute a new substance, but the consequences of 
the answer will influence regulation in differing ways depending on whether 
                                                
12 List I and List II substances are contained in the Dangerous Substances Directive 
(76/464/EEC), however as part of the ongoing restructuring of the Community water policy, 
the Directive on Dangerous Substances is now integrated in the Water Framework Directive
(2000/60/EC) which was adopted in September 2000, and Directive 76/464/EEC will be fully 
repealed in 2013. Directive 76/464/EEC has been codified as Directive 2006/11/EC on 
pollution caused by certain dangerous substances discharged into the aquatic environment of 
the Community.
13 Dangerous Substance means a substance contained in the "Information Approved for the 
Classification and Labelling of Dangerous Substances and Dangerous Preparations (Seventh 
Edition)” (UK Approved Supply List) or if not on this list is one or more of the categories of 
danger contained in Schedule 1 of this regulation.
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the new substance now requires first-time approval or whether its new nature 
takes it outside of the list regulated substances. 
(b) Risk Characterisation – concentration thresholds, volumes, & 
tonnage
If the nanoscale form falls under the relevant definitions within the various 
environmental regulations, the nanomaterial may still escape the jurisdiction of 
the regulation if it fails to satisfy concentration thresholds 
Examples: 
List of Waste Regulations – concentration levels of hazardousness for those 
wastes with a ‘Mirror’ entry code;14 PPC Regulations - emission levels;
Water Industry Act 1991 - discharge levels; Producer Responsibility 
Obligations (Packaging Waste) Regulations 2005; - tonnage values.
It is unlikely that, due to the possible unique properties of nanomaterials, they 
will meet any of the relevant concentration, emission or discharge levels. For 
example, the emission level values under the PPC regulations are based on 
the environmental risks of the macro equivalent, which may be different from 
the nanomaterial due to the different reactions of materials at the nanoscale.  
To ensure the capture of nanomaterial, the relevant competent authority 
needs to be able to monitor and sample the relevant media and therefore they 
will require technical equipment to undertake appropriate sampling to identify 
nanomaterials. Moreover, given current uncertainties in relation to the 
potential impacts of nanomaterials on human health and/or the environment, it 
may not be possible to assess the impacts of many nanomaterials. Such 
uncertainties relate both to the potential for adverse effects and to the level at 
which these effects might occur,
In summary, the lack of knowledge on the effects of nanomaterials is likely to 
lead to a gap in the setting of appropriate concentration and emission levels.
(c) Extent of legislation to regulate specific types of risk
Example: 
Landfill (England & Wales) Regulations 2002; Hazardous Waste (England 
& Wales) Regulations 2005; & List of Wastes (England) Regulations 2005
Current waste legislation is extensive in terms of the types of waste covered 
dictating waste management options for certain prescribed waste types.  
However, one major gap in relation to reducing damage, both to human health 
and the environment from leaching within landfill to water sources and 
emissions to air, is the control of domestic waste that might contain 
nanomaterials.  Domestic hazardous waste is exempt from the more stringent 
                                                
14 Once a waste has been identified as possessing dangerous substances it must then be 
assessed as to whether it is an ‘Absolute’ waste that is will be hazardous no matter the 
concentration of hazardous properties or a ‘Mirror’ waste which will only be hazardous if it 
contains dangerous substances in concentrations at or above the appropriate threshold or a 
test shows a hazardous property.  The thresholds applied are H1 to H14 located in the 
Schedule 3 of Hazardous Waste Regulations.
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waste management options required for commercial and industrial hazardous 
waste.  For example, hazardous waste can only be disposed of to those 
landfill sites identified as hazardous.  Only separately collected domestic 
hazardous waste is included in this provision.  As such, a potential gap in the 
regulation of nanomaterials is the disposal of such materials to non-hazardous 
waste landfill, which remains the standard waste disposal route for UK 
domestic waste.  With the existing lack of knowledge about the impacts of 
substances at the nanoscale, the danger that nanoparticles could move 
through a landfill and potentially enter any water supply is an obvious concern.
6.2.3 Health and Safety 
The EU has standardised regulations relating to the control of the health and 
safety hazards of industrial chemicals and their risks in the workplace.  In the 
UK this harmonised process has been adopted under the umbrella of the 
Health and Safety at Work Act 1974.  To ensure chemicals are regulated 
appropriately, the regulations are aimed at suppliers, users of chemicals and 
the regulatory authority15 itself.  The controls upon the introduction and 
notification of chemicals coming onto the market will dictate how 
nanomaterials are regulated later in the lifecycle chain and will prove 
influential in determining whether nanomaterials will fall within numerous other 
consumer and environmental protection regulations.
(a) Legislation dealing the identification and notification of new 
substances
Example: 
Regulation 4 of the Notification of New Substances Regulations 1993 
(NONS) – “Subject to regulations 6 and 7, a person shall not place a new 
substance on the market in a total quantity of one tonne or more per year 
unless he has sent to the competent authority a notification including…”
Decisions made under NONS will determine the regulatory control of many 
nanomaterials as they move through their lifecycle.  Under this system, the 
supplier is responsible for determining whether the nanosubstance is an 
existing or a new substance.  A potential gap is likely to result from this 
process as it is unlikely that all suppliers will possess the necessary data to 
make an informed decision relating to whether the presence of  nanoparticles 
suggests a new substance or an existing one.  A substance will be classed as 
‘existing’ if it is included in the European Inventory of Existing Commercial 
Chemical Substances.16 As only changes in chemical structure comprise a 
new substance and not a change in form (size and shape), it is likely that 
nanomaterials may be classed as existing and that, as such, no further tests 
need to be conducted in relation to the potential risks of that substance.  
Consequently, there would be no requirement to provide additional 
information to subsequent users and the substance would pass through its 
                                                
15 Health and Safety Executive
16 The Health and Safety Executive considered this issue in their report (HSE 2006), 
concluding that it was novel materials made from the ‘bottom-up’ that would require 
notification for example carbon fullerenes and their derivatives.
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lifecycle without additional scrutiny. There would be no labelling for supply and 
no information to introduce, where necessary, measures to reduce potential 
risks during use and disposal.  
It is worth noting that the Royal Society has recently produced a policy 
document stating that substances in the nanoform that are not on the 
European Inventory of Existing Commercial Chemical Substances shall be 
regarded as new substances17. This of course is not a legally binding 
mandate. 
(b) Legislation dealing with concentration levels
Example: 
Regulation 4 of the Notification of New Substances Regulations 1993 
(NONS) (as above)
Even where a nanomaterial is identified as a new substance, notification is 
dependent on concentration thresholds being met.  A two-tier test is applied. 
The first test, as laid down in Regulation 4, states that full notification is 
required when a new substance is placed on the market in a total quantity of 
one tonne or more per year.  The second test, contained in Regulation 5, 
requires further testing of the substance where certain tonnage levels are met. 
The result of the second test is that the greater the quantity of a substance in 
production, the greater the data requirements on its properties imposed by the 
regulators.  Much will therefore depend upon the precise quantities of new 
substances in circulation. As such this is taking no account of the need for and 
extent of testing chemicals by reference to particle size.  The production of an 
existing substance in nanoparticulate form does not of itself trigger any 
additional testing. Regulation is governed at lest in part by the bulk of the 
material in which the nanoparticles are incorporated. 
(c) Legislation dealing with marketing of dangerous substances 
Example: 
Regulation 4(1) of the Chemicals (Hazards Identification for Packaging) 
Regulations 2002 (CHIP): “No person shall supply a dangerous substance or 
a dangerous preparation unless it has been classified in accordance with 
paragraphs (2) to (7)…” This requires suppliers to identify, and where 
appropriate, categorise the hazards of the substances supplied. 
Linked closely to the identification of new substances under NONS, the CHIP 
Regulations rely on capturing dangerous substances because they are listed 
in the Approved Supply List18 or constitute a new substance under NONS.  
                                                
17 Royal Society RS Policy Document 35/06, Nanoscience and nanotechnologies: 
opportunities and uncertainties; Two year review of progress on Government actions: Joint 
academies’ response to the Council for Science and Technology’s call for evidence, 2006
18 "Information Approved for the Classification and Labelling of Dangerous Substances and 
Dangerous Preparations (Eighth Edition)" approved by the Health and Safety Commission on 
26 July 2005
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Currently, no ‘existing’ substances19 at the nanoscale have been through this 
system.  Consequently, the classification will be at the discretion of the 
supplier and this self-classification could lead to potential gaps.  If classed as 
a new substance a safety data sheet will be required for hazardous 
nanomaterials.  A general issue is the lack of sufficient information and 
knowledge available on toxicological hazards and appropriate exposure limits. 
It will therefore be difficult to provide the relevant data and undertake the 
necessary risk assessments.
Any substance classed as hazardous will require a supplier to provide 
information relating to the hazards of the substance supplied.  If not classed 
as hazardous, no new data would be generated on the risks or hazards 
relating to the identified nanomaterial. If this were to happen, nanomaterials 
could move through their lifecycle without any further assessment of their 
properties.
(d) Legislation dealing with workplace risk management 
Example: 
Regulations 3, 4 and 6 of the Control of Substances Hazardous to Health 
Regulations 2002 creates duties under the Regulations, prohibiting certain 
substances, and demands assessments of the risk to health from by work 
involving substances hazardous to health.
Regulations require employers to either prevent, or, in instances where this is 
not practical, to control potential risks from exposure to hazardous chemicals. 
The regulations provide a valuable system for assessing and managing any 
potential risks that may arise. However, there are potential gaps in relation to 
the management of risks arising from the use of nanomaterials.  A potential 
gap arises as employers rely on the data sheets prepared by suppliers of 
chemicals under CHIP. If the substance is not classed under CHIP, no safety 
data sheet will be prepared and consequently employers will not, as a rule, 
undertake any risk assessment of the substance in the work place or, in turn, 
introduce any risk management procedures.  Any risk assessments rely upon 
available information on the hazards together with knowledge of the local 
conditions of exposure.  Risk assessments are therefore based on both sound 
scientific information and past experience. In terms of nanomaterials this 
information is likely to be incomplete and there are likely to be deficiencies in 
the level of available information.
6.3 Lifecycle Analysis
Nanomaterials are developed and commercially manufactured, formulated 
into products to be used by industry and/or consumers, before recovery or 
final disposal.  To assess the full extent of any potential gaps in the regulatory 
framework, it is necessary to analyse the relevant regulations from this 
                                                
19 An "existing substance" is defined as one that is listed in the European Inventory of Existing 
Commercial Chemical Substances (EINECS) and was placed on the market before 
September 1981
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lifecycle perspective.  A Lifecycle Map (see Annex 3) provides the basis of the 
relevant lifecycle phases of any nanomaterial. 
Later in this section there is a Lifecycle Table (Table 3B) below, which draws 
on the regulatory gap assessment conducted in Annex 6.20 The Lifecycle 
Table represents the assessment of eight distinct lifecycle stages:
 Research & Development; 
 Production of Nanomaterial;
 Supply of nanomaterials/chemicals;
 Use of nanomaterials as a raw material or within other 
chemicals/substances in the production of goods;
 Wholesale and retail of products;
 Commercial and industrial use of products;
 Consumer use of products; and
 End disposal
These stages are assessed against the five criteria applied in the Regulatory 
Gaps Table (Scope; Risk Characterisation; Risk Assessment; Risk 
Management and Information Base) as found in the relevant groups of 
regulations that are analysed in the Report. In this way it is hoped to identify 
the potential gaps arising at each phase of the lifecycle. In Lifecycle Table 
these groups are identified by an individual coloured symbol.  Each group of 
regulations was qualified by a potential gap (see Table 3A for details).  
6.3.1. The Lifecycle Table
The Lifecycle Table indicates that at each lifecycle phase potential gaps may 
arise in the relevant regulations, for example at the research and development
phase four potential gaps are identified: 
(a) Introduction/Notification Regulations 
Unless the nanoscale form is considered to constitute a change in the 
chemical structure, a potential gap arises, as nanomaterials are likely to be 
classed as ‘existing’ substances21 rather than as new substances.  If classed 
as ‘existing’ the availability of future information for subsequent users of the 
nanomaterial including its physicochemical, toxicological and ecotoxicological 
properties may not be formulated.  The nanomaterial could therefore, pass 
through the various stages of the lifecycle without additional scrutiny of its 
unique properties. As a consequence, there would be no labelling for supply 
and no information to introduce, where necessary, measures to reduce 
potential risks during use and disposal.  New testing strategies may need to 
be identified to assess the unique qualities of nanomaterials and their 
potential impacts in different scenarios.  If classed as a ‘new’ substance some 
potential to fall below any relevant threshold or concentration levels may 
                                                
20 Which in turn is summarised in the Gap Table (Annex 4B)
21 An "existing substance" is defined as one that is listed in the European Inventory of Existing 
Commercial Chemical Substances (EINECS) and was placed on the market before 
September 1981.
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remain.  Potential gaps arise due to a lack of available scientific data on 
hazardous components and a lack of information on impacts and effects of 
nanomaterials on human health and the environment.
(b) Health & Safety 
If identified as non-hazardous, subsequent users would be dependent on 
existing data as no new data would be generated on the potential risks 
relating to the identified nanomaterial. Consequently, nanomaterials could 
move through their lifecycle without any further consideration of the risk 
potentials to human health.  Again there is a lack of available scientific data on 
hazardous components and a lack of information on impacts and effects of 
nanomaterials on human health and the environment.
(c) Environmental Protection
 Relevant environmental control regulations such as the Pollution Prevention 
and Control Regulations do not cover emissions resulting from the R&D 
process. As a consequence there is no regulation of emissions at this stage in 
the lifecycle.  In terms of discharges to water, the identified nanomaterial may 
not be classed as on of the prescribed substances and even if it is, it may fall 
below any discharge thresholds identified in the regulations.  Potential gaps 
also may arise due to the general lack of information on impacts and effects of 
nanomaterials on human health and the environment.
(d) Waste
 Any waste generated as a result of the activity may be difficult to classify 
under the appropriate regulations, although R&D waste cannot be sent to 
landfill.  The relevant waste disposal route will be determined based on 
whether the waste is coded as hazardous or non-hazardous and a further gap 
may arise where appropriate hazardous thresholds are required to be met.
Consequently at each phase of the lifecycle different parties will be required to 
meet different regulatory obligations to reduce risk to human and/or the 
environment. For example at the R&D phase, companies must comply with 
appropriate waste legislation in terms of a duty of care to ensure waste is 
disposed by a licensed waste carrier and that R&D waste is not disposed to 
landfill.   This duty of care applies to all following phases (Production, Supply, 
Manufacture, Wholesale, Consumer and Domestic use) and ensures that 
hazardous waste is disposed to a hazardous waste facility. Waste licensing 
seeks too ensure that appropriate conditions are placed upon the handling 
and disposal of all wastes, but as indicated above, nanomaterials in the 
domestic waste chain may be difficult to regulate.
A regulatory framework should ensure that any substance that may cause 
harm to human health and/or the environment is effectively regulated at 
whatever phase in the lifecycle.  Whilst some regulations (such as NONS) 
may address both health and safety and environmental risk, others address 
only one specific issue for example the human health impacts of a particular 
consumer product. Whilst a product may be classed as safe in terms of 
human health, it may have a negative environmental impact particularly in 
terms of cumulative effects perhaps arising from disposal to non-hazardous 
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landfill sites and subsequent risk of leaching.   In fact, the same product may 
be regulated differently depending on the user, for example industry will be 
subject to stricter controls relating to the disposal of any product containing 
dangerous substances than a consumer disposing the same product in the 
domestic waste stream Consequently, a potential gap may exist as consumer 
products containing nanomaterials might be disposed to landfill, with negative 
environmental impacts.  
In summary, some of the potential gaps that may arise from a lifecycle 
perspective are:
1. If a nanomaterial is introduced as an ‘existing substance’ and not subject to 
notification under NONS or under any other relevant regulation, there is the 
possibility that it will not be subject to any additional assessment of its unique 
properties with possible impacts of these properties on human health and/or 
the environmental throughout its lifecycle.
2. Whilst many products may be deemed safe under consumer protection 
regulations, environmental issues may not be addressed, particularly in light 
of the prescriptive and often restrictive extent of environmental regulations.
3. Whilst it may appear that there are a substantial number of potential gaps in 
Table 3, many of the gaps arise due to a lack of existing data on the potential 
effects of nanomaterials on human health and the environment. The table 
identifies this and it reflects the impact of this paucity of information in relation 
to risk assessment and risk management.
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Table 3A: Explanatory Note for Table 3B
Symbols
Introduction/Notification of Nanmomaterials
Health & Safety
Producer Responsibility - Product Quality & Safety
Consumer Protection
Environmental Control
Waste
Gap Identification
1 – Gap if classed as existing substance and equivalent of macro scale substance 
– may result in insufficient assessment of unique properties of nanomaterial
2 – Gap if classed as new substance and therefore not a prescribed substance 
under the regulations
3 – Gap if falls below concentration threshold levels and therefore no longer 
within remit of regulation
4 – Gap if classed as non-hazardous substance
5 – Gap if falls below emission/discharge levels
6 – Gap if lack of appropriate technical standards
7 – Gap if lack of information on scientific data on hazardous components
8 – Gap if lack of information on impacts and effects of nanomaterials on human 
health and the environment
9 – Gap if hazardous waste from domestic use
10. – Gap if falls out with general scope of regulations (e.g. under Food 
Regulations not classed as ‘novel’)
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Table 3B: Lifecycle Gap Table
Lifecycle Scope Risk 
Characterisation
Risk Assessment Risk Management Information Base
Research & 
Development
       
       1                              1, 
2
       1                               2, 
4  
       3                             1, 2, 
5
        3                               3
       
        1, 7                             4, 8
        1, 6, 7                           4, 8
        
        1, 8                             4, 6, 
7, 8
      
       8                                   4, 7, 
8
     
        7, 8                          4, 7, 8
        
       7, 8                           
Production -
Nanomaterials
     
       1                            1, 2
       1, 4                         2, 
4
       3                             1, 2, 
5
         
           3                           3
        
        1, 8                             4, 8
            6, 7, 8                         4, 
8
      
       1, 6, 7, 8                     4, 6, 
7, 8
    
       6, 7, 8                           4, 7, 
8 
      
        7, 8                            
       7, 8                                4, 7, 8
Supply
      1                       4
            
       1, 4                          4          
       8                              1, 2, 
5 
       3, 4, 8            
                                       3
    
       1                                  4
       1                                  4, 8
       
       1, 6, 7, 8         8            4, 7 
8
        6, 7                             4, 7, 
8
     7                               4, 7, 8
       
       8                               4, 7, 8
Manufacture 
Use in  
Products
       1, 10         1, 2        1, 
2
     1                            2, 
4
                     
       3                              1, 2, 
5
                                       
       4, 8            3           3   
        8, 10                           4, 8
       4, 8                              4, 8
   
       3, 8                              4, 6, 
7, 8
        6, 7                8           4, 7, 
8
       4, 7, 8                      4, 7, 8
        8                             8
Wholesale & 
Retail        1, 10                       1, 
2
       1, 4                          4
        8                              3
       4, 8                          3 
       6, 7, 8                          4, 8
      
     4, 8                   4, 8
       6, 7, 8                          8
       6, 7                              4, 7, 
8
       8                              4, 7, 8
                   
        8                             4, 7, 8
Commercial &
Industrial Use
               1
       1                             4
       8                             3 
       4, 8
                                       3
                                           4, 8
       7, 8
       
        4, 8                              4, 8
       
                                           8
        
        6, 7                             4, 7, 
8
                                       4, 7, 8
     
     8                              4, 7, 8
Consumer 
Use
     1                                
4, 9
       8
       7, 8
                                       8, 9
       8
     7, 8
       8                                   8, 9
     7, 8                    4, 7, 
8, 9
       8
                               
        8                             8
        7, 8
                                       8, 9
Disposal
       1,2, 4,                      1, 
2
       1                              2, 
4
        3                               1,5
       4, 8                          3, 5
       4, 8                          4, 8
        4, 8                         4, 6, 7, 
8
      8                                 4, 6, 
7, 8
     6, 7                             4, 6, 
7, 8
       4, 7, 8                     4, 7, 8
     8                             6, 7, 8
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7.0 REGULATORY DEVELOPMENTS AND SUPPORTING MECHANISMS –   
           HORIZON SCANNING
7.1 Standards and Definitions
The uncertain impact of nanotechnology generates questions about the extent to which 
new products and processes using nanoparticles fall within the scope of existing 
regulatory provisions.  As illustrated above, the coverage under existing regulations is 
inevitably patchy since the measures were not designed with nanotechnology in mind. 
The extent to which the current regulatory framework can be adapted to include 
nanomaterials depends to a great extent on the setting of safety thresholds using 
conceptual models of risk assessment.  A critical aspect of the regulation of 
nanotechnology is establishing the positioning of benchmarks.  Standard setting 
organisations, such as the British Standards Institute (BSI), the International Standards 
Organization (ISO),22 and the European Committee for Standardization (CEN)23 are at the 
forefront of resolving issues of definition and taxonomy in relation to nanoparticles (BSI, 
2005). This work is vital. It will enhance the prospects of a uniform global response to the 
marketing and circulation of nanomaterials. Also, at a domestic or EU level, it will form the 
basis of working within existing regulatory frameworks by overcoming terminological 
difficulties and resolving uncertainties as to appropriate standards.
7.2 Voluntary Reporting Initiatives
Achieving a standardised approach to nanotechnology has been supplemented by the 
emergence of voluntary reporting initiatives. In September 2006, Defra launched a 
Voluntary Reporting Scheme (Defra, 2006a) designed to run for a period of two years.  Its 
primary objective, alongside a dedicated programme of Government research, is to 
gather evidence relevant to understanding the potential risks posed by engineered 
nanoscale materials.  The US Environmental Protection Agency has entered into 
discussion with the National Pollution Prevention and Toxics Advisory Committee 
(NPPTAC) about the development of a voluntary reporting pilot program for 
nanotechnology companies and researchers (NNI, 2006).  
7.3 Good Practice
The development of good practice standards is already beginning to gain momentum in 
the international sphere. Several good practice frameworks exist aiming to promote 
consistent approaches to the risk analysis of nanoparticles. (Shatkin and Barry, 2006:553-
556; Environmental Defense and Du Pont, 2005; Jacobstein, 2006)   For example, the 
European Commission funded ‘Nanosafe I’ project has developed a framework for 
assessing risks to workers, consumers and the environment posed by nanoparticle 
production (VDI, 2004).  The second phase of the Nanosafe project (‘Nanosafe II’) is 
currently underway, aiming to build upon findings in the phase one project and deliver 
                                                
22 ISO Technical Committee (TC) 229.  TC229 is divided into three separating Working Groups (WG), each 
responsible for establishing a standardised approach to the following aspects of nanotechnology: 
terminology and nomenclature (WG1); measurement and characterisation (WG2); and health, safety and 
environment (WG3).
23 In March 2004, the CEN Technical Board established the Nanotechnology Working Group (CEN/BTWG 
166) to assess the need for the standardisation of activities involving the manufacture of nanoparticles.
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clear assessment and management recommendations for the safe production of 
nanomaterials.24
7.3.1 An Example: Globally Harmonised System of Classification and Labelling of 
Chemicals
Despite the prevalence of chemical products, there is little international harmonisation or 
common standards.  As a result of jurisdictional variations in the definition of ‘hazard’, a 
chemical may be considered flammable in one country, but not another.
Recognising the value of the extensive global trade in chemicals, a global system of 
harmonising the approach to classifying and labelling chemicals has been identified as 
necessary.  The system is anticipated to include the following elements:
(a) harmonized criteria for classifying substances and mixtures according to their 
health, environmental and physical hazards; and
(b) harmonized hazard communication elements, including requirements for 
labelling and safety data sheets25. 
GHS is currently under negotiation in the EU, and its introduction and implementation at 
the European level will result in it replacing CHIP.  The aim of GHS is to introduce a 
worldwide system for hazard communication; it will therefore be a vital development for 
the control of nanomaterials.  Central to GHS is the development of a common and 
coherent approach to defining and classifying hazards, and communicating information on 
labels and safety data sheets GHS will consequently provide the underlying infrastructure 
for establishing national, comprehensive chemical safety programmes.  GHS is proposed 
to cover all types of chemicals and will be based on intrinsic properties (hazards) of 
chemicals and includes dilute solutions and mixtures.  Pharmaceutical products, food 
additives, cosmetics and pesticide residues in foods will not be covered at the point of 
intentional intake but will be covered where workers may be exposed and this also 
extends to transportation.  
A potential gap arises as the test of hazards looks to known ingredient information and 
due to the lack of available data on nano-ingredients the test may be incomplete.  An 
important element of GHS is a requirement to include precautionary information in order 
to harmonise precautionary statements.
8.0 RESPONDING TO REGULATION – PRIORITIES
8.1 Evidence Base
Throughout this report, the Regulatory Gap Table, the Lifecycle Gap Table and the 
individual regulatory assessments, the lack of available information has been identified. 
Such is the significance of this gap that it permeates throughout the regulatory framework 
and to the different stages in the lifecycle of any nanomaterial.  Summarised below is a 
list of some of the main information gaps.
                                                
24 See Nanosafe II website: http://www.nanosafe.org/
25 United Nations Economic Commission for Europe, Globally Harmonised System of Classification and 
Labelling of Chemicals, First Revised Edition, 2005 [Font]
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 Effects of nanomaterials – current paucity of information on the potential effects of 
nanomaterials on either human health or the environment may mean that insufficient 
control procedures can be implemented.
 Comparison with equivalent macro scale substances - this may aggravate the existing 
information problems as there are currently no requirements for new tests and 
subsequent analysis of results to be undertaken.
 Indications of danger – the lack of sufficient information and knowledge available on 
toxicological hazards and appropriate exposure limits makes it difficult to provide the 
relevant data required in Safety Data Sheets and undertake the necessary risk 
assessments.
 Lifecycle approach – extended producer responsibility regulations require that a lifecycle 
approach be applied to the design of equipment.  By so doing it is hoped to reduce the 
impacts of the product on human health and the environment by ensuring any 
hazardous components are so identified, limited, or easily separated from the product 
for final disposal.  Gaps in the evidence base therefore may replicate throughout the 
substance’s lifecycle.
8.2 Standards
From both the Regulatory Gap Table and the Lifecycle Gap Table it is apparent that with 
general standards applicable to definition and scope, nanomaterials would be captured 
under the regulatory framework. However at present, aided by insufficient evidence, there 
are difficulties in the following areas:
 Existing and new substances – appropriate guidance for those responsible for 
notification is required on novel applications of nanomaterials to ensure that these 
substances are classed accurately and consistently. 
 Hazard identification – currently under various regulations suppliers are required to 
determine whether or not nanomaterials will be hazardous. Due to possible shortfalls in 
the evidence base, at present there is a risk that they may be incorrectly categorised or 
that parties will make contradictory determinations. On the other hand the existing 
regulatory framework could be utilised in the immediate future as hazard indicators are 
developed for free, engineered nanomaterials (accepting that not all will necessarily be 
hazardous). This will be aided in the future by the standardised hazard identifications 
being proposed under the Globally Harmonised System of Classification and Labelling.
 Listed substances: EU Directives contain prescribed substances to limit the impact on 
the environment, but such lists are not always uniform and this makes uniformity difficult 
in the UK also. While this is not a problem confined to nanomaterials, the potential 
prescription of such materials may exacerbate this problem.
8.3 Regulating in the face of uncertainty
The finding that knowledge of the characteristics of nanoparticles and their potential risk 
implications is incomplete highlights the importance of regulatory decision-making in this
context.  The precautionary principle is an accepted means of informing the regulation of 
scientifically uncertain threats.  Development of nanotechnologies is continuing alongside 
further research as to the nature and extent of feasible new risks. The Royal Society and 
Royal Academy of Engineering argue that  “many applications of nanotechnology pose no 
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new health or safety risks” while acknowledging areas where more research should be 
conducted.
Risk assessment processes necessarily involve elements of uncertainty, but in some 
cases the paucity of current scientific knowledge about the properties of nanomaterials, 
and their likely impact on human health and the environment, will preclude clear hazard 
characterisation and assessment.  In the light of a lack of dose-response and exposure 
data, together with questions surrounding the appropriateness of safety thresholds and 
existing risk assessment methods there is a need for a regulatory response to ensure that 
potential risks are assessed in the light of available scientific information.  Where a 
credible threat has been identified whose scope and impact are scientifically uncertain, 
the existing regulatory framework should be employed to ensure that scrutiny takes place, 
decision-making is transparent and proportionate, is undertaken on a case-by-case basis, 
and is subject to review as new information becomes available.
9.0 CONCLUSION AND RECOMMENDATIONS 
The process of identifying relevant legislation and assessing its capacity to encompass 
hazards associated with nanomaterials has posed a number of challenges – not least 
because the list of potential uses nanotechnology is almost limitless. Nonetheless if 
nanotechnology is to continue to benefit a wide range of industry sectors these problems 
must be recognised and resolved.  
The principal finding in this report is that potential regulatory gaps arise as a direct result 
of incomplete information about the implications of human and environmental exposure to 
nanoparticles, rather than any major regulatory oversight.  It was unlikely from the outset 
of this study that each of the regulatory provisions identified would be sufficiently robust to 
capture all potential risks associated with use of nanoparticles.  This general lack of 
information about the potential impacts of nanotechnologies can lead to uncertainties 
relating to the setting of appropriate exposure levels, and raises fundamental questions 
about fulfilling the manner in which obligations arising under regulations might be 
translated in practice.  
Questions of definition and threshold levels underpin this report.  Regulatory queries have 
been raised in respect of each of the three main areas of protection – consumer 
protection, environmental protection, and health and safety.  As a result of incomplete 
information about the potential human and environmental implications of free, engineered 
nanomaterials, the ability of regulatory measures providing general exemptions or 
prescribing specific substance thresholds to capture potential risks associated with 
nanotechnologies is unclear.  Prescriptive regulations are necessarily restrictive in nature.  
For example, whilst the pollution prevention regulations lay down a framework for 
reducing environmental harm, their remit is limited to prescribed processes and 
substances and, even if a process falls within the list of activities it will only be regulated 
under the system if it meets the production threshold levels. Consequently, the activities 
of many companies may fall outside the scope of these regulations whether or not they 
involve the use of nanotechnologies.  Similarly, in relation to producer responsibility 
regulations, the Producer Responsibility Obligations (Packaging Waste) Regulations refer 
to prescribed substances, and only apply to companies with a turnover of £2,000,000 and 
which handle in aggregate more than 50 tonnes of packaging or packaging materials per 
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year.  Thresholds of this nature inevitably limit the capacity to supervise the development, 
circulation and use of free, engineered nanoparticles.
Where regulation chooses as its primary method the prescription of certain listed 
substances so that their handling, use or disposal might be controlled, little attention is 
likely to be given to substances that have been developed through nanotechnology that 
are not easily categorised alongside listed substances. Such new substances potentially 
fall out of regulation because they are not included within the schedule of controlled 
substances. 
Where it is possible that potential risks posed by nanotechnologies are not captured by 
specific definitions and thresholds set out in regulatory provisions, overarching regulations 
exist setting out general safety requirements (see, for example, General Product Safety 
Regulations 2005; Regulation (EC) No.178/2002 on General Principles of Food Law).  
Despite the fact that human health safeguards are established under broad regimes of 
safety, the potential impact of nanoparticles after consumer use must be borne in mind.  A 
consideration of the implications of nanomaterials throughout their lifecycle is critical to 
the undertaking of thorough risk assessment processes.  Even where risk assessment 
procedures established under existing regulatory frameworks appear robust, their ability 
to accurately characterise and assess potential risks associated with nanotechnologies is 
limited by fundamental uncertainties about the impact of exposure to free, engineered 
nanomaterials.  
This paper was commissioned as and consequently presents a gap analysis. More 
thought and considerably more work needs to be given to the next logical task of devising 
regulatory structures that can successfully bridge such gaps. This is perhaps a more 
challenging task given the pressures of assuaging legitimate public concern while taking 
care also not to stifle innovation. In the meantime it seems apparent that some transitional 
solutions would assist. In the light of the paucity of information in this area, further 
research into the nature of free, engineered nanomaterials and the implications of human 
and environmental exposure must be promoted. Meanwhile, risk governance processes 
in characterising, assessing, managing and communicating levels of risk should be 
conducted within the framework of existing regulation as appropriate. 
In light of the general lack of information relating to their associated risks, it is would seem 
prudent that an examination of the specific properties of free, engineered nanomaterials 
and an assessment of their associated risks be conducted prior to being placed on the 
market irrespective of whether those materials are deemed to be ‘new’ or ‘existing’ 
substances. Similarly free, engineered nanomaterials might be classed as ‘hazardous’ 
substances unless or until there is sufficient evidence of their safety in particular a 
context.  Finally attention needs to be given to regulations that work by reference to 
thresholds to try and ensure that appropriate safety assessments are triggered outside of 
the threshold levels where free, engineered nanomaterials might prove problematic.
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Annex 1 
Literature Review on Nanotechnology Regulation
A. Introduction
The word ‘nanos’ is etymologically Greek, denoting ‘dwarf’. (Einsiedel and Goldenberg, 
2006: 213) ‘Nano’ is a derivative of ‘nanos’, and is used by scientists to denote one 
billionth. (Kulinowski, 2006: 14) Described as the technology of the ‘vanishingly small’, 
‘nanotechnology’ has dozens of varied and contested definitions. (UNESCO, 2006: 4; 
Kulinowski, 2006: 14). UNESCO employs the term ‘nanotechnology’ to denote both basic 
and applied scientific research; and defines it as the “research conducted at the 
nanoscale…or one billionth of a metre.” (UNESCO, 2006: 5)
     The UK Royal Society and Royal Academy of Engineering distinguish between 
‘nanoscience’ and ‘nanotechnology’, describing the former as the ‘study and manipulation’ 
of nanoscale particles, and the latter as the ‘design, characterization and production’ of 
‘structures, devices and systems’ at the nanoscale. (RS/RAEng, 2004).  
     The US National Nanotechnology Initiative defines nanotechnology as “…research 
and technology development at the atomic, molecular, or macromolecular levels, in length 
scale of approximately 1 to 100 nm range, to provide a fundamental understanding of 
phenomena and materials at the nanoscale and to create and use structures, devices, 
and systems that have novel properties and functions because of their small and/or 
intermediate size.” (The US National Nanotechnology Initiative, 2006)
     In essence, nanotechnology is about invisible miniscule particles that straddle the 
worlds of physics, biochemistry, physical chemistry, and microscopy. The particles are 
otherwise known as nanomaterials, and possess unique properties and behaviour not 
exhibited in traditional materials. (Theodore and Kunz, 2005:1-2)  
     Essentially, nanotechnology covers the techniques of building things from the bottom 
up, atom by atom, and molecule by molecule. This is generally contrasted with the 
traditional industry standard of building things from the top, with large chunks of traditional 
raw materials manoeuvred in place to construct specific products such as integrated 
circuits or an ocean liner. (Drexler, 1990:163-67) The distinction may not be so clear as 
the top down production of nanomaterials is by no means unknown. (RS/RA Eng Report, 
2004:6)
     Although he did not use the term ‘nanotechnology’, (UNESCO, 2006:7) he 
contemporary concept of nanotechnology is widely attributed to the Nobel Prize winning 
theoretical physicist, Richard Feynman, who in a famous 1959 paper: ‘There is Plenty of 
Room at the Bottom’, (Feynman, 1960: 22-35) envisioned the development of 
nanomachines capable of building other nanomachines and other products with atom by 
atom control. (Drexler, 2006:26) Feynman’s hypothesis is as follows:
The principles of physics, as far as I can see, do not speak 
against the possibility of manoeuvring things atom by atom …[I]t 
would be in principle, possible…for a physicist to synthesize any 
chemical substance that the chemist writes down…How? Put the 
atoms down where the chemist says, and so you make the 
substance. The problems of chemistry and biology can be greatly 
helped if our ability to see what we are doing, and to do things on 
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an atomic level is ultimately developed – a development which                      
I think cannot be avoided. (Feynman, 1960:33-34)
     Feynman’s hypothesis found an inveterate believer in Eric Drexler, a nanotechnology 
enthusiast, who in a 1986 book: Engines of Creation: The Coming Era of 
Nanotechnology, posits that nanotechnology has an inherent capability to manufacture 
anything simply by piling waste materials into a box of nanoscale assemblers that would 
reconfigure the materials into desired forms. UNESCO, 2006:7) In Drexler’s words, “…we 
are moving towards assemblers, toward an era of molecular manufacturing giving 
thorough and inexpensive control of the structure of matter.” (Drexler, 1990:240-42)
     However, the prospects of molecular manufacturing and minuscule, foraging, self-
replicating, out-of-control systems, (Rip, 2006:274) transforming the natural planet into “a 
mass of uninhabitable ‘grey goo’”, (UNESCO, 2006:8) have fed apocalyptic fears, (ETC 
Group, 2003; Joy, 2000:238) and inspired popular fiction. (Landon, 2004:131-146) This 
has had the unintended consequences of blurring the boundary between nano-fiction and 
nanotechnology reality. (Rip, 2006:274) It has also raised the fears that policy makers 
could overreact with a neo-Luddite proactive legislative or policy measures that could 
stifle or stop the technology in its tracks. (Rip, 2006:274).
B. Current and Potential Commercial Applications of Nanotechnology
The 21st Century nanotechnology, although at a nascent state, (UK Advisory Group on 
Nanotechnology, 2002:23) now transcends the surreal and the fictional realm as 
evidenced by its commercial applications in fields as diverse as environmental science, 
medicine, electronics, plant protection products and agrochemicals, etc. (Theodore and 
Kunz, 2005:1-2)
     UNESCO’s list of recent commercial nanotechnology products comprises: Cerax 
nanowax for snow skis, Franz Ziener waterproof ski jacket (Nanotex), wrinkle and stain 
resistant nano-care clothing, L’Oreal deep penetrating skin cream, Kodak’s OLED 
(organic light emitting diodes) camera, performance sunglasses, nanofilm anti-reflective 
coating, Z-COTE sunscreen, Babolat nanotube tennis racket, InMat’s nanotech tennis 
balls, Shockjock Aerogel footwarmers, Simmons washable bed mattress, etc… 
(UNESCO, 2006:1-2)
     Nanotechnology is now a multi-billion dollar industry, and its value is expected to spiral 
to US$ 1 trillion by 2015. Currently at 49%, the United States has the largest share of the 
nanotechnology market, followed by the European Union’s 30%, and the rest of the 
world’s 21%. Within the European Union, the United Kingdom is said to account for close 
to one third of the European 30% nanotechnology market share. (Boxall, Aitken, and Hull, 
2005)
     In the UK, approximately 50 companies are manufacturing, processing and/or 
researching and using nanomaterials. Furthermore, there are 55 non-commercial entities 
involved in nanotechnology-related research and developments activities. (Chaudhry, 
Boxall, Aitken, and Hull, 2005)The main nanomaterials currently being produced in the 
UK include nanopowders (metals, metal oxides, alloys), magnetic nanomaterials, carbon 
nanotubes (single, multi-walled), nanoceramics, nano-silica (fumed, colloidal), quantum 
dots (metal and semi-conducting nanocrystals), polymer composites containing 
nanomaterials, and thin films (nm scale). (Chaudhry, Boxall, Aitken, and Hull, 2005)
(a) Nanotechnology in the Medical Field
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Nanotechnology has the potential to enable precision delivery of pharmaceutical products 
and eliminate ‘side effects’ which is the bane of drug delivery. (Langer, 2003:50)
According to Lorraine Sheremeta, special nanoscale materials like “…liposomes, 
polymers, silica and hydroxypatite are being used to encapsulate drugs and protect them 
from biological processes in the body.” (Sheremeta, 2006:249-250)
     Quite unlike their microscale counterparts, these special nanomaterials in which drugs 
are wrapped facilitate better drug delivery through the blood brain barrier, into the central 
nervous system. This efficiency in drug delivery has raised the prospects of improved 
drug delivery to the retina of the eye through the blood-retina barrier, as well as improved 
treatments for Parkinson’s disease, Huntington’s disease, brain tumours, etc. 
(Sheremeta, 2006:249-250) Other nanotechnology applications in the medical field 
include: improved surgical robotic tools, (Leary et al., 2006:822) medical imaging, (Winter 
et al., 2001:54) genetic testing, (Pilarski, et al., 2004:40-45) etc.
(b) Nanotechnology in the Environment
Nanotechnology could provide sufficient clean water for human consumption, agriculture, 
and industrial uses through improved method of water purification. (Bellobono, et al., 
2005:87-94) The application of Nanotechnology to the environment is still in various 
stages of development, and deals mainly with pollution prevention and treatments. 
(Theodore and Kunz, 2005:3-4)
     According to Louis Theodore and Robert G. Kunz, nanotechnology applications to the 
environment include sensing of pollutants, pH, and chemical warfare agents, ultraviolet 
light (UV)-activated catalysts for treatment of environmental contaminants, removal of 
environmental contaminants from various media, including in situ remediation of 
pesticides, polychlorinated biphenyls (PCBs), and chlorinated organic solvents, such as 
trichloroethylene (TCE), post-treatment of contaminated soils, sediments, and soil wastes, 
oil-water separation, destruction of bacteria, including anthrax, purification of drinking 
water without chlorination, etc. (Theodore and Kunz, 2005:3-4)
(c) Nanotechnology in Food Processing and Packaging
Nanoparticles could aid enzymes used in food processing to disperse more quickly 
through food matrices and enhance their activities. Food enzymes are used to alter food 
components to improve flavour, nutritional value, or other desirable characteristics. (Bai, 
et al, 2006:770-777)  
Nanomaterials could also improve the characteristics of food packaging materials. These 
include the strength, barrier properties, antimicrobial properties, and stability to heat and 
cold. For instance, incorporation of nanoparticles of clay into an ethylene-vinyl alcohol 
copolymer and into a poly(lactic acid) biopolymer, considerably increased barrier 
properties to oxygen. The packaging could improve shelf life of food products. (Lagaron, 
et al., 2005:994-998) 
     Other nanotechnology uses in the food industry include cleansing and disinfection, and 
improved biosensors to detect the presence of gases in packaged food. With regards to 
cleansing and disinfection, it has been demonstrated that deposition of silver on 
nanoparticles of titanium dioxide significantly increases its bacteriocidal effects against E. 
coli, (Kim, et al., 2006: 143-146) while titanium dioxide combined with carbon nanotubes 
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significantly enhanced disinfectant properties against Bacillus cereus spores. (Krishna, et 
al., 2005:393-397)
C. Potential Risks and Dangers of Nanotechnology: Toxicology/Safety of 
Nanoparticles and Structures
Nanotechnology discourses are often characterised by potential risks of nanomaterials to 
humans and the environment. (Wolfson, 2003:376-396)  These range from the fantastic to 
the genuine. For instance, Bill Joy fears that the technology could precipitate the rise of 
super-intelligent machines that could dominate humanity and the world. (Joy, 2000:238) 
There are also the fears of self-replicating nanomachines that could transform everything 
in their path into copies of themselves. (Reynolds, 2001:10683)
     The prospect of risks is also a divisive factor, with nanotechnology protagonists and 
antagonists downplaying it and hyping it respectively. Gaskell et al aptly put the conflicting 
views on nanotechnology thus:
With the ability to engineer and control systems at the 
nanometric scale, the enthusiasts predict transformative 
opportunities in areas as diverse as the environment, medical 
practice, electronics and novel materials. For the critics, the quality 
of life will be threatened by out-of-control self-replicating systems, 
miniaturized weapons of mass destruction, invisible surveillance 
techniques and unknown impacts of nanotubes… (Gaskell, et al., 
2005:82)
It has been suggested that in the absence of hard data to the contrary, divisive, 
speculative and fantastic claims about nanotechnology risks will persist, especially in the 
realm of the science fiction. (Lewak, 2004:210) 
(a) Health and Safety Risks
There are however genuine health and safety concerns from human exposure to 
nanomaterials. One potential point of contact with nanoparticles is the human skin. 
Although very little experimental data is available, smaller nanoparticles are said to have 
the ability to penetrate deeply enough to be absorbed by macrophages. With the available 
data, it is impossible to predict with certainty the extent to which nanoparticles could 
penetrate the skin. (Hoet, et al., 2004:12-26)
     Another potential point of nanoparticles’ contact with humans is through the lungs. 
While most dust particles are caught up in the mucus lining the airways during inhalation, 
nanoparticles are said to be small enough to venture deeper into the lungs and the air 
sacs or alveoli. 
     According to inhalation experiments with rodents, while low concentrations of 
nanoparticles could be mopped up from the lungs by macrophages, higher concentrations 
could potentially overwhelm the macrophages and cause inflammation of the lungs. Apart 
from inflammatory reactions in the lungs, inhaled nanoparticles could also adversely 
affect the nervous and cardiovascular systems. (Hoet, et al., 2004:12-26) Very recently, 
there was a nanotechnology-based product scare, when 110 European customers 
reported respiratory symptoms, after using “Magic Nano”, a spray-on ceramic sealant 
designed to repel dirt. (Piller, 2006)  Although this led to recall, the product apparently 
made no use of nanomaterials.
     The gastrointestinal tract is yet another point of contact of nanoparticles with humans. 
Nanoparticles could be absorbed via the intestine and find their way into the circulatory 
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system. It is not clear the extent of the damage that ingested nanoparticles  could cause 
to the intestine. (Hoet, et al., 2004:12-26) 
(b) Ecological and Environmental Risks
Early studies found that some nanoparticles caused inflammation in the lungs of rodents, 
and killed fish and organisms in soil and water, with significant ecological importance. 
(Kuzma, 2006:8) Although there is no conclusive data on the adverse effects of 
nanoparticles on species, the air, the soil, and water, the Royal Society and Royal 
Academy of Engineering in the United Kingdom recommended no use of nanoparticles 
and nanotubes in environmental applications until appropriate research was conducted 
and concluded. In the meantime factories and research laboratories were advised to treat 
these substances as hazardous and seek to reduce or remove them from waste streams. 
(RS/RA Eng. 2004) The UK Government, in its written response of February 2005 to the 
Royal Society’s recommendation, states in paragraph 44 thus:
We are supportive of the precautionary stance taken by the Royal 
Society and Royal Academy of Engineering in their Report. Given 
the uncertainty associated with risks to the environment from 
release of free manufactured nanoparticles and nanotubes, the 
Report asks industry to reduce or remove these from waste 
streams. We support this recommendation and will, with other 
stakeholders (including Local Authorities), work in partnership with 
industry, to help implement it. (HM, 2005:11)
While the UK Government is treading the characteristic European precautionary route 
with regards to the release of nanoparticles into the environment, the Office of Research 
Development at the US Environmental Protection Agency has no immediate plans of 
doing the same. (Kuzma, 2006:8)
     In essence, the full ramifications of the potential risks of nanomaterials to human 
health and the environment are not fully understood yet, and more research would be 
required to do so. A preliminary framework has been drafted on what kinds of research 
are needed, and how the ensuing data could be incorporated into safety decisions. 
(Morgan, 2005:1621-1635)
D. Public Participation and Reception of Nanotechnology
 In order to pre-empt and prevent the public scepticism that characterised the reception of 
genetically modified food, especially in Europe, scientists, stakeholders, and authorities 
are anxious to encourage open public participation and dialogue on the implications of 
nanotechnology for society. (Barnett, et al., 2006:201)  The work of the Royal Society and 
Royal Academy of may be seen as a step at engaging the general public in a participatory 
dialogue. (Barnett, et al., 2006:201)  In fact, the UK Government, in response to the Royal 
Society’s Report, wrote that it was “committed to promoting constructive dialogue on 
nanotechnologies.” (HM, 2005:20) 
     It has been suggested that public concerns over risk and doubts over benefits must be 
honestly and transparently addressed at the early stage of nanotechnology development, 
to obviate public scepticism. (Barnett, et al., 2006:201) It is however a contentious point, 
whether or not the public’s lack of understanding and knowledge of new technologies is 
solely responsible for their scepticism. (Barnett, et al., 2006:201) Although public 
knowledge about risks emanates mostly from the media, (Theodore et al., 2005:292-293) 
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the interface between media risk amplification, and public perception of new technologies 
is said to be very complex and subject to debate. (Murdock, et al., 2004:37)
     In the United Kingdom, little is known at present about public understandings of 
nanotechnology. (Barnett et al., 2006:201) There is however no evidence so far to 
suggest that the public mood in the UK vis-à-vis nanotechnology resonates with the 
sceptical mood towards genetically modified food in the 1990s. (Barnett et al., 2006:202)
     A recent national survey shows that of a nationally representative sample of 1005, only 
29 per cent said they had heard about nanotechnology, and only 19 per cent of the 
sample could offer a definition of nanotechnology. Of those who could offer a definition, 
68 per cent thought nanotechnology would make life better in the future, while 4 per cent 
said it would make life worse. (Barnett et al., 2006:198-199)  However, it is said that the 
Americans have much more positive views of nanotechnology than the Europeans. 
(Gaskell et al., 2005:84)
E. Nanotechnology Regulation
Regulating an emerging technology is said to be tricky since it necessarily involves 
striking a balance between precaution and venture. (Christoph, 2006:38) The 
precautionary principle, as championed by the European Union, requires that where an 
assessment of available scientific information shows reasonable grounds for concerns for 
possible adverse effects, in the face of scientific uncertainties, then priority must be given 
to human health and the environment. (Commission of the European Communities, 2000)
     The UK Government, in its response to the 2004 Royal Society and the Royal 
Academy of Engineering Report on nanotechnology, supported the precautionary stance 
espoused in the Royal Society’s Report. (HM, 2005:52) This however should not translate 
to placing a moratorium on nanotechnology R&D and applications as some groups such 
as the Canadian ETC have demanded. (ETC Group, 2003) The fact that there are 
presently 50 UK companies, and 55 non-commercial UK entities, actively involve in R&D 
and manufacturing of nanotechnology-based products would appear to support the fact 
that the Government for now has no nanotechnology moratorium plans. (Chaudhry et al., 
2005)
     A key issue in nanotechnology regulation is the adequacy of existing laws to grapple 
with issues raised by nanotechnology. In other words, are nanotechnology-specific laws 
imperative or would the existing laws be adequate? Scholars and groups like ETC have 
called for a new nanotechnology-specific regulatory regime, while others have argued that 
new regulations are unnecessary, since risks could be effectively managed by the 
effective utilisation of the existing regulatory regime. (Bennett, 2004:27)
F. Ownership and Intellectual Property Rights in Nanotechnology
Although nanotechnology is still in its infancy, Intellectual property rights already govern 
to the area to some extent prompting analysts to regard such rights as a threat to the 
technology. (Vaidhyanathan, 2006: 225) Between 1997 and 2002, US patents on 
nanotechnology-related products and processes grew from 3623 to 6425. 
(Vaidhyanathan, 2006: 227) A search of patents databases from 1976 onwards revealed 
over 89,000 worldwide patents on nanotechnology related inventions. (Vaidhyanathan, 
2006: 227) There are fears that the rush to patent inventions relating to nanotechnology 
could trigger a patent ‘arms race’, that would lead to generally broad patent claims, 
encourage patent litigation, and stultify future progress and innovations in 
nanotechnology. (Vaidhyanathan, 2006: 232-233)
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G. Liability Issues in Nanotechnology Products and Applications
It has been posited that as the commercial applications of nanotechnology increased, so 
would the relevance of civil liability for defective products, and the release of 
nanoparticles into the environment. (Hannah et al., 2006:237) With regards to 
nanotechnology related civil liability, the relevant area of law in the UK has been identified 
as tortious liability for personal injuries, liability for damage to property, and the ensuing 
direct economic loss, negligence, contractual liability for personal injury, liability for patent 
and copyright infringement, professional liability, and insurance contracts. (Hannah et al., 
2006:237)  The 2004 Royal Society and Royal Academy of Engineering Report advocates 
a strict liability regime for personal injury for the protection of the public. (RS/RA Eng. 
2004)
H. The Ethics of Nanotechnology
Scholars have called for ethical governance of nanotechnology. (Sheremeta et al., 
2006:74-77) One of the main ethical concerns is the use to which nanotechnology would 
be put? Geoffrey Hunt asks whether the technology would be used to fight world poverty, 
promote equality, global justice, peace, a sustainable environment and reduce over 
consumption. (Hunt, 2006:183) Since nanotechnology has great potentials in the medical 
field, Lorraine Sheremeta cautions that research involving human subjects in 
nanotechnology should be done in accordance with human dignity and within the limits of
morally acceptable rules. (Sheremeta, 2006:249-250)
I. Risk and precaution
It has been suggested by some that the precautionary principle should not immediately 
apply to nanotechnologies for two reasons. First, nanotechnology is a generic term for an 
agglomeration of enabling technologies, rather than a definable set of products and 
processes, which can be assessed in terms of adverse effects. (Rip, 2006:270)  Second, 
nanotechnology is mostly promise and sometimes, fantastic speculations. Consequently, 
it is argued that the precautionary principle is ill-suited to what amount in effect to science 
fiction, since ‘what is “reasonable concern” becomes itself a contested issue.’ (Rip, 
2006:270)
There is consensus across the EU (European Commission, Scientific Committee on 
Emerging and Newly Identified Health Risks (SCENIHR) 2006) and UK, (RS/RA Eng. 
2004) however; that a precautionary approach to the regulation of nanotechnologies is 
appropriate, given the extent of uncertainty relating to exposure to free, engineered 
nanoparticles (HSE, 2004; HM Government, 2005; Institute of Medicine, 2005).  The 
extent to which existing regulatory provisions reflect the precautionary principle has been 
subject to debate.  Whilst it is widely accepted that the use of nanotechnologies will 
extend to a range of industrial sectors, knowledge about potential applications and 
implications of nanomaterials is incomplete.  In response to this information deficit, there 
have been calls for a detailed consideration of the manner in which hazards arising from 
applications of nanotechnology are managed. (RS/RA Eng. 2004) A number of regulatory 
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reviews have been conducted (Defra, 2005; Defra, 2006; HSE, 2006; FSA, 2006).26  By 
and large, they conclude that, given the paucity of information about the likely impact of 
nanotechnology, a precautionary approach to risk is of paramount importance (Defra, 
2005; RS/RAEng, 2004).
The precautionary principle, which has come to dominate the regulatory climate in relation 
to new technologies, underlies the UK government’s approach to nanotechnology.  This 
pre-emptive stance is underpinned by the government’s commitment to ‘Better 
Regulation’, and more broadly by the European Community’s focus on a high level of 
public health, safety, environmental and consumer protection. (European Commission, 
Communication from the Commission, COM338, 2004)
Report Key findings in respect of regulation
RS/RAEng (2004) Nanoscience and 
Nanotechnologies: Opportunities 
and Uncertainties.
 Concludes that lack of evidence relating to risks posed 
by manufactured nanoparticles has resulted in 
considerable uncertainty.
 Recommends that relevant regulatory bodies consider 
whether existing regulations adequately protect human 
health and the environment from potential risks posed, 
and address any regulatory gaps arising.
HM Government (2005) Response to 
the RS/ RAEng Report.
 Because of their novel properties, free engineered 
nanoparticles should be treated as new chemicals under 
UK and EU legislation in order to trigger safety tests and 
clear labelling requirements.
 Safety assessment on the basis of the bulk form of a 
chemical cannot be used to infer safety of its 
nanoparticulate counterpart.  Regulations must be 
reviewed to take into account the fact that nanoparticles 
might have greater toxicity than the bulk form of a 
chemical.
 The adequacy of current regulatory frameworks will be 
reviewed to ensure that safeguards to public health are 
sufficiently robust. 
 Free, engineered nanoparticles used as ingredients in 
consumer products should undergo thorough safety 
assessment by the relevant scientific advisory body 
before being placed on the market.
 In order to ensure that products of nanotechnologies are 
properly regulated, sector specific regulations may be 
required in addition to REACH.  This issue is to be 
addressed through regulatory review.
Defra (2006) A Scoping Study to 
Identify Gaps in Environmental 
Regulation for the Products and 
Applications of Nanotechnologies.
 Regulatory gaps identified arise from either exemptions 
provided for by legislative frameworks or from lack of 
information relation to:
o The scope of definitions;
o Current understanding of risks associated 
with exposure to nanomaterials;
                                                
26 Defra, Characterising the Potential Risks Posed by Engineered Nanoparticles: A First UK Government 
Research Report (Department for Environment, Food and Rural Affairs; London; 2005); FSA, Draft Report 
of FSA Regulatory Review: A Review of Potential Implications of Nanotechnologies for Regulations and 
Risk Assessment in Relation to Food (Food Standards Agency; London; 2006); HSE, Review of the 
Adequacy of Current Regulatory Regimes to Secure Effective Regulation of Nanoparticles Created by 
Nanotechnology (Health and Safety Executive; London; 2006).
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o Agreed dose units that can be used in 
assessment of hazard and exposure;
o Methods for risk characterisation and 
measurement; and
o Potential impacts of nanomaterials on 
human health and the environment.
HSE (2006) Review of the Adequacy 
of Current Regulatory Regimes to 
Secure Effective Regulation of 
Nanoparticles Created by 
Nanotechnology.
 The principles of existing regulations are appropriate and 
applicable to nanomaterials.
 There is no need to fundamentally change existing 
regulations, nor to introduce new provisions.
 There are many gaps in knowledge about 
nanomaterials.  These gaps will make it difficult for those 
involved in the regulatory process to fully discharge their 
responsibilities within the relevant regulations.  
 By virtue of this lack of information, regulation in some 
sector areas will require the exercise of judgement.  This 
might lead to different interpretations of the appropriate 
position within certain regulations.
 Regulatory issues must be considered on an EU-wide 
basis.
 Much of the EU legislation identified in the Report is 
subject to change under the envisaged REACH system.  
FSA (2006) Draft Report of FSA 
Regulatory Review.
 Current information suggests that most potential uses of 
nanotechnology in relation to food will be subject to an 
approval process prior to being permitted for use.
 There are no major regulatory gaps in principle.
 There is uncertainty as to whether some applications of 
nanotechnology would be captured by certain existing 
regulations.
 The view of independent committees COT, COC, and 
COM is that existing procedures of risk assessment can 
apply to nanomaterials. 
 There are no major gaps in information for the 
identification of hazards associated with 
nanotechnologies.
 Risk assessment procedures should include 
mechanisms to facilitate provision of information relating 
to nanomaterials.
 Onus should be placed on manufacturers of 
nanomaterials to supply information needed for risk 
assessment.
The uncertainty with which the impact of nanotechnology presents itself raises questions 
about the extent to which new products and processes using nanoparticles fall within the 
scope of existing regulatory provisions.  The absence of a comprehensive understanding 
of the consequences of the manufacture of nanomaterials has led to demands for a 
robust regulatory structure that ensures that threats are anticipated and, where possible, 
avoided.  
The regulatory emphasis in relation to new technologies is on the setting of safety 
thresholds using conceptual models of risk assessment.  A critical aspect of the regulation 
of nanotechnology is establishing the positioning of benchmarks.  Standard setting 
organisations, such as the British Standards Institute (BSI), the International Standards 
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Organization (ISO), European Committee for Standardization (CEN) are at the forefront of 
resolving issues of definition and taxonomy in relation to nanoparticles.
In spite of this drive towards the global standardisation on nanotechnology, the use of 
nanotechnology is not governed by a single regulatory framework.  Rather, a number of 
different legislative provisions apply.  This inevitably renders complicated the analysis of 
the regulation of nanotechnology.  A number of scoping studies identify current legislative 
provisions that could conceivably address risks associated with the application of 
nanotechnology in various sectors of industry. (Chaudhry, et al., 2006) Risks posed to 
human health and those posed to the environment tend to be dealt with 
separately. (Aitken, 2004; Chaudhry, et al., 2006)) As a result, there is a lack of studies 
whose breadth is sufficient to cover risks to both human health and the environment in the 
context of all known current and potential uses of nanotechnology.  This report provides 
an exhaustive examination of regulatory structures across all sectors in which 
nanotechnology is used, or is likely to be used.
Although regulatory gap analyses to date suggest that, on the whole, potential hazards 
emerging from current applications of nanotechnology fall within existing regulatory 
frameworks, (RS/RAEng (2004); (Chaudhry, et al., 2006) little has been said about the
way in which a proper regulatory response might be modelled in the future.  This 
provokes key questions about the optimum balance between the role of industry, 
producer responsibility, stakeholder involvement, and government intervention, and 
whether public health and environmental protection might be better served through an 
integrated regulatory regime (Bennett, 2004).  It is inevitable that the on-going 
development of applications and processes using nanotechnology will place new 
demands on existing regulatory structures.  An important and often overlooked issue is 
determining how regulatory approaches might respond to such a rapidly evolving industry.
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Annex 2 – Questionnaire
A s s e s s m e n t o f G a p s i n t h e R e g u l a t i o n o f
N a n o t e c h n o l o g y & N a n o m a t e r i a l s
Q u e s t i o n n a i r e
The BRASS Centre is conducting a research project for the Office of Science and 
Innovation in the DTI into the actual and/or potential gaps in the regulation of 
nanotechnologies and nanomaterials. As a recognised expert in the sector your 
contribution to this research would be highly valued, and we would be very grateful if you 
could complete this questionnaire.  
Part 1: General Details
Part 2: Application of Nanotechnology
Name:
Organisation:
Position: Sector:
Contact Details:
Current Applications
1. In the attached Table 1 (see below) of applications of nanotechnology, please 
comment if this is an accurate representation of known current product related 
applications?
Yes No
Comments:
2. If No, please provide a list of product applications that are not included.
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Future Applications
1. In your experience what areas of nanotechnology are likely to experience the 
greatest rate of development over the following two time periods?
a. 2 years
b. 5 years
2. In your opinion what are the main risks associated with these identified future 
applications (in terms of public health, environment)?
3. In your opinion which nanotechnology products have the potential to lead to 
the highest risk in application? Please also indicate what are the risks specific to 
those applications?
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Part 3: Information Base
1. Does the current scientific knowledge on the impacts of nanotechnology and 
nanomaterials keep pace with the developments of nanotechnology?
Yes No
2. If No, what in your opinion are the general gaps in the information/scientific 
knowledge base?
3. In your opinion is the practice of ‘read-across’ using data from an existing 
substance as a prediction of the toxicity of a new substance used to determine 
the potential risks of new applications of nanotechnology?
Yes No
4(a) If Yes, what in your opinion, are the potential risks, if any, in the 
continuance of this practice?
4(b) In your opinion does this practice need to be controlled under a regulatory 
framework?
Yes No
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Part 4: Regulation
5. In your opinion, is there a need to develop an interdisciplinary centre to 
research the toxicity, epidemiology, persistence and bioaccumulation of 
nanoparticles and nanotubes and their exposure pathways?
Yes No
Please provide details
1. What, if any, are the current practices used to monitor and collate information 
on any risks associated with the manufacture, supply, formulation and use of 
nanotechnology and nanomaterials?
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2. In your opinion does the current regulatory framework adequately cover the 
regulation of the manufacture, supply, formulation and use of nanomaterials?
Yes No
If No, Please comment:
3. In your opinion what is the most important element (e.g. regulation, guidance, 
information, etc) of any regulatory framework, which will ensure that 
nanomaterials are manufactured, supplied, formulated and used safely?
Please list any necessary appropriate measures:
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4.  Given the lack of scientific certainty is a regulatory approach based on the 
precautionary principle desirable?
Yes No
Please comment – if Yes – the role it should play/how it can be achieved and if 
No – the reason why?
5(a) In your opinion to what extent has it been possible to subject nanomaterials 
to risk assessment processes?
5 (b) To your knowledge, what have been the main findings of any risk 
assessments conducted under 6(a)?
53
5(c) Are current risk assessment processes sufficient to cover the actual or 
potential risks associated with nanomaterials/nanotechnology?
Yes No
If No, please comment
5(d) In your opinion please outline what is the current practice in the 
determination of setting standards in terms of definition and taxonomy?
6. In general, current existing legislation fails to adequately govern 
nanomaterials due to the element of size/scale – in your opinion how can this be 
resolved?
7. Is there need for a moratorium on the commercialisation of 
nanosmaterials/nanotechnologies?
Yes No
Please comment on the reasons for your response:
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8. In your opinion at what point should regulation of nanomaterials commence?
9.  In your opinion what are the potential risk prevention approaches?
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Thank You for Your Assistance With This Research. Please return your completed
questionnaire to:
Frances Hines
Research Manager
BRASS Centre
Cardiff University
55 Park Place
Cardiff
CF 10 3AT
OR
FAX it to 02920 876061
OR
Email it to hinesf@cardiff.ac.uk
ANY QUERIES OR PROBLEMS PLEASE CONTACT
FRANCES HINES BRASS RESEARCH MANAGER on 02920 876562
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Annex 3: NANOTECHNOLOGY LIFECYCLE MAP 
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Storage
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Storage
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Packaging
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Storage Packaging
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Storage
Packaging
CONSUMER 
USE
Packaging
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recovery, recycling, 
incineration and landfill)
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Packaging
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ASSESSMENT OF THE GAPS IN THE REGULATION OF NANOTECHNOLOGY
Annex 4A – Regulatory Gaps Table
Regulatory 
Group
Scope Risk Characterisation Risk Assessment Risk Management Information Base
Summary – Group 1: The regulations considered in Group 1 are essentially linked to the issues considered in Group 2.   The information 
derived from the classification of nanomaterials as new or existing substances may impact on the level of information available to undertake the 
necessary obligations under various regulations required for health and safety reasons, in particular in relation to storage, packaging, 
transportation, labelling and the precautions required for the management of the use of nanomaterials either as a raw material or as a
substance contained within a product.
Group 1 = 
Production 
/Introduction-
nanomaterials 
1. Classification of 
nanomaterials – if it is 
considered that the 
nanoscale form does 
not constitute a change 
in the chemical 
structure, a potential 
gap arises as 
nanomaterials are likely 
to be classed as 
‘existing’ substances27
rather than as new 
substances.  If classed 
as ‘existing’ there may 
be a potential gap 
relating to the 
availability of future 
information for 
1. If classed as a new 
substance, notification 
arises only where 
mass produced and 
mass triggers meet 
prescribed quantities -
Threshold triggers 
used to determine the 
need for and extent of 
testing chemicals do 
not take account of 
particle size, therefore 
the production of a 
substance in 
nanoparticulate form 
does not trigger any 
additional testing. And 
may be subject to 
1. Risk assessment 
procedures under 
NONS are the 
responsibility of the 
competent authority 
and not supplier 
therefore not use 
specific32, which could 
lead to gaps in extent 
of information.
2. Exposure 
assessment 
qualitative due to lack 
of available data.
3. Hazard 
Identification –
notification of new 
substances requires 
1. Monitoring -
COSHH
When a COSHH 
assessment indicates 
the need, monitoring 
of exposure should be 
carried out using a 
valid and suitable 
method.  
Nanoparticles in the 
form of fibres, such as 
carbon nanotubes, 
may need specific 
exposure 
measurement 
methods to be 
developed. Current 
methods of 
1. At present a dearth 
in the scientific data 
on the toxic properties 
of nanomaterials may 
require a 
reassessment of 
reference values to 
measure the potential 
risks associated with 
the nanoscale.
2. Suppliers of 
nanomaterials are 
responsible for 
providing safety data 
on physical and 
chemical properties, 
stability and reactivity, 
toxicological 
                                                
27 An "existing substance" is defined as one that is listed in the European Inventory of Existing Commercial Chemical Substances (EINECS) and was placed 
on the market before September 1981.
28 Notification of New Substances Regulations 1992, EU Existing Substances Regulations 793/93/EEC and Biocidal Products Regulations 2002
29 Is the document entitled "Information Approved for the Classification and Labelling of Dangerous Substances and Dangerous Preparations (Eighth Edition)" 
approved by the Health and Safety Commission on 26 July 2005
30 Medicines for Human Use (Marketing Authorisations etc.) Regulations 1994 (as amended)
31 Registration, Evaluation and Authorisation of Chemicals 
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subsequent users with 
the nanosubstance 
passing through its 
lifecycle without 
additional scrutiny of its 
unique properties. 
Consequently, no 
labelling for supply and 
no information to 
introduce, where 
necessary, measures to 
reduce potential risks 
during use and 
disposal.
2. Currently, no 
nanoscale substances 
have been assessed 
against the EU process 
under NONS, ESR or 
BPR28 - as such self-
classification under 
CHIPS relies on the 
notification of 
substances and their 
presence in the 
Approved Supply List29
to determine 
hazardousness. With no 
nanoscale substances 
on this List, suppliers 
have no information on 
which to assess 
whether the 
reduced level of testing 
due to the small 
quantity.  Gap may 
arise due to potential 
inadequate testing of 
properties.
2. Due to the scale of 
nanomaterials a 
different metric for 
assessing exposure 
may be required to 
capture particular risks 
associated with the 
nanoscale and 
substances at this 
scale may need to be 
subject to a higher 
standard of testing.
tests to be conducted 
on physicochemical, 
toxicological and eco-
toxicological 
properties of notified 
substances. Hazard 
information derived 
from this process 
required by suppliers 
under CHIP 
obligations. At present 
standardised testing in 
terms of timing and 
extent outlined in 
NONs relating to 
hazardous may not be 
sufficient for 
nanomaterials. 
Consequently, 
reference values in 
terms of nanoparticles 
may need to be 
reassessed due to the 
lack of scientific data 
on the toxic properties 
of chemicals at this 
scale
monitoring exposure 
may not be 
appropriate with 
nanoscale fibres.
2. Management of 
potential risks 
downstream -
COSHH principles of 
good control should 
be capable of being 
adapted to the control 
of nanomaterials.  
However, the 
performance and 
effectiveness of 
conventional methods 
will need to be 
assessed e.g. PPE33
will only provide the 
intended level of 
protection if correctly 
specified or fitted.
information, ecological 
information, disposal 
considerations and 
transport information.  
General issue is the 
lack of sufficient 
information and 
knowledge available 
on toxicological 
hazards, appropriate 
exposure limits – it will 
be difficult to provide 
the relevant data and 
undertake the 
necessary risk 
assessments.  
Current gap is the 
lack of available 
information on the 
potential indications of 
danger.
                                                                                                                                                                                                                                         
32 This is likely to change under REACH with responsibility for risk assessment lying with the supplier and not the Health & Safety Executive and the 
Environment Agency.
33 Personal Protective Equipment
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nanomaterial is 
hazardous or not.  An 
incorrect classification 
could lead to 
consequences in 
subsequent legislation 
applicable to the use of 
the substance and on 
the potential controls to 
reduce damage to 
human health or the 
environment. 
3. Research & 
Development – Often 
regulations do not 
extend to R & D for 
example the absence of 
prior authorisation for 
the use of new 
substances in biocidal 
products for R&D or 
experimental purposes 
could potentially allow 
new substances 
incorporating 
nanoparticles to be  
uncontrolled or 
unregulated.  In 
addition, the Medicines 
Regulation30s does not 
extend to cover 
medicinal products 
intended for research 
and development trials.  
This creates a potential 
gap in the regulation of 
risks associated with 
Horizon Scanning –
REACH: Registration 
dependent on tonnage 
triggers, which 
currently may exclude 
nanomaterials
2. Data requirements 
Horizon Scanning –
REACH: Extend the 
responsibility to both 
new and existing 
Horizon Scanning –
REACH:  Whilst risk 
management is 
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nanomaterials, relating 
in particular to the 
subsequent disposal of 
products and 
downstream 
environmental exposure 
to potentially hazardous 
substances  
Horizon Scanning –
REACH31: If the nano-
equivalent is considered 
to be the same as the 
registered substance 
appropriateness of 
existing data may be 
insufficient.  No 
chemical at the 
nanaosize scale 
currently considered as 
‘substances of very high 
concern’.
will vary according to 
tonnage of substance 
produced – current 
proposed threshold 
may be too high for 
nanomaterials.
substances but only 
applies to substances 
supplied in quantities 
over 10 tonne/yr 
(unless of particular 
concern In addition, 
there is a question 
over whether the tests 
required are relevant 
for the risk 
assessment of 
nanomaterials as 
methodologies for 
chemical safety 
assessment are 
based on 
‘conventional’ 
methodologies for 
assessing chemical 
risks which may not 
be appropriate for 
assessing potential 
risks associated with 
nano-substances.  
identified as the 
responsibility of those  
enterprises that 
manufacture, import, 
place on the market 
or use these 
substances – the 
responsibility only 
applies to substances 
supplied in quantities 
over 1 tonne/yr 
(unless of particular 
concern).
Summary – Group 2: A number of regulations are considered under this heading from those that deal specifically aimed at suppliers, those 
aimed at recipients and users of chemicals and those aimed at the regulatory authority.   Suppliers must ensure that they convey information to 
the recipients on the physicochemical (e.g. flammability) and toxicological hazards of their chemicals.  NONS (see Group 1 above) requires 
standardised testing of hazardous properties of industrial chemicals new onto the market.  The information generated by these tests can be 
used further downstream by users in assessing appropriate risk assessments for risk management procedures required to ensure the safe use, 
transportation and disposal of chemicals. 
Scope Risk 
Characterisation
Risk Assessment Risk Management Information Base
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Group 2 = 
Health  & 
Safety
1. Definition of Hazardous 
Substance (COSHH, 
CHIP, Dangerous 
Substances & COMAH34) 
– whether a substance is 
classed as hazardous 
and therefore requiring 
certain undertakings will 
depend on the 
classification used under 
CHIP35.  As discussed in 
Group 1, suppliers use 
the Approved Supply 
List36.  As yet, no 
‘existing’ substances in 
nanosized form have 
been through this EU 
system. Suppliers will 
need to gather and 
consider all of the 
relevant data on that 
substance and determine 
the classification 
themselves using any 
available guidance.  Due 
to the general lack of 
available data on 
nanomaterials and any 
consequential impacts 
and subsequent hazards 
1. Hazardous to 
Health (COSHH) –
substance is 
hazardous to health 
if it is on the 
Approved Supply List 
or meets an 
approved 
occupational 
exposure limit or is 
present as a dust at 
a concentration 
greater than 4 
mg/m3 (respirable 
fraction) or 10mg/m3 
(inhalable fraction), 
as 8-hour time-
weighted average 
values.  From 
current, limited 
understanding of the 
toxicology of 
nanomaterials it 
would be unwise to 
regard exposures to
nanomaterials at or 
below 4 mg/m3 (8h 
TWA) respirable dust 
as representing 
adequate control 
1. Material Safety 
Data Sheets (CHIP) -
General issue is the 
lack of sufficient 
information and 
knowledge available 
on toxicological 
hazards, appropriate 
exposure limits – it will 
be difficult to provide 
the relevant data and 
undertake the 
necessary risk 
assessments.  Poor 
quality of the data 
could lead to an 
incorrect interpretation 
of the data by users 
downstream. 
However, where 
nanomaterials are 
classed as hazardous 
MSD sheets will be 
required.
2. COSHH risk 
assessment is based 
on using available 
information on the 
hazards and 
knowledge of the local 
1. An accurate risk 
assessment should 
lead to an employer 
putting into place 
appropriate risk 
management 
procedures.  Where 
appropriate 
information exists for 
nanomaterials, risk 
management 
procedures are likely 
to be implemented, 
however at present 
the current level of 
information and 
knowledge may lead 
to potential gaps in 
the appropriate 
precautionary 
measures.
2. Monitoring – a 
good risk 
management system 
will also involve a 
monitoring of 
exposure – due to 
scale of 
nanomaterials a 
specific exposure 
1. To conduct risk 
assessments the 
following information 
is lacking;
a. sufficient 
toxicological hazard 
information for most 
nanoparticles;
b. reliable, affordable 
and standardised 
exposure 
measurement and 
characterisation 
methods; and
c. an agreed definition 
of the most 
appropriate dose 
metric(s) to use in 
hazard and exposure 
studies.  This applies 
to COSHH & Biocidal 
products.
2. Potential risks to 
health – employers 
under COSHH must 
undertake health 
surveillance of 
employers at risk of 
exposure – current 
there is insufficient 
                                                
34 Control of Substances Hazardous to Health Regulations, Chemicals (Hazard Information and Packaging for Supply) Regulations, Dangerous Substances 
and Explosive Atmospheres Regulations 2002 & Control of Major Accident Hazards Regulations
35 The regulation does not extend to chemicals such as cosmetics and medicines.
36 Chemicals examined under NONS, ESR or BPR in the UK (or, in other EU Member States, the corresponding regulations) will have their classification and 
labelling (C&L) agreed at EU level and entered into ‘Annex I’ of the Dangerous Substances Directive.  This ‘Annex I’ (transposed into the UK ‘Approved 
Supply list’, ASL) also lists the C&L for a considerable number of other existing substances that have been through the EU-wide procedure of agreeing C&L 
positions.
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– the process of 
classification could lead 
to incorrect classifications 
resulting in any potential 
hazards not being 
addressed down the 
supply chain.  
If classified as non-
hazardous - subsequent 
users would be 
dependent on existing 
data as no new data 
would be generated on 
the potential risks or 
hazards relating to the 
identified nanomaterial. 
Consequently, 
nanomaterials could 
move through their 
lifecycle without any 
further assessment of 
their properties.
2. Major Accidents –
Sites that store 
dangerous substances 
contained in a prescribed 
list of substances. Most 
nanomaterials are likely 
to fall outside the very 
prescriptive COMAH 
definition of a ‘dangerous 
substance’, and therefore 
will not be covered by 
associated 
confidently with 
health protection37.
2. Major Accidents –
Where sites store 
substances 
containing 
nanomaterials that 
may be covered by 
the prescriptive list, 
they must then meet 
threshold levels.  It is 
unlikely that the 
storage of any 
nanomaterials will 
meet the high 
threshold levels 
outlined in COMAH.
conditions of 
exposure.  Risk 
assessment are 
therefore based on 
both sound scientific 
information and past 
experience; in terms 
of nanomaterials this 
information is likely to 
be incomplete and 
there are likely to be 
deficiencies in the 
level of available 
information
3. COMAH – top tier 
sites are required to 
undertake risk 
assessment, which 
results in a safety 
report. To undertake 
an appropriate risk 
assessment, data 
must be relevant to 
the actual formulation 
used – consequently 
an assessment of the 
range of formulations 
with a corresponding 
range of effects and 
subsequently a range 
of effects data.  At 
present it is unlikely 
that this range of data 
measurement method 
may need to be 
developed.
3. Under the Health & 
Safety at Work Act, 
employers must 
ensure the safety of 
all employees at 
work.   They are 
required to assess 
any potential risk 
arising from the use 
of certain products 
and act accordingly.   
The risk assessment 
process and 
management of any 
potential risks is often 
aided by the relevant 
information provided 
by producers and 
suppliers.  Any gaps 
existing at the supply 
of information stage 
will be carried down 
the supply chain. 
3. Biocidal Products -
Prior to placing on the 
market of a product 
for use in 
experimental or R&D 
purposes, a dossier of 
information on the 
knowledge available 
concerning the 
potential risks to 
employees. 
3. Often the 
identification of the 
relevant classification 
is the responsibility of 
the producer or site 
e.g. (COMAH).  It is 
the onus of the site 
operator to identify the 
appropriate hazards, 
with insufficient 
information currently 
available, concern 
must be raised over 
the current 
identification of 
hazard classification. 
Incomplete 
information will also 
have a bearing on the 
effectiveness of safety 
measures put un 
place according to 
employer obligations.
4. An HSE report has 
identified that 
increasing range of 
explosive materials 
are being 
manufactured as 
                                                                                                                                                                                                                                         
37 Health and Safety Executive, Review of the adequacy of current regulatory regimes to secure effective regulation of nanoparticles created by 
nanotechnology
38 Health and Safety Laboratory, Literature Review: Explosion Hazards Associated with Nanopowders, HSL/2004/12 (HSe; 2004).
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these Regulations.  Many 
potential sources for 
nanomaterials (e.g. 
aluminium, copper, iron, 
silver, titanium) which 
could be considered 
dangerous are not 
referred to in the list. 
is available to fully 
comply with risk 
assessment 
requirements. 
possible effects on 
human or animal 
health and the 
environment must be 
compiled.  The 
required dossier will 
likely reveal 
information on 
biocidal products with 
nanoparticles.
nanopowders.38  
Although extensive 
literature on explosive 
characteristics of 
micron-scale 
powders, no data on 
nanopowders.
Summary – Group 3: The concept behind Extended Producer Responsibility applies equally to nanomaterials, requiring producers or 
manufacturers to minimise human and environmental exposure to free nanoparticles at all stages of the lifecycle and should also form an 
integral part of the innovation and design process.   A number of types of products, substances or activities have been identified by the 
regulator for control applying a lifecycle approach; this requires manufacture to consider at the design phase, the means of limiting the impacts 
of the product on the environment and human health.
Scope Risk Characterisation Risk Assessment Risk Management Information Base
Group 3 = 
Producer 
Responsibility 
– Product 
Quality & 
Safety
1. Prohibition or 
Restriction of Certain 
types of substances
The prohibition or 
restriction can extend to 
prescribed substances 
(RoHS) or to more 
general substances 
(ELV). In RoHS, 
whether nanomaterials 
are covered by the 
regulations will depend 
on whether the set 
concentration levels are 
set.  Restricted 
substances under ELV 
1. Thresholds Limits
The issue is whether 
the threshold limits are 
set at appropriate 
levels to prevent the 
materialisation of 
potential risks to 
human health or the 
environment posed by 
nanoparticles in 
substances/products. 
Often the limits set do 
not refer to particle 
size (e.g. motor fuel).  
It is conceivable that 
the present limits in 
1. In some of the 
regulations the scope 
is restricted to a 
specific safety 
procedure for example 
the need to obtain a 
detonation resistance 
certificate41 and does 
not regulate any 
potential 
environmental 
hazards and risks 
associated with the 
use of these products.  
There is no 
assessment required 
1. Design 
Requirements
A number of the 
regulations require 
that a lifecycle 
approach be applied 
to the design of 
equipment.  By so 
doing reducing the 
impacts of the product 
on human health and 
the environment by 
ensuring any 
hazardous 
components are so 
identified, limited or 
If nanomaterials are 
accurately classified 
and increased 
information on 
potential impacts 
become available 
many of the 
regulations should 
ensure that 
nanomaterials are 
captured and
managed 
appropriately.
2. Lifecycle Approach
- the lack of scientific 
information on the 
                                                
39 For example the presence of heavy metals in Batteries and Accumulators (Containing Dangerous Substances) Regulations 1994 (as amended)and End of 
Life Vehicles Regulations 2003
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are those identified in 
the Approved Supply 
List (see comments 
above on whether 
nanomaterials will be 
covered by this List).
2. Extent of definition –
for many of the 
regulations there are 
potential gaps on 
whether the nano-
equivalent of a 
substance will be 
classed as an ‘existing’ 
substance or as a new 
substance39.  If classed 
as an ‘existing’ 
substance, whilst 
perhaps covered by the 
regulations, whether the 
unique properties of the 
nanoscale form will be 
identified in risk 
assessments. If classed 
as a ‘new’ substance, a 
potential gap may arise 
if the nanoscale form is 
excluded from the 
regulations.
3. Packaging –
regulation aim to reduce 
many of the 
regulations will fail to 
capture potential 
threats arising from the 
use of nanomaterials40. 
Further, given 
concerns that 
toxicological profile of 
nanomaterials creates 
a greater potential risk 
to human health or the 
environment, the 
concentration levels 
are set at too high a 
level to capture 
potential risks 
associated with 
nanoparticles. 
2. The danger that 
thresholds are 
inappropriately set with 
regard to potential 
risks posed by 
nanomaterials means 
that nanocomponents 
and products 
containing 
nanomaterials can be 
marketed without 
further scrutiny.
3. RoHS - The 
of the potential risks of 
nanomaterials and as 
such no management 
procedures to deal 
with any impacts 
arising out of the risk 
assessment.
2. Vigour of safety 
requirements - the 
medical devices 
Directives* explicitly 
require that in 
assessing the safety 
of medical devices, 
attention must be paid 
to the choice of 
materials used and 
their toxicity.  Annex I 
to Directive 98/79/EC 
makes no reference to 
taking into account the 
toxicity of particular 
materials used in the 
design and 
manufacture of in vitro
devices, although it is 
anticipated that in 
conducting safety 
assessments in 
general, material 
toxicity is a central 
easily separated from 
the product for final 
disposal.  These 
provisions will extent 
to the presence of 
nanomaterials once 
sufficient levels of 
information become 
available.
impacts of 
nanomaterials on 
human health and the 
environment is likely 
to prohibit a full 
lifecycle approach and 
as such to limit any 
potential harm from 
nanomaterials, it is 
recommended that 
they are classed as 
hazardous 
substances.
3. Medical Devices - It 
is recognised that 
knowledge about the 
implications of human 
exposure to 
nanoparticles is 
incomplete.  Despite 
the fact European 
Directives42 establish 
a general framework 
of safety, there 
remains, as with other 
current and future 
applications of 
nanotechnology, a 
paucity of information 
about the human 
health impact of 
                                                                                                                                                                                                                                         
40 The overarching safety framework established by the General Product Safety Regulations 2005 applies, should the parameter limits fail to capture risks 
arising from the placing on the market of fuel containing nanoparticles under the Motor Fuel Regulations.
41 Ammonium Nitrate Materials (High Nitrogen Content) Safety Regulations 2003
42  * - Directive 93/42/EEC concerning medical devices; Directive 98/79/EC on in vitro diagnostic medical devices; and Directive 90/385/EEC on implantable 
medical devices
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the amount of noxious 
metals and other 
substances as well as 
the potential toxicity of 
packaging waste and to 
limit their environmental 
impact.  Nanomaterials 
are likely to be captured 
under the regulation if 
they are classed as a 
hazardous substance or 
material and if so any 
emissions will be 
minimised.  As the 
regulations extend 
throughout the lifecycle 
of packaging including 
manufacturing; 
manufacturers will rely 
on information supplied 
to them by chemical 
suppliers who in turn 
will rely on data 
provided under NONS* 
notification.  Potential 
gaps at these stages 
will therefore impact on 
other users. 
concentration levels 
set down in RoHs have 
been derived from 
information of the 
impacts of these 
restricted substances 
at the macro level and 
therefore the 
availability at the 
nanoscale may require 
reassessment of the 
concentration value 
levels. 
consideration. exposure to 
nanomaterials.  
Scope Risk Characterisation Risk Assessment Risk Management Information Base
Summary – Group 4: ensure consumer product safety by requiring that products placed on the market or supplied by producers and 
distributors are deemed to be safe and establishing a framework for safety assessment.
Group 4 –
Consumer 
1.  General Products
Definition of Risk43  -
1. Cosmetic Products 
– Concentration Levels 
1. General Products
Safety Standards –
1. Food – Migration of 
Active and Intelligent 
1. Cosmetic Products 
– Information Gaps
                                                
43 As provided by the General Product Safety Regulations 2005 - A ‘safe product’ is defined as a product which, under normal or reasonably foreseeable 
conditions of use does not present any risk or only the minimum risks compatible with the product's use.
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Protection The Regulation does 
not provide a clear 
definition of ‘risk’ in this 
context44and as such 
has potential 
implications for the 
assessment of product 
safety.  It is anticipated 
that due to the broad 
nature of the 
regulations they will 
extend to cover current 
and potential 
applications of 
nanotechnology in 
consumer goods.
2. Cosmetic Products –
a. Definition of cosmetic 
product - sufficiently 
wide to include 
nanomaterials. 
– Prohibited and 
Restricted Substances
- If substances 
containing 
nanomaterials are 
deemed to be 
equivalent to their non-
nanomaterial 
counterpart whose use 
is restricted, the issue 
is whether the weight 
and concentration 
limits specified are 
appropriately set to 
account for potential 
risks associated with 
human & 
environmental 
exposure to 
nanoparticles.  The 
toxicity profile of 
Where no applicable 
product or national 
regulations exist, 
safety is assessed 
according to voluntary 
EU harmonised 
standards51.
Compliance with 
voluntary standards 
does not guarantee 
that a product will be 
deemed to be safe if it 
fails to establish 
appropriate safety 
levels in respect of 
nanomaterials. 
Standards, therefore, 
can be seen to 
provide a de minimis
threshold of safety.  It 
is recommended that 
Nanomaterials -
Although the 
migration of nano-
constituents to 
foodstuffs is 
potentially permitted 
by the Regulation52, 
Article 4 requires pre-
market authorisation 
of substances 
deliberately 
incorporated into 
active materials and 
articles to be released 
into food or the 
environment 
surrounding food shall 
be authorised and 
used in accordance 
with the relevant 
Community provisions 
information necessary 
for the risk 
assessment of dermal 
exposure to 
nanoparticles is 
lacking.
2. Food – Food 
Safety54  - Safety 
assessments of 
nanomaterials in food 
products are currently 
based on incomplete 
information, and might 
not accurately reflect 
the likely effect of 
nanotechnology.  It is 
likely that applications 
of nanotechnology will 
be deemed to 
represent an 
‘emerging risk’ 
                                                                                                                                                                                                                                         
44 Although note that ‘serious risk’ is defined by Regulation 2 as a serious risk, including one the effects of which are not immediate, requiring rapid 
intervention.
45 Even if food products were to fall outside the scope of the regime established by the Food Safety Act 1990 is still sufficiently broad to cover potential 
dangers arising from the use nanotechnology in relation to foodstuffs in general.  Products falling outside the definition of ‘food’ will be caught by overarching 
frameworks such as the General Principles of Food Law Regulation (EC) No.178/2002 and the General Product Safety Regulations 2005
46 Food Additives Directive 89/107/EEC.
47 Sweeteners in Food Regulations 1995 (as amended), Colours in Food Regulations 1995 (as amended) and Miscellaneous Food Additives Regulations 
1995 (as amended)
48 Novel Foods and Novel Food Ingredients Regulations 1997
49 See Food and Drink Federation, Response to FSA Draft Report of Regulatory Review of the Use of Nanotechnologies in Relation to Food 
http://www.fdf.org.uk/responses/fdf_response_nano.pdf, accessed October 2006.
50 Contaminants in Food Regulation (EC) No. 315/93
51 Council Resolution, 7 May 1985, ‘New Approach to Technical Harmonization and Standards’.
52 Materials and Articles in Contact with Food Regulation (EC) 1935/2004
53 Directive 2002/72/EC relating to plastic materials and articles intended to come into contact with foodstuffs (as amended)
54 General Principles of Food Law Regulation (EC) 178/2002
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Products supplied to 
consumers that fall 
outside the scope of the 
Regulation 3(1) 
definition are likely to 
fall within the scope of 
the General Product 
Safety Regulations 
2005, which establishes 
a framework for 
ensuring that intended 
for or likely to be used 
by consumers under 
normal or foreseeable 
conditions are safe. 
b. Prohibited and 
Restricted Ingredients
Whether covered by 
regulations will depend 
on whether listed 
substances and those 
containing 
nanoparticles can be 
considered to be 
equivalent for the 
purposes of the 
Regulations.  If classed 
as equivalent coverage 
under the regulations 
will be dependent on 
listed concentrations 
levels.   If not classed 
as equivalent to the 
macro form it is 
conceivable that the 
use of the substance in 
cosmetic products will 
nanomaterials if 
potentially markedly 
different from the non-
nanoscale equivalent 
and therefore reduced 
quantities could pose a 
greater threat to 
human health and the 
environment.  
2. Food – Novelty 
Food
For those 
nanomaterials in food 
products aleady on the 
market will fail the 
novelty test48 - it is 
unlikely that the 
novelty threshold has 
been tested in relation 
to the use of 
nanomaterials in food, 
given that 
nanotechnologies in 
this context are still in 
the research and 
development stage.49
Purity Criteria – Under 
the regulations limited 
to 2 substances due to 
the uncertainty of their 
safety – their 
restriction is based on 
particle size.  It is 
recommended that 
particle size is included 
in the purity criteria as 
standard practice and 
harmonised standards 
that take into account 
the characteristics of 
nanoparticles are 
developed.
2. Cosmetic Products 
– Safety Evaluation -
Precise chemical 
nature of the 
ingredient and its 
structural formula, if 
known, should be 
identified in the safety 
evaluation.  Although 
there are no specific 
requirements relating 
to nanomaterials in 
cosmetic products, it 
is unlikely, given 
incomplete 
information about the 
implications of human 
& environmental 
exposure to 
nanomaterials, that a 
full safety evaluation 
could be conducted 
on cosmetic products 
containing 
nanoparticles.  
Detergents - The 
issue is whether the 
safety provisions set 
out in the Regulation 
are capable of 
identifying potential 
risks associated with 
relating to food safety.  
Whether migration 
thresholds are 
sufficient to manage 
potential dangers 
posed by 
nanomaterials
Given that the 
European Directive53
does not differentiate 
between 
nanomaterials and 
materials and articles 
produced by 
‘traditional’ means, it
is uncertain whether 
the migration 
threshold set within 
the Directive would 
provide adequate 
protection against 
threats posed by 
nanoparticles.
pursuant to 
Regulation.  Given the 
novelty of 
nanotechnology and 
the lack of complete 
knowledge about its 
implications, the 
feasibility of thorough 
risk assessment is 
thwarted by scientific 
uncertainty.
3. Migratory 
Nanomaterials -
Under the 2001 
Scientific Committee 
on Food Guidelines, 
the toxicological 
dataset required to 
determine safety 
depend on migration 
values.   It is 
conceivable, given the 
novelty of applications 
of nanotechnology, 
datasets are 
insufficiently 
‘extensive’ to 
establish the safety of 
food contact materials 
containing 
nanoparticles falling 
within the ‘high 
migration’ category.  
Establishing the 
safety of food contact 
materials containing 
nanoparticles falling 
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not be covered by the 
regulations.
3. Food
Definition: Novel Food -
It is unclear whether the 
uses of nanomaterials 
in foodstuffs will bring 
food product referred to 
in the Food Safety Act 
within the meaning of 
‘novel food’.  Given that 
reference is made to 
the novelty of the food 
product rather than to 
its process of 
manufacture or 
composition, it is 
conceivable that the 
production of foodstuffs 
using nanotechnology is 
insufficient to render it 
‘novel’ for the purposes 
of the Act45.  
‘Substantial 
Equivalence’ - the test 
applies only in relation
to certain categories of 
food and food 
ingredients. It is unlikely 
that current and 
potential applications of 
nanotechnology 
identified will fall into 
any of the identified 
categories.  The 
consequence is that 
novel foods containing 
therefore gain 
coverage of 
nanomaterials.
Contaminant 
Thresholds50 - for food 
containing a 
contaminant in 
quantities that pose an 
unacceptable threat to 
public health must not 
be placed on the 
market. It is unclear 
whether the thresholds 
specified in the Annex 
to Regulation 
466/2001 are set at 
appropriate levels to 
control potential risks 
arising from 
applications of 
nanotechnology in this 
context.  Taking into 
account recognised 
properties of 
nanomaterials, such as 
increased toxicity, it is 
conceivable that the 
maximum level 
thresholds specified 
provide inadequate 
protection to consumer 
health.  
exposure to 
nanomaterials.  It is 
likely that the 
requirements are 
sufficiently thorough to 
identify possible 
threats arising from 
the use of 
nanomaterials.  
However, a 
complementary risk 
assessment is only 
required in relation to 
surfactants that fail 
the ultimate 
biodegradability test.  
It is conceivable that 
primary and ultimate 
biodegradability 
testing fails to detect 
potential risks 
associated with 
exposure to 
nanomaterials, which 
might be expected to 
be identified by a 
complementary risk 
assessment.  
3. Food – If 
nanomaterials did 
satisfy the ‘substantial 
equivalence test’ - a 
finding of substantial 
(or partial) 
equivalence under the 
Novel Food 
Regulations would 
within the ‘low 
migration’ category, 
however, poses less 
of an evidential 
challenge.  Given that 
only a limited dataset 
is required in relation 
to low migration 
constituents, it is 
conceivable that 
materials and articles 
containing 
nanoparticles are 
deemed to be ‘safe’ 
and marketed before 
more robust datasets 
on human and 
environmental 
exposure are 
developed.
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nanomaterials cannot 
be treated in the same 
manner with respect to 
safety to an existing 
food or food 
component.
Food Additives – due to 
extent of definition, it is 
likely that nanomaterials 
will be captured as a 
food additive under the 
European regulations46, 
it is also likely that 
should nanomaterials 
fail to be covered as 
additives under the 
relevant UK 
regulations47, the 
European legislation 
should secure their 
coverage.
create a potential 
loophole for the safety 
assessment of foods 
containing 
nanomaterials, as the 
Regulations do not 
explicitly set out 
specific criteria to 
assess the safety of 
novel foods on the 
basis of particle size. 
In addition if found 
substantially 
equivalent, no further 
toxicological testing is 
required.  In the case 
of the partial, 
toxicological testing 
required only in 
relation to novel traits.  
Scope Risk Characterisation Risk Assessment Risk Management Information Base
Summary – Group 5: A wide variety of regulations are considered in Group 5.  Whilst some control emissions from pollutants to all media, 
others deal solely with controlling, restricting or prohibiting emissions to air or discharges to water.
Group 5  -
Environmental 
Control
1. Control of Emissions 
Prescribed Activities
Such is the innovative 
nature of 
nanotechnology 
production that they 
may not meet the 
activity descriptions 
within the PPC 
Regulations55. For 
1. Control of Emissions 
– Threshold Levels
Many of the sectors 
identified in the PPC 
regulations under 
which nanomaterials 
may be produced are 
unlikely to meet the 
prescribed thresholds 
and therefore are likely 
1. Control of 
Emissions –
Environmental 
Assessment Levels -
The majority of EALs 
for air have been 
extrapolated from 
occupational exposure 
limits (OELs) using 
suitable uncertainty 
1. Control of 
Emissions – Best 
Available Technique -
Based on current 
scientific knowledge, 
there may be a 
number of issues in 
determining an 
acceptable level of 
emissions, the 
1. Control of 
Emissions – Permit 
Information – provide 
information on the 
nature and quantities 
of foreseeable 
emissions from the 
installation. Given the 
current uncertainty in 
relation to the 
                                                
55 Pollution Prevention and Control (England and Wales) Regulations 2000,  the Environmental Protection (Prescribed Processes and Substances) 
Regulations 1991 (as amended),
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example, in the PPC 
Regulations, chemical 
industry activities must 
involve the production 
of chemicals ‘in a 
chemical plant by 
chemical processing for 
commercial purposes’ 
and this would exclude 
nanomaterials  
produced using solely 
physical production 
routes.
2. Control of Emissions 
– Prescribed 
Substances & 
Pollutants56 – PPC 
Regulations provides a 
list of polluting 
substances – whether 
nanomaterials will be 
covered by the list may 
depend on whether 
nanoscale form is 
classed as the 
equivalent of the macro 
form.  If it is then it will 
be covered by the 
regulations – although 
subject to threshold 
to be exempted under 
the regulations.  
2. Control of Emissions 
– Emission Level 
Values
May be set in permit 
for all pollutants likely 
to be released – may 
depend on whether 
pollutant is classed as 
an existing or new 
substance.  If existing -
ELV estimated on the 
basis of the 
environmental risks of 
the macro equivalent, 
which may be different 
from the nanomaterial.  
If not captured under 
the list of prescribed 
substances – the 
levels may be too high 
as they are unlikely to 
satisfy the ‘significant 
quantity’ threshold.
3. Water Quality –
Discharge of Urban 
Wastewater58 - As the 
regulations provide 
concentration level for 
factors, which allow 
for the differences 
between occupational 
exposure to chemicals 
and the exposure of 
the general population 
to the pollutant in 
ambient air. It is not 
known whether such 
limit values will be 
revised although it is 
unlikely that this will 
happen in the short 
term. The absence of 
this hierarchy of 
information could 
cause difficulties in 
setting appropriate 
EAL/ELVs.
2. Water Quality –
Permitting Discharges 
to Groundwater –
Environment Agency 
required to assess the 
risk of the discharge 
polluting or altering 
the quality of the 
groundwater - This 
may be assessed by 
using current 
appropriate 
preventative 
measures or the Best 
Available Technology 
(BAT).  The general 
lack of scientific 
knowledge on the 
management of 
nanomaterials may 
itself mean that the 
definition of BAT 
cannot extend to 
nanomaterials.
2. Control of 
Emissions -
Monitoring - Based on 
current evidence 
about the relative 
toxicity of 
nanomaterials 
compared with the 
same material at the 
macro scale, it is 
possible that ELVs 
relevant to 
nanoparticles would, 
on a mass basis, be 
much lower. 
However, the current 
means of measuring 
potential impacts of 
nanomaterials on 
human health and/or 
the environment in 
relation both to the 
potential effects and 
the level at which 
these effects might 
occur, it may not be 
possible to assess the 
impacts of many 
nanomaterials.
2. Water Quality –
Consent to Discharge 
- Even if 
nanomaterials 
qualified as a pollutant 
and triggered 
conditions on 
discharge consents. 
In order to be able to 
impose conditions, 
one requires 
appropriate and 
relevant information to 
ensure that 
appropriate volumes 
and rates can be 
applied.  
Trade Effluent - it is 
                                                                                                                                                                                                                                         
56 Water Resources Act 1991, Pollution Prevention and Control (England and Wales) Regulations 2000,  the Environmental Protection (Prescribed Processes 
and Substances) Regulations 1991 (as amended), Groundwater Regulations 1998, Surface Waters (Dangerous Substances) (Classification) Regulations 
1997 & 1998
57 Urban Waste Water Treatment (England and Wales) Regulations 1994
58 Urban Waste Water Treatment (England and Wales) Regulations 1994
59 Water Environment (Water Framework Directive) (England and Wales) Regulations 2003
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levels (which may be 
too high for the 
nanoscale).   If the 
nanomaterial is not 
classed as the 
equivalent of the macro 
form it may not be 
covered by the 
regulations.  In other 
regulations brought 
under the PPC regime, 
prescribed substances 
are listed for the 
different media (air, 
land, water), 
nanomaterials may only 
be covered if they are 
classed as existing 
substances but then 
restricted to 
assessment and 
analysis against the 
macro equivalent, which 
may impact on any risk 
precaution measures.
3. Water Quality –
Substances present in 
water – Regulations57
seek to reduce the level 
of nutrients in waters 
categorised as 
‘sensitive areas’.  The 
criteria are not 
prescriptive but make 
recommendations as to 
which types of nutrients 
should be reduced by 
specific substances, 
nanomaterials are 
unlikely to be captured 
and even if they were 
captured under the 
regulations, it is likely 
that the concentration 
levels will be too high 
to capture their specific 
properties.
4. Water Quality –
Annual Mean 
Concentrations - mean 
concentration assists 
in the classification of 
the water source 
ensuring that the 
concentration of the 
dangerous substance 
does not exceed that 
listed.  With the low 
levels associated with 
nanomaterials it is 
foreseeable that in a 
number of occasions, 
they will, if classed as 
a dangerous 
substance, fall below 
these threshold limits.
techniques and these 
standard tests may 
not capture the 
different level of 
pressures, effects and 
potential risks 
introduced by 
nanomaterials.
and monitoring the 
emissions is unlikely 
to be applicable to 
monitoring any 
emissions resulting 
from nanomaterial 
pollutants.
3. Water Quality –
Substances present 
in water -
Nanomaterials, which 
have effects on the 
chemical or ecological 
quality of water could 
be considered a 
pressure on the 
quality, however in 
order to measure the 
pressure, standard 
tests need to be 
applied – current test 
procedures may not 
capture the different 
level of pressures 
introduced by 
nanomaterials.
4. Water Quality –
Testing - It is likely 
that the current 
standards for 
monitoring water 
status will not capture 
the effects of 
nanomaterials, if the 
presence of 
substances at the 
nanoscale is likely to 
unlikely that there is 
sufficient available 
information to fulfil the 
requirements to 
provide information on 
the impact of the 
discharge on 
sewerage services or 
the necessary steps 
to be taken.
3. Water Quality - no 
deterioration of water 
quality - Due to the 
current scientific 
knowledge available, 
any water that may be 
contaminated with 
nanomaterials that are 
deleterious to the 
environment or 
human health may not 
be detected due to the 
current technical 
standards available 
for monitoring water 
quality.  
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further treatment. With 
its limited coverage it is 
unlikely that these 
regulations will extend 
to nanomaterials.
affect the quality of 
water.
5. Water Quality –
Programme of 
Measures59 - Any 
programme of 
measures is likely to 
be linked to the 
analysis identifying 
pressures on water 
quality, any lack of 
information or gaps at 
the analysis stage will 
impact on identifying 
the relevant 
programme of 
measures in particular 
those relating to 
prevention or control 
of the input of 
pollutants.
Summary – Group 6:  Waste will be generated throughout the lifecycle of nanomaterials from formulation, manufacture, supply, use as raw 
material and product use by both industrial and domestic users.   Waste, in general, is classified as hazardous, inert or non-hazardous.  
Classification may dictate the particular disposal route available to the waste type e.g. hazardous waste prohibited from disposal to non-
hazardous or inert landfill.  It will also determine whether waste types can be mixed or require separation, whether components need to be 
removed prior to treatment and disposal, whether presence of waste must meet certain acceptance criteria.  An incorrect classification of 
nanomaterial waste or waste containing nanomaterials may result in an inappropriate waste management option being chosen.  Waste 
legislation includes waste types, waste disposal methods, waste licensing and the identification of specific substances, which have been 
identified 
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Scope Risk Characterisation Risk Assessment Risk Management Information Base
Group 6 = 
Waste
1. In current 
classification system no 
codes identify the 
presence of 
nanomaterials, merely 
the presence of 
dangerous substances.
2. The definition of 
hazardous waste and 
whether it extends to 
nanomaterials may 
result in potential gaps 
in the regulation of 
nanomaterial waste.  At 
present no 
nanomaterial has been 
identified as a 
dangerous substance 
under the appropriate 
legislation outlined in 
Group 1 above.  As a 
consequence waste 
generators, responsible 
for classifying waste 
types, have at present 
insufficient information 
to make an accurate 
classification.  If 
nanomaterials not 
classed as hazardous 
they can be disposed to 
landfill, mixed with other 
waste types  
1. If classed as 
hazardous waste (to 
identify disposal route), 
depending on the 
relevant chapter of the 
list of wastes, 
nanomaterials may still 
be subject to relevant 
concentration levels63, 
as not all hazardous 
codes are ‘absolute’64
but producer can 
determine if the 
nanosubstance meets 
the relevant threshold 
levels of 
hazardousness.  If it is 
believed that they do 
not (often relying on 
available data 
produced under 
NONS, ESR and 
BPR65) they therefore 
fall below the threshold 
limits and can be 
classed as non-
hazardous.
2. Domestic Waste
The existing 
framework cannot 
accommodate any 
specific requirements 
to manage domestic 
Waste management 
facilities are subject to 
emission and 
discharge consents 
and limitations to 
reduce the level of 
potential pollution 
arising from waste 
management 
activities.
1. Emission Levels
(waste incineration) 
are based on best 
available techniques. 
Currently, no limits 
exist for fine particles, 
which may be a 
concern in terms of 
nanomaterials and as 
a consequence result 
in another gap in the 
control of any 
emissions from the 
incineration of certain 
nanomaterials. 
Present levels reflect 
current knowledge on 
the polluting effects of 
emissions, which may 
be different in terms of 
the effects of 
nanomaterials.
2. Discharges to 
1. Duty of Care – lays 
down the system of 
managing the transfer 
and disposal of waste 
including the 
requirement for a 
transfer note when 
waste is transferred.   
Identification of waste 
is via List of Waste 
and as this may not 
capture waste 
containing 
nanomaterials, which 
is hazardous in 
particular food from 
food processing or 
packaging waste.   
Where waste is not 
properly identified it 
may as a 
consequence the 
most appropriate 
means of disposal 
may not be identified. 
2. Technical 
requirements & 
Technical Standards
– many of the current 
technical standards 
based on current 
knowledge of 
potential risks –
1. Information for 
waste management 
licences - At present 
the information is 
likely to be based on 
standard tests and the 
current test 
procedures may not 
capture the different 
level of pressures 
introduced by 
nanomaterials.
2. Permit Conditions
relating to restricted 
substances allowed to 
be discharged from 
waste management 
facilities - It is unlikely 
that due to the lack of 
available scientific 
data that the relevant 
precautions can be 
evaluated and this 
lack of information 
can extend to the 
maximum quantity of 
any nanoscale 
substance that may 
be permitted to be 
discharged.  
3. Dismantling 
information – (ELV) –
Producers to provided 
                                                
60 Restriction on the use of certain Hazardous Substances in Electrical and Electronic Equipment Regulations 2005
61 End-of-Life Vehicles Regulations 2003
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3. At present some 
applications of 
nanomaterial (e.g. food 
processing) do not have 
any hazardous 
classification; therefore 
waste cannot be 
identified as containing 
nanomaterials if they 
are considered 
hazardous.
4. Numerous waste 
regulations have been 
passed under extended 
producer responsibility 
regimes to restrict 
certain substances 
being disposed via 
specific routes.  Some 
are prescribed 
substances (e.g. 
RoHS60) and others 
refer to hazardous 
substances in more 
general terms (ELV61).   
Potential gaps may 
arise due to the extent 
of the definition and 
whether nanomaterials 
waste containing 
products with 
nanosized substances, 
consequently disposal 
method may not be the 
most appropriate and 
in the UK today it is 
most likely to be to a 
non-hazardous landfill 
site. 
3. Waste Acceptance 
Criteria (landfill) –
Questions may arise 
over the lack of 
information relating to 
the disposal of 
consumer products to 
non-hazardous landfill 
sites and the potential 
risk of emissions to 
groundwater, surface 
water or surrounding 
environment; 
jeopardise 
environmental 
systems.
groundwater (waste 
licensing) utilises List I 
and List II 
substances66 -
concern may arise 
over whether 
nanomaterial is 
equated to a macro 
form on one of the 
lists, if this occurs any 
assessment of risks 
will be at the macro 
scale and not at the 
unique properties of 
the nanomaterial.  
Consequently, 
discharge may be 
permitted without any 
further assessment. 
3.  Pollution control 
regulations are based 
on the current 
knowledge of the 
polluting effects of 
emissions from known 
substances; this may 
be different in terms of 
the effects of 
nanomaterials.   
standards may need 
to be reassessed due 
to the introduction of 
nanomaterials where, 
at present, little 
knowledge is known 
about the long-term 
impacts.
3. Waste Acceptance 
Procedures at Landfill 
require detailed data 
to be held on the 
quantities, source and 
characteristics, and in 
terms of hazardous –
its location on the 
site. The current 
system should be 
capable of dealing 
with the disposal of 
nanomaterials if they 
are correctly 
classified particularly 
if classified as 
hazardous – potential 
gap is the 
management of 
domestic waste.   
WEEE is likely to 
information to assist in 
the dismantling of 
hazardous materials –
with current lack of
available data, 
producers may not be 
able to provide the 
relevant information 
on nanomaterials 
present in vehicle 
components.
4. General Information 
Gaps - Potential gap 
due to the lack of 
available data in 
terms of the effects of 
nanomaterials and 
their potential to travel 
through the landfill 
and therefore escape.  
                                                                                                                                                                                                                                         
62 An "existing substance" is defined as one that is listed in the European Inventory of Existing Commercial Chemical Substances (EINECS).
63 The thresholds applied are H1 to H14 located in the Schedule 3 of Hazardous Waste (England & Wales) Regulations 2005
64 That is will be classed as a hazardous waste no matter the concentration level of any dangerous substance present in the waste.
65 Notification  of New Substances Regulations 1992, EU Existing Substances Regulations 793/93/EEC and Biocidal Products Regulations 2002
66 List I and List II substances contained in the Dangerous Substances Directive (76/464/EEC), however as part of the ongoing restructuring of the 
Community water policy, the Directive on Dangerous Substances is now integrated in the Water Framework Directive (2000/60/EC) which was adopted in 
September 2000, and Directive 76/464/EEC will be fully repealed in 2013. Directive 76/464/EEC has been codified as Directive 2006/11/EC on pollution 
caused by certain dangerous substances discharged into the aquatic environment of the Community.
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can be captured as 
prescribed substances 
or as a hazardous 
substance under the 
Approved Supply List –
as stated under Group 
1, no nanomaterials 
exist on this list.  If 
classed as non-
hazardous, components 
containing 
nanomaterials may not 
be segregated and may 
be incorrectly disposed 
via a means which may 
result in higher 
exposure.  However, if 
applying the Approved 
Supply List, the 
nanomaterial is classed 
as an ‘existing’ 
substance62a potential 
gap may arise if the 
nano form is assessed 
on the same principles 
as the macro form.  If 
the nano form is 
classed as a ‘new’ 
substance and 
therefore assessed on 
its own potential risks, a 
gap may arise if the 
new substance falls out 
of the scope of the 
regulations.
capture any 
nanomaterials in 
electrical and 
electronic equipment 
if this is disposed via 
a ‘take-back’ system.
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ANNEX 4B: Legislation identified within each of the groups of regulation used in Annex 4A
Group Name Legislation 
1. Production/Introduction onto Market Notification of New Substances Regulations 1993
Directive - Registration, Evaluation and Authorisation of Chemicals (Proposed)
The Biocidal Products Regulations 2001(as amended)
Chemicals (Hazard Information & Packaging for Supply) Regulations 2002
2. Health & Safety Control of Major Accident Hazard Regulations 1999 (as amended)
Control of Substances Hazardous to Health Regulations 2002 (as amended)
Dangerous Substances and Explosive Atmospheres Regulations 2002
Health & Safety at Work Act 1974
Management of Health & Safety at Work Regulations
The Biocidal Products Regulations 2001(as amended)
Chemicals (Hazard Information and Packaging for Supply) Regulations 2002 (as 
amended)
Notification of New Substances Regulations 1993
3. Producer Responsibility – Product 
Quality & Safety
Ammonium Nitrate Materials (High Nitrogen Content) Safety Regulations 2003
Batteries and Accumulators (Containing Dangerous Substances) Regulations 1994 
(as amended)
Medical Devices Regulations 2002 (as amended)
Medicines Act 1968
Medicines for Human Use (Marketing Authorisations etc.) Regulations 1994 (as 
amended)
Motor Fuel (Composition and Content) Regulations 1999 (as amended)
End-of-Life Vehicles Regulations 2003
Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic 
Equipment Regulations 2005
Directive 2002/96/EC on Waste Electrical and Electronic Equipment
Packaging (Essential Requirements) Regulations 2003
Producer Responsibility Obligations (Packaging Waste) Regulations 2005
4. Consumer Protection Batteries and Accumulators (Containing Dangerous Substances) Regulations 1994 
(as amended)
Motor Fuel (Composition and Content) Regulations 1999 (as amended)
Biocidal Products Regulations 2001 (as amended)
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Dangerous Substances & Explosions Atmosphere Regulations 2002
Medical Devices Regulations 2002 (as amended)
Medicines Act 1968
Medicines for Human Use (Marketing Authorisations etc.) Regulations 1994 (as 
amended)
Veterinary Medicines Regulations 2005
Building Regulations 2000 (as amended)
Textile Products (Indications of Fibre Content) Regulations 1986 (as amended)
Electrical Equipment (Safety) Regulations 1994
Control of Pesticides Regulations 1986 (as amended)
Fertilisers Regulations 1991 (as amended
Plant Protection Products Regulations 2005 (as amended)
Detergents Regulations
Cosmetic Products (Safety) Regulations 2004 (as amended)
General Product Safety Regulations 2005
Additives Directive 89/107/EEC (as amended)
Articles in Contact with Food Regulations 1987 (as amended
Colours in Food Regulations 1995 (as amended
Contaminants in Food (England) Regulations 2005
Food Safety 2005 Act 1990 (as amended)
Materials and Articles in Contact with Food (England) Regulations 2005
Miscellaneous Food Additives Regulations 1995 (as amended
Novel Foods and Novel Food Ingredients Regulations 1997 (as amended
Plastic Materials and Articles in Contact with Food Regulations 1998 (as amended)
Regulation (EC) No.178/2002 on General Principles of Food Law
5. Environmental Control Ammonium Nitrate Materials (High Nitrogen Content) Safety Regulations 2003
Environmental Protection Act 1990 (as amended)
Pollution Prevention and Control (England and Wales) Regulations 2000 (as 
amended)
Control of Pollution (Oil Storage) (England) Regulations 2001
Control of Pollution (Silage, Slurry and Agricultural Fuel Oil) Regulations 1991 (as 
amended)
Environmental Protection (Prescribed Processes and Substances) Regulations 1991 
Air Quality (England) Regulations 2000
Clean Air Act 1993
Air Quality Limit Values Regulations 2003
Groundwater Regulations 1998
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Surface Waters (Dangerous Substances) (Classification) Regulations 1997
Surface Waters (Dangerous Substances) (Classification) Regulations 1998
Trade Effluents (Prescribed Processed and Substances) Regulations 1989 (as 
amended)
Urban Waste Water Treatment (England and Wales) Regulations 1994
Water Industry Act 1991
Water Act 2003
Water Environment (Water Framework Directive) (England and Wales) Regulations 
2003
Water Resources Act 1991
6. Waste Disposal Directive 2002/96/EC on Waste Electrical and Electronic Equipment
End-of-Life Vehicles Regulations 2003
Environmental Protection Act 1990
Packaging (Essential Requirements) Regulations 2003
Producer Responsibility Obligations (Packaging Waste) Regulations 2005
Hazardous Waste (England and Wales) Regulations 2005
Landfill (England and Wales) Regulations 2002
List of Wastes (England) Regulations 2005
Waste Incineration (England and Wales) Regulations 2002
Waste Management Licensing Regulations 1994
79
Annex 5 – Regulatory Analysis (Templates)
Annex 5 contains a comprehensive analysis of the regulations identified in the Table of 
Current Regulations (Table 2).  Key findings are analysed in Annex 4A above.
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Legislation: N o t i f i c a t i o n  o f  N e w  S u b s t a n c e s  R e g u l a t i o n s  1 9 9 3 67 ( N O N S )
Summary of Purpose: NONS aims to identify the possible risks posed to people and the environment from placing new substances68 on the market69.  It 
does this by obtaining information about new substances so that users can be made aware of the dangers and if necessary, recommendations for controls to 
be made.  The supplier of the new substance is obliged to ensure that this information is available.  The review of the data included in a notification ensures 
that the substance is labelled for supply, and that there is sufficient information to take appropriate measures to reduce risks during use and disposal
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. New 
Substance
Part I -
Interpretation
NONS deals with substances that are 
placed on the market after September 
1981. Substances already included in 
the European Inventory of Existing 
Commercial Chemical Substances 
(EINECS), a list of commercial 
substances which were marketed in the 
EC at some time between 1 Jan 1971 
and 18 Sept 1981, are exempt from the 
NONs regulations.
Under the regulations, it is the 
responsibility of the supplier to 
determine whether or not their 
substance is on EINECS and therefore 
‘existing’.
1. Supplier decision – whilst accepted that the 
general knowledge relating to nanomaterials 
is increasing – it is unlikely that all suppliers 
will possess the necessary data to make an 
informed decision relating to whether a 
nanoparticle is a new substance or existing.   
A potential gap in notification may occur.
2(a) If not classed as a new substance:
Only changes in chemical structure constitute 
a new substance, whereas changes in form 
(e.g. size or shape) do not – exception is 
polymers. If nanomaterials are not classed as 
new substances and consequently are not 
subject to the notification system under 
NONS, no further assessment of the potential 
risks of these substances need be conducted.  
1. At present no entries exist in the 
Manual of Decisions70 relating to the issue 
of nanoparticle notification.  New guidance 
and policies are required to ensure that 
the Competent Authorities and the 
supplier have sufficient information 
available to make the necessary 
assessment.  For certain types of 
nanomaterials (carbon structures) there 
may need to be a precautionary principle 
approach requiring these to be 
automatically classed as new substances.  
2(a) There would be no additional 
information passed onto any subsequent 
users and the substance would pass 
through its lifecycle without additional 
scrutiny, therefore no labelling for supply 
and no information to introduce, where 
necessary, measures to reduce potential 
risks during use and disposal.  
                                                
67 Implementing part of EC Directive 92/32/EEC
68 A substance is a chemical element or compound in the natural state or obtained by any production process, including any additive necessary to preserve 
the stability of the product and any impurity deriving from the process used, but excluding any solvent which may be separated without affecting the stability of 
the substance or changing its composition.
69 Supplying a new substance includes selling it, lending it to someone else, passing it on, giving it away or importing it into the EC.
70 A manual, which records precedents and procedures for the interpretation on NONS, this is a guidance document and not legally binding.
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2(b)If classed as new substance
2(b) Substance is subject to the 
notification procedures outlined in Part II 
of the regulation.
2. Notification 
(*)
Part II
Notification is required when a new 
substance is placed on the market.  The 
notification scheme operates on a 
system whereby the content of any test 
package is in proportion to the level of 
the supply.  The more of a substance 
supplied the more in depth are the 
required tests.
2 part test:
a. New Chemicals – Level of testing 
required is determined by the mass 
produced, with the lowest mass trigger 
currently set at 10kg per annum.
b. Mass Triggers – the more of an 
existing substance that is produced, the 
more data on its properties are required 
by regulators.
1. Neither of the triggers used to determine 
the need for and extent of testing chemicals 
take account of particle size, therefore the 
production of an existing substance in 
nanoparticulate form does not trigger any 
additional testing.  As such reduced 
notification requirements exist for small 
quantities.
2. Regulations as a whole do not extend to 
‘downstream’ users (unless it has to be 
classified and a safety data sheet supplied 
with substance further down the stream) in 
terms of nanomaterials this may be more 
problematic due to the lack of scientific 
information currently available on the impacts 
of use.
1. As the properties of materials are 
known to change at the nanoscale, a 
precautionary approach is advised and 
under NONS nanomaterials should be 
subject to higher scales of testing and not 
subject to reduced notification procedures 
due to lack of quantity.  
2. This is a general NONS issue that is 
proposed to be addressed in REACH^, 
which will extend the responsibility to 
‘downstream’ users.
3. As raised in the Royal Society/Royal 
Academy report - consider “trigger levels” 
based on some property which reflects 
particle size.
3. Hazard 
Identification
Schedule 1 -
identification
Schedule 3 -
testing
1. Data from standard test methods is 
required on the physicochemical, 
toxicological and eco-toxicological 
properties of notified substances.
1(a) Toxicity of chemicals in the form of free 
nanomaterials cannot be predicted from their 
toxicity in a larger form and consequently in 
some cases they may/will be more toxic than 
the same mass of the same chemical in its 
larger form.
1(b) The standardised testing in terms of 
timing and extent outlined in NONs relating to 
hazardous may not be sufficient for 
nanomaterials. In terms of toxicology testing 
via the most relevant route of exposure –
there appears to be a gap as there is concern 
that in terms of nanos the inhalation route 
could arise earlier and more often because of 
the identified concerns for toxicity towards the 
respiratory tract via the route of exposure.
1(a&b) There may need to be a 
reassessment of the time and extent of 
the tests required for nanomaterials.  This 
would not be an overcomplicated 
alteration to the existing regulations.  
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2. Schedule 1 outlines dangerous 
substance and the categories of danger 
and their characteristic properties.
1 (c)  Concern has been raised by the HSE in 
terms of the possibility of the use of ‘read-
across’ – using data from an existing 
substance as a prediction of the toxicity of the 
new substance.
2. Reference values in terms of nanomaterials 
may need to be reassessed due to the lack of 
scientific data on the toxic properties of 
chemicals at this scale.
1 (c) Appropriate guidance for suppliers is 
required to ensure that substances 
classed as new nanomaterials are not 
automatically assessed against existing 
data for the microsized form.
2. While the Schedule in paragraph (c) 
allows an exemption from the 
classifications it is premised on the 
availability of facts, which currently may 
not be available and as such the 
exemption may need to be expanded to 
ensure that nanomaterials do not escape 
the reference values.
4. Exposure 
Assessment 
Schedule 2
Need to assess the potential for 
exposure.
Given that the notification process will pre-
empt complete production there is not usually 
any measured data available.  Assessment 
therefore qualitative.
Further guidance likely to be required and 
a different metric for testing exposure may 
be required.
5. Risk 
Assessment & 
Risk 
Management (**)
Part III
Competent Authority71 responsible for 
carrying out any necessary risk 
assessments of the real and potential 
risks created by the substance to 
human health and the environment.
As identified by the EC, this is not an 
appropriate allocation of responsibility – as 
the suppliers of substances are a more direct 
source of information – therefore the risk 
assessment is not use specific, which could 
be significant in terms of nanomaterials.
General risk assessment responsibilities 
likely to be altered in REACH^ to place 
responsibility on manufacturer, importer or 
user. 
Applying a precautionary approach, 
nanomaterials could be treated as if they 
were hazardous and appropriate risk 
management procedures adopted.
Linked 
Legislation
* - CHIP – Substances to be packaged and labelled in accordance with the requirements of the Chemicals (Hazard Information & 
Packaging) Regulations 1993 – nanomaterials not yet fully tested should fall under the requirement to carry the label “Caution –
substance not yet fully tested”.
** - COSHH72 – The information provided for a NONS notification should enable recipients of new substances who use them in their 
workplace to apply the requirements of COSHH.  Further users of new substances need to be able to put in place the necessary 
containment, personal protective equipment and disposal measures, any gaps in NONS will subsequently impact on the ability of 
further uses to comply under the terms of related regulations.
Horizon 
Scanning
^ Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH) – due to replace NONS and other chemical 
regulations throughout the EC.
Key feature of draft REACH is that the tonnage triggers for required information are higher than in NONS, consequently, the regulation 
of nanomaterials could be more relaxed under the regime.  However, REACH should introduce testing requirements not only for ‘new’ 
                                                
71 In England & Wales the Competent Authority is  Health & Safety Executive working in partnership with the Environment Agency.
72 Control of Substances Hazardous to Health Regulations 2002.
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chemicals but also for those previously classed as ‘existing’.  REACH is expected to place greater responsibility on the manufacturer 
and introduce more standardised testing procedures, therefore if REACH can be extended to include substances at the nanoscale –
better regulation through the lifecycle of the substance will be introduced.
Legislation: Registration, Evaluation and Authorisation of Chemicals  (REACH)73
Summary of Purpose: The proposed new EU chemicals policy will require producers and importers of intentionally produced chemicals to register them 
along with the information needed to use them safely including basic health and environmental safety information on all chemicals they started producing and 
importing before 1981.  The aim of this new legislation is to increase the necessary level of protection required for the safe use of chemicals by placing 
responsibility for the safety of chemicals on manufacturers.  At present no date has been set for the introduction of REACH within the EU.  As this proposal is 
still under negotiation it is premature to analysis in detail the impact of REACH on nanotechnology.  REACH will replace major pieces of legislation including 
NONS and ESR and it is expected to place greater responsibility on the manufacturer and introduce more standardised testing procedures, therefore if 
REACH can be extended to include substances at the nanoscale – better regulation through the lifecycle of the substance will be introduced.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Definition 1. Definition - “a chemical element and 
its compounds in the natural state or 
obtained by any manufacturing process, 
including any additive necessary to 
preserve its stability and any impurity 
deriving from the process…”.
A key consideration in this regard is the fact 
the nano-equivalent of a substance could 
have different physicochemical and 
ecotoxicological properties from the 
substance itself. 
1(a) If nano-equivalent is considered to be a 1(a) The registrant may submit a different 
                                                
73  This proposed new directive will replace the Dangerous Substances Directive, the Dangerous Preparations Directive, the Safety Data Sheets Directive, 
ESR, the Marketing and Use Directive and associated Directives.
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2. All substances are covered under the 
regulation unless they are explicitly 
exempted under its scope.
different substances?
1(b) If the nano-equivalent is considered to be 
the same as the registered substance?
2. Other materials exempt from the REACH 
Regulation such as intermediates and 
polymers may also pose regulatory gaps 
under REACH.
registration dossier for the nano-
substance (if produced in volumes greater 
than 1 tonne/yr).  This means that the 
manufacturer would be required to 
generate hazard information on 
nanomaterials prior to placing them on the 
market.
1(b) The hazard information would still be 
available, although the appropriateness of 
the data for the potential risks of 
nanomaterials would be open to 
discussion.
It is recommended that chemicals in the 
nanosize scale be treated as new 
substances under REACH.  As recognised 
by the HSE Report74 the trigger thresholds 
limits could be reassessed once relevant 
data becomes available.
2. Registration Requires manufacturers and importers 
of chemicals to register them and 
provide relevant information on their 
substances and to use that data to 
manage them safely.
1. Registration is reliant on tonnage triggers. 
These triggers for required information are at 
present higher than those required in NONS.   
As a consequence, nanomaterials could 
escape the requirements for the collection and 
submission into the regulatory system of 
information on nanomaterials.  It is, therefore, 
unclear how REACH will capture 
nanomaterials based on tonnage exceptions 
and the different levels of data requirements.
2. Data requirements will vary according to 
the tonnage of substances produced with the 
threshold being set at 1 tonne per year – this 
may be too high a threshold for 
nanomaterials.
1. The regulation of nanomaterials based 
on tonnage as a threshold, as proposed 
for existing chemicals under REACH, 
needs to be considered further because 
there are many more nanoparticles to the 
tonne than is the case for larger particles, 
and their behaviour in the body and in the 
environment may be different (SCENIHR,
2005). 
2. There is currently no limit to the 
potential applications and uses of 
nanoparticles – as such regulations need 
to be able to address relevant factors in 
particular thresholds.
3. Authorisation REACH process will identify extremely No tonnage trigger required.  Current estimate In France commentators have urged that 
                                                                                                                                                                                                                                         
74 Health & Safety Executive, Review of the adequacy of current regulatory regimes to secure effective regulation of nanoparticles created by nanotechnology
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hazardous chemicals and classify them 
as ‘substances of very high concern’.  
Those so identified will be made subject 
to a process known as authorisation.  
Goal is that chemicals so identified are 
phased out and replaced with suitable, 
safer replacements.
is that this is likely to be a small percentage 
(below 5%)75.  A gap exists as again 
chemicals at the nanosize scale have not 
been included.
nanomaterials should be considered a 
special class of very high concern under 
REACH76.   Once evidence is obtained on 
the impact they can, where appropriate, 
be moved from this classification.
4. Risk 
Assessment & 
Management of 
Risk
1. Proactive approach to risk 
assessment (or evaluation) undertaken 
for dangerous substances over 10 
tonne/yr and for substances of 
particular concern
2. Under REACH, responsibility for the 
management of the risks of substances 
should lie with the enterprises that 
manufacture, import, place on the 
market or use these substances.
1. Only applies to substances supplied in 
quantities over 10 tonne/yr (unless of 
particular concern)
2. Only applies to substances supplied in 
quantities over 1 tonne/yr (unless of particular 
concern)
REACH will introduce testing 
requirements not only for ‘new’ chemicals 
but also for those previously classed as 
‘existing’.  However, there is a question 
over whether the tests required is relevant 
for the risk assessment of nanomaterials 
as methodologies for chemical safety 
assessment are based on ‘conventional’ 
methodologies for assessing chemical 
risks which may not be appropriate for 
assessing risks associated with nano-
substances.
5. Timescales The full implementation period for 
REACH is expected to be 2016 – with 
the highest volume chemicals and those 
known to have dangerous properties to 
be dealt with first.  By 2016 it is 
expected that there will be safety data 
sheets on approximately 30,000 
chemicals.
This list excludes substances at the nanosize 
scale, consequently any inclusion is likely to 
increase the estimated number of chemical 
substances covered.
Linked 
Legislation
Horizon 
Scanning
                                                                                                                                                                                                                                         
75 European Environmental Bureau, Countdown to REACH, media briefing on the new EU chemicals policy, 
76 AFFSET Report, 2006
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Legislation: Biocidal Products Regulations 2001 (as amended)77
Summary of Purpose: Broadly speaking, the Regulations cover non-agricultural pest control products.  The Regulations aim to control human and 
environmental exposure to biocidal products by establishing a framework for applications to be made for agreement at Community level that an active 
substance can be used in a biocidal product, and by requiring that authorisation is sought and granted before biocidal products to which these Regulations 
apply are placed on the market.  The Regulations stipulate that no person shall place on the market a new active substance for use in a biocidal product 
unless an application to a competent authority has been made for inclusion of that new active substance in Annex I, IA or IB of Directive 98/8/EC.  
Furthermore, no person shall place on the market or use a biocidal product unless that biocidal product has been authorised in accordance with the 
provisions of the Regulations.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Definition of 
‘biocidal product’
Regulation 2 defines ‘biocidal product’ 
as:
‘an active substance or a preparation 
containing one or more active 
substances, in the form in which it is 
supplied to the user, intended to 
destroy, deter, render harmless, prevent 
the action of, or otherwise exert a 
controlling effect on, any harmful 
organism by chemical or biological 
means’.
No gap identified. It is foreseen that nanomaterials will be 
used in the manufacture of biocidal 
products.
2. Active 
Substances
 Regulation 4 prohibits the placing on 
the market of an active substance in a 
biocidal product unless an application 
has been made to Ministers or the 
competent authority for the inclusion of 
a new active substance listed in Annex 
I, IA, or IB to the Directive.  Regulation 
5 requires that an application is 
accompanied by a dossier setting out 
specific information about the safety of 
the substance.  The Directive requires 
that a dossier includes the following 
information:
 Applicant
 Identity of the active substance
 1.  Incomplete information base
Lack of complete information about 
nanomaterials might preclude a full safety 
assessment based on the data requirements 
set out in the Directive.  In the absence of full 
information, the exercise of judgement might 
result in inconsistencies in the application of 
regulatory requirements.   
                                                
77 Implementing the EC Directive 98/8/EC
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 Physical and chemical properties of 
the active substance
 Methods of detection and 
identification
 Effectiveness against target 
organisms and intended uses
 Toxicological profile for man and 
animals including metabolism
 Ecotoxicological profile including 
environmental fate and behaviour 
 Measures necessary to protect man, 
animals and the environment
 Classification and labelling
3. Biocidal 
products
Regulation 8 prohibits the marketing of 
biocidal products without prior 
authorisation or registration in 
accordance with the Regulations.
Ministers shall not authorise a biocidal 
product unless:
(a) the following conditions are satisfied, 
namely:
(i) at least one active substance in the 
biocidal product is included in Annex I 
at the time the authorisation is granted;
(ii) any other active substances in the 
biocidal product are included in Annex I 
or Annex IA at the time the 
authorisation is granted; and
(iii) any requirements set out in Annex I 
or Annex IA relating to the active 
substances in the biocidal product have 
been fulfilled; and
(b) the Ministers have made the 
determinations referred to in Schedule 
3.
 1.  Whether safety requirements are 
sufficiently broad to encompass potential risks 
posed by nanomaterials.
The principal problem arises from the lack of 
information relating to potential risks which in 
turn precludes a full safety assessment.   
See Chemicals (Hazard Information and 
Packaging for Supply) Regulations 1994 
regulatory analysis template.
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Schedule 3 sets requires that the 
biocidal product in question has no 
unacceptable effects on the target 
organisms, human or animal health, 
surface water or groundwater, or on the 
environment.
Regulation 9 goes on to stipulate that 
Ministers shall not authorise a biocidal 
product for use by the public, or for 
placing on the market for use by the 
public, where that biocidal product is 
classified as:
(a) toxic;
(b) very toxic;
(c) carcinogenic category 1;
(d) carcinogenic category 2;
(e) mutagenic category 1;
(f) mutagenic category 2;
(g) toxic for reproduction category 1; or
(h) toxic for reproduction category 2.
Note that this classification is conducted 
in accordance with the Chemicals
(Hazard Information and Packaging for 
Supply) Regulations 1994.
A dossier supporting the application is 
also required.  The dossier contain 
information such as the physical and 
chemical properties of the biocidal 
product relating to use, storage and 
transport; the product-type and field of 
use of the biocidal product; the intended 
category of users; the intended method 
of use; and efficacy data.
4. Frame-
formulations
Regulation 18 establishes a mechanism 
for frame-formulations.  Accordingly, 
Ministers may, at the same time 
1.  Whether the inclusion of nanoparticles in 
substances already authorised or registered 
would fall under Regulation 18.
It is recommended that biocidal products 
containing nanomaterials are deemed to 
have sufficiently different properties to 
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as granting an authorisation in respect 
of a biocidal product under regulation 9 
or 13, or granting a registration in 
respect of a biocidal product under 
regulation 10 or 14, issue a frame-
formulation which includes that biocidal 
product and they shall communicate 
that frame-formulation to that applicant.
A frame-formulation is a reference to 
specifications for a group of biocidal 
products which have the same use; are 
used by the same type of user; and 
contain the same active substances of 
the same specification, and whose 
composition, when compared with the 
composition of a biocidal product which 
has been authorised or registered in 
accordance with these Regulations, is 
the same as the composition of that 
biocidal product.
In conducting this comparison, 
variations which do not reduce the 
efficacy of, nor affect the level of risk 
associated with, the biocidal products in 
question shall be disregarded.
A potential gap arises if a biocidal product 
manufactured containing nanomaterials is 
deemed to be sufficiently similar to a biocidal 
product already authorised or registered, thus 
triggering a Regulation 18 frame-formulation.
their bulk material counterparts, thus 
falling outside the scope of Regulation 18.
Linked  
Legislation
Chemicals (Hazard Information and Packaging for Supply) Regulations 1994
Plant Protection Products Regulations 2005 – covers agricultural pesticides and prohibits the use of pesticides without prior 
approval.
Fertiliser Regulations 1991
Horizon 
Scanning
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Legislation: C h e m i c a l s  ( H a z a r d  I n f o r m a t i o n  a n d  P a c k a g i n g  f o r  S u p p l y )  R e g u l a t i o n s  
2 0 0 2 78
Summary of Purpose: CHIP applies to suppliers of dangerous chemicals and deals with the marketing of dangerous substances and preparations.  Its 
purpose is to protect people and the environment from the effects of those chemicals by requiring suppliers to provide information about the dangers and to 
package chemicals safely.  CHIP requires suppliers of chemicals to decide whether they are 'dangerous' and in what way, and then provide information to 
their customers in the form of warning labels and safety data sheets. The chemicals must also be packaged properly.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Classification Requires suppliers to identify, and 
where appropriate, categorise the 
hazards of the substances supplied. 
Suppliers determine what kind of 
hazards associated with the chemical 
and explain the hazard – known as the 
Risk Phrase.
Regulations exclude a number of 
substances e.g. cosmetics and 
medicines.  
CHIP applies if the substance or 
preparation is hazardous.
To classify substances, suppliers are obliged 
to use the UK ‘Approved Supply List79’, which 
contains substances that have been 
examined under various systems e.g. NONS, 
ESR, BPR and substances considered 
through an EU-wide procedure.  Currently, no 
‘existing80’ substances at the nanoscale have 
been through this system.  Consequently, it 
will be at the discretion of the supplier to 
determine the classification – this self-
classification could lead to potential gaps.
1. If classed as hazardous?
Supplier would be required to provide 
information relating to the hazards of the 
substance supplied.
2. If classed as non-hazardous?
Subsequent users would be dependent on 
existing data as no new data would be 
generated on the potential risks or hazards 
relating to the identified nanomaterial, 
consequently, nanomaterials could move 
through their lifecycle without any further 
Due to the general lack of available data 
on nanomaterials and any consequential 
impacts and subsequent hazards – the 
process of classification could lead to 
incorrect classifications resulting in any 
potential hazards not being addressed 
down the supply chain.  If the 
classification is wrong then all subsequent 
elements under CHIP may be wrong.
This determination could have 
consequences on subsequent legislation 
applicable to the use of the substance and 
on the potential controls to reduce 
damage to human health or the 
environment.  
                                                
78 As amended 2005 (SI 2571) and enacts the EC Dangerous Substances Directive, the Dangerous Preparations Directive and the Safety Data Sheets 
Directive
79 Is the document entitled "Information Approved for the Classification and Labelling of Dangerous Substances and Dangerous Preparations (Eighth Edition)" 
approved by the Health and Safety Commission on 26 July 2005
80 An "existing substance" is defined as one that is listed in the European Inventory of Existing Commercial Chemical Substances (EINECS) and was placed 
on the market before September 1981
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assessment of their properties. 
2. Supply CHIP deals specifically with the supply 
of chemical substances.  Supply 
includes: sell, offer for sale, provide 
commercial samples, import or transfer 
chemicals from one person to another. 
Supply must include package to avoid 
spillage or inadvertent exposure along 
the supply line, and to label them so 
that all those transporting them or 
receiving them know something about 
the substances.
This requires the supplier to possess 
knowledge on the indications of danger, with 
the lack of available data – it is likely that this 
procedure may not be complied with fully.
The main potential gap problem will be the 
reliance on suppliers to classify and 
provide data on nanomaterials, which at 
present is not available.  Once data 
becomes available specified guidance is 
advised.
3. Information Regulations require suppliers to give a 
“materials safety data sheet” or msds, 
for every substance supplied. The types 
of information required include:
Physical and Chemical properties, 
Stability and reactivity, Toxicological 
Information, Ecological Information, 
Disposal considerations and Transport 
information 
If considered a new substance – a safety data 
sheet will be required for hazardous 
nanomaterials.
1. General issue is the lack of sufficient 
information and knowledge available on 
toxicological hazards, appropriate exposure 
limits – it will be difficult to provide the relevant 
data and undertake the necessary risk 
assessments.  As highlighted in the HSE 
review, concern exists over the quality of the 
data and the interpretation of this data by 
others. 
2. HSE has also raised concern in terms of 
the possibility of the use of ‘read-across’ –
using data from an existing substance as a 
prediction of the toxicity of the new 
substance81.
3. New exposure scenarios may have to be 
developed for the safety data sheets for 
nanomaterials.
1. This issue should lessen once data 
becomes available.
2. Appropriate guidance for suppliers is 
required to ensure that substances 
classed as new nanoparticles are not 
automatically assessed against existing 
data for the microsized form
Linked 
Legislation
Control of Major Accident Hazards Regulations - COMAH legislation requires notification (in the UK, to HSE) of sites where
substances with hazardous properties that correspond to certain CHIP classification criteria are stored in quantities above specified 
tonnage triggers.  Information provided under CHIP will be used by employers to assess and manage the risks within the work place.
                                                
81 Health and Safety Executive, Review of the adequacy of current regulatory regimes to secure effective regulation of nanoparticles created by 
nanotechnology
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Control of Substances Hazardous to Health Regulations 2002 – Information provided on safety data sheets will be used by 
employers to assist with their risk assessment obligation under this regulation.
Notification of New Substances Regulations 1993 – requires standardised testing of hazardous properties of new chemical 
substances, those substances identified as new feed into EU level and Annex I of the Dangerous Substances Directive.
Dangerous Substances Directive – As part of the ongoing restructuring of the Community water policy, the Directive 76/464/EEC 
on Dangerous Substances is now integrated in the Water Framework Directive (2000/60/EC) which was adopted in September 
2000, and Directive 76/464/EEC will be fully repealed in 2013. Directive 76/464/EEC has been codified as Directive 2006/11/EC on 
pollution caused by certain dangerous substances discharged into the aquatic environment of the community.
Dangerous Substances and Explosives Atmospheres Regulations - Employers’ use of the information in the safety data sheets to 
assess and manage the risks covered by this type of workplace control law.
Carriage of Dangerous Goods (Classification, Packaging and Labelling) and Use of Transportable Pressure Receptacles 
Regulations 1996 
Plant Protection Products Regulations 1995
Horizon
Scanning
Globally Harmonised System – currently under negotiation in the EU, this will introduce a new system for classification and labelling of substances 
and preparations, which will replace the current EU system and therefore CHIP.  The aim of GHS is to introduce a worldwide system for hazard 
communication; it will therefore be a vital development for the control of nanomaterials.  It aims to develop a common and coherent approach to 
defining and classifying hazards, and communicating information on labels and safety data sheets and as consequence will provide the underlying 
infrastructure for establishing national, comprehensive chemical safety programs.  GHS is proposed to cover all types of chemicals and will be based 
on intrinsic properties (hazards) of chemicals and includes dilute solutions and mixtures.  Pharmaceutical, food additives, cosmetics and pesticide 
residues in foods will not be covered at the point of intentional intake but will be covered where workers may be exposed and also extends to 
transportation.  Classification includes health and environment hazards, physical hazards and mixtures.  Communication of the hazards is via labels 
and safety data sheets.  Possible gap may arise as the test of hazards looks to known ingredient information and due to the lack of available data on 
nano-ingredients the test may be incomplete.  An important element of GHS is a requirement to include precautionary information in order to 
harmonise precautionary statements.
Legislation: C o n t r o l  o f  M a j o r  A c c i d e n t  H a z a r d  R e g u l a t i o n s  1 9 9 9 82
Summary of Purpose:  COMAH applies mainly to the chemical industry, but also to some storage activities, explosives and nuclear sites, and other 
industries where threshold quantities of dangerous substances identified in the Regulations are kept or used.  It applies to companies that manufacture, store 
or transport dangerous chemicals and explosives and deals with the assessing the risks and consequences of fire, explosion and substantial release of toxic 
chemicals in an industrial incident. A key element of COMAH is the increased emphasis on major accidents that may affect the environment.
                                                
82 As amended by Control of Major Accident Hazards (Amendment) Regulations 2005.   They implement Council Directive 96/82/EC known as the Seveso II 
Directive, as amended by Directive 2003/105/EC
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Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Notification Requires notification of sites where
substances with hazardous components 
and which correspond to certain CHIP* 
classifications are stored in quantities 
above specified tonnage triggers.
This is a self classification process with the 
onus being on a site operator to identify the 
appropriate hazardous classification in order 
to determine whether or not COMAH applies. 
However, part of the notification procedure 
involves an agreement between operator and 
regulator on a risk assessment and 
identification of the relevant measures to 
mitigate the risk.  Access to available data on 
the potential effects is fundamental to the 
effective applicability of this regulation.  
The effective operation of this regulation 
depends on the availability of reliable 
information. Historically, many substances 
have been marketed and used without 
their hazardous properties having been 
fully explored.83  Without appropriate 
guidance, there is a danger that this may 
also occur in the assessment of 
nanomaterials.
2. Dangerous 
Substances
Schedule 1
Schedule 1 provides a list of identified 
substances (Part 2) which will be 
classed as dangerous under the 
regulation and a further list of 
categories (Part 3) to be applied to 
substances not specifically identified 
under Part 2.
Most nanomaterials are likely to fall outside 
the very prescriptive COMAH definition of a 
‘dangerous substance’, and therefore will not 
be covered by these Regulations.  Many 
potential sources for nanomaterials (e.g. 
aluminium, copper, iron, silver, titanium) which 
could be considered dangerous are not 
referred to in the list. 
1. If definition not applicable to 
nanomaterials?
If chemicals at the nanosize scale do not 
comply with the definition, no further 
assessment of the potential risks need be 
undertaken and no safety precautions 
required.
2. If definition applicable to nanomaterials? 
Nanomaterial is then subject to threshold 
triggers - may still escape coverage under the 
regulations due to the relatively high threshold 
requirements (see box 3 below).
The actual level of danger in terms of a 
major accident hazard will depend on their 
potential impacts on human health and the 
environment – this will be dependent on 
future information on the impacts of 
nanomaterials.  Whilst accepted that 
quantities are likely to be small, it cannot 
be assumed that the reactions and 
impacts of ecotoxicological properties of 
nanomaterials will be the same as their 
macro-equivalents.  For example, recent 
research has shown that the explosive 
properties of nanopowders are greater 
due to the increased surface area.
3. Threshold 
Triggers
Two-tier system.
Sets down a variety of thresholds 
Even where the ‘dangerous substance’ 
definition is met, unlikely that the quantities of 
Gap in regulation could be addressed by 
recognising the nanoscale properties of 
                                                
83 Health and Safety Executive, Review of the adequacy of current regulatory regimes to secure effective regulation of nanoparticles created by 
nanotechnology
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against each of the identified 
substances and categories.  If 
thresholds met or exceeded Tier 1 
thresholds a Major Accident Prevention 
Plan must be prepared. If Tier 2 
thresholds are met or exceeded 
additional requirement of a Safety 
Report and an off-site emergency plan.
materials produced and stored will meet the 
requirements of COMAH regulations.
The threshold levels provided refer to the 
maximum quantities, which are present at any 
time and as such unlikely to extend the 
coverage of the regulations to nanomaterials. 
chemicals can be classed as toxic or very 
toxic thereby ensuring they are captured 
under dangerous substances definition 
and subsequently the availability of a 
lower threshold. However the lower tier 
requires no assessment of the potential 
risk on the surrounding environment.
4. Risk 
Assessment**
Sites classed under the top tier are 
required to provide a safety report, 
which will require a risk assessment. 
Risk assessment involves 
understanding the nature of hazardous 
situations, what their outcome may be 
and how likely it is that adverse effects 
will occur.  Risk assessments can be 
undertaken to different levels of detail: 
qualitative, semi-quantitative and 
quantitative.
To undertake an appropriate risk assessment, 
data must be relevant to the actual 
formulation used – consequently an 
assessment of the range of formulations with 
a corresponding range of effects and 
subsequently a range of effects data.  At 
present it is unlikely that this range of data is 
available to fully comply with risk assessment 
requirements.  If effective risk assessments 
are not possible, the relevant management 
systems may not be put in place by the 
operator.
Additional guidance will be required to 
ensure that any potential effects are 
captured.
Linked 
Legislation
* - Chemicals (Hazard Information and Packaging for Supply) Regulations 2002 - CHIP requires suppliers of chemicals to decide 
whether they are 'dangerous' and in what way, and provide information to their customers in the form of warning labels and safety 
data sheets. The chemicals must also be packaged properly.
** - Pollution Prevention and Control (England & Wales) Regulations 2000 – risk assessment procedures required under this 
regulation are potentially available to operators with a duty under COMAH.
Horizon 
Scanning
Legislation: C o n t r o l  o f  S u b s t a n c e s  H a z a r d o u s  t o  H e a l t h  R e g u l a t i o n s  2 0 0 2 84
Summary of Purpose:  The main piece of legislation covering control of the risks to employees and other people arising from exposure to harmful 
substances generated out of or in connection with any work activity under the employer's control.  The main objective of the Regulations is to reduce 
occupational ill health by setting out a simple framework for controlling hazardous substances in the workplace.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
                                                
84 Implementing all or parts of the following Community provisions: Directive 78/610/EEC; Directive 89/677/EEC; Directive 90/394/EEC; Directive 96/55/EC; 
Directive 98/24/EC; Directive 2000/54/EC.
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1. Scope Extends to hazardous materials which 
are supplied substances, substances 
generated during work activity, naturally 
occurring substances and biological 
agents.
No gap identified. The general framework of COSHH should 
provide the relevant protections to 
nanomaterials in the work place when 
information on the effects and impacts of 
these substances become more available.  
Alterations may need to be made to 
guidance documents as this information 
becomes available.
2. Hazardous to 
Health
Is in the Approved Supply List* with 
Harmful, Toxic, Very Toxic, Irritant or 
Corrosive, is present as a dust at a 
concentration greater than 4 mg/m3 
(respirable fraction) or 10mg/m3 
(inhalable fraction), as 8-hour time-
weighted average values; has an 
approved occupational exposure limit 
and/or represents a risk to human 
health from its presence or the way it is 
used in the workplace.
Linked to CHIP** due to the reference to the 
Approved Supply List85 as a means of 
identifying hazardous substance.  Currently, 
no ‘existing’ substances at the nanoscale 
appear on this list.  Consequently, it will be at 
the discretion of the supplier to determine the 
classification – this self-classification could 
lead to potential gaps.  As such the gap in 
CHIP impacts on the effectiveness of this 
regulation.  If the substance is not classed 
under CHIP, no safety data sheet will be 
prepared and as a consequence employers 
will not, as a rule, undertake any risk 
assessment of the substance in the work 
place and therefore not prepare any risk 
management procedures.
From current, limited understanding of the 
toxicology of nanomaterials it would be 
unwise to regard exposures to
nanomaterials at or below 4 mg/m3 (8h 
TWA) respirable dust as representing 
adequate control associated, confidently, 
with health protection86.
3. Risk 
Assessment (Reg. 
6)
To be conducted by using available 
information on the hazards and 
knowledge of the local conditions of 
exposure.  A list of elements for 
consideration is contained in the 
regulation.
Risk assessment are therefore based on both 
sound scientific information and past 
experience; in terms of nanomaterials this 
information is likely to be incomplete and 
there are likely to be deficiencies in the level 
of available information It has been stated that 
in terms of nanotechnology there is a lack of 
the following:
a. sufficient toxicological hazard information 
for most nanoparticles;
b. reliable, affordable and standardised 
Conventional methods of measuring dust 
concentration may give incorrect results88. 
Consequently, users may need to 
consider whether current protective 
methods are appropriate in relation to 
chemicals at the nanoscale.
Safety Data Sheets supplied by suppliers 
under CHIP is often used as a source of 
information for employers, however as 
outlined in the assessment of CHIP, the 
                                                
85 Is the document entitled "Information Approved for the Classification and Labelling of Dangerous Substances and Dangerous Preparations (Eighth Edition)" 
approved by the Health and Safety Commission on 26 July 2005
86 Health and Safety Executive, Review of the adequacy of current regulatory regimes to secure effective regulation of nanoparticles created by 
nanotechnology
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exposure measurement and
characterisation methods; and
c. an agreed definition of the most appropriate 
dose metric(s) to use in hazard and exposure 
studies87.
Without this basic information, conducting an 
appropriate risk assessment will be very 
difficult and therefore developing or applying 
the appropriate risk management procedures.
general lack of available information 
impacts on this regulation as well.
4. Risk 
Management
Employers must prevent exposure, 
where this is not reasonably practical 
they must adequately control it.  They 
are required to ensure that control 
measures are used.
COSHH principles of good control should be 
capable of being adapted to the control of 
nanomaterials.  However, the performance 
and effectiveness of conventional methods 
will need to be assessed e.g. PPE89 will only 
provide the intended level of protection if 
correctly specified or fitted.
One of the recommendations in the Royal 
Society/Royal Academy of Engineering 
report (Appendix I) is to suggest the 
introduction of occupational exposure 
limits for manufactured nanoparticles that 
are lower than might be the case for 
somewhat similar materials in larger 
particle form.
Linked 
Legislation
* - Notification of New Substances Regulations 1993 – requires standardised testing of hazardous properties of new chemical 
substances, those substances identified as new feed into EU level and Annex I of the Dangerous Substances Directive, transposed 
into the UK at the Approved Supply List.
** - Chemical (Hazardous Information and Packaging for Supply) Regulations 2002 - Identification and classification of 
nanomaterials will be the responsibility of suppliers under CHIP, this initial classification can be used by subsequent users who will 
also rely on the information provided in ‘Safety Data Sheets’.
Horizon 
Scanning
Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH) – due to replace NONS and other chemical 
regulations throughout the EC.
Key feature of draft REACH is that the tonnage triggers for required information are higher than in NONS, consequently, the regulation 
of nanoparticles could be more relaxed under the regime.  However, REACH should introduce testing requirements not only for ‘new’ 
chemicals but also for those previously classed as ‘existing’.  REACH is expected to place greater responsibility on the manufacturer 
and introduce more standardised testing procedures, therefore if REACH can be extended to include substances at the nanoscale –
better regulation through the lifecycle of the substance will be introduced.
Legislation: Dangerous Substances and Explosive Atmospheres Regulations 200290
                                                                                                                                                                                                                                         
87 Health & Safety Executive, Nanotechnology, Horizon Scanning Information Note No HSIN1
88 Health & Safety Executive, Nanotechnology, Horizon Scanning Information Note No HSIN1
89 Personal Protective Equipment
90 Implementing Directive 98/24/EC on the protection of the health and safety of workers from the risks related to chemical agents at work, and Directive 
99/92/EC on minimum requirements for improving the safety and health protection of workers potentially at risk from explosive atmospheres.
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Summary of Purpose: The Dangerous Substances and Explosive Atmosphere Regulations 2002 implement Directive 98/24/EC on 
the protection of the health and safety of workers from the risks related to chemical agents at work, and Directive 99/92/EC on 
minimum requirements for improving the safety and health protection of workers potentially at risk from explosive atmospheres.  
The Regulations impose certain obligations employers to eliminate or reduce risks from fire, explosion, or other events arising from 
the hazardous properties of a ‘dangerous substance’.  
Content for 
Analysis
Summary of regulations Gap or Potential Gap Comment/Impact
I. Definitions
Regulation 2(1)
Regulation 2(1) defines a ‘dangerous 
substance’ as:
 A substance or preparation which 
meets the criteria in the Approved 
Guide to the Classification and 
Labelling of Dangerous Substances 
and Dangerous Preparations for 
classification as a substance or 
preparation which is explosive, 
oxidising, extremely flammable, 
highly flammable or flammable, 
whether or not that substance or 
preparation is classified under the 
Chemicals (Hazard Information and 
Packaging for Supply) Regulations 
2002;
 A substance or preparation which 
because of its physico-chemical or 
chemical properties and the way it 
is used or is present at the 
workplace creates a risk, not being 
a substance or preparation falling 
within the subparagraph above; or
 Any dust, whether in the form of 
solid particles or fibrous materials or 
otherwise, which can form an 
explosive mixture with air or an 
explosive atmosphere, not being a 
Breadth of definition
The question is whether the Regulation 2(1) 
definition is sufficiently broad to encompass 
substances containing nanoparticles.
To date, no substances containing 
nanoparticles have been through the 
Approved Guide system.91  It falls to the 
discretion of the supplier, therefore, to 
determine whether a substance is to be 
classified as ‘dangerous’.  Given the lack of 
information about the implications of exposure 
to nanoparticles, it is conceivable that no 
evidence of risk is construed as ‘no risk’ of 
harm.  Comparison of substances containing 
nanoparticles with non-nanoparticle 
counterparts might result in inaccurate risk 
predictions.
Lacking data about exposure in the workplace 
to nanoparticles also poses a potential 
problem in respect of the second and third 
subparagraphs.  An HSE report has identified 
that increasing range of explosive materials 
are being manufactured as nanopowders.92  
Although extensive literature on explosive 
characteristics of micron-scale powders, no 
data on nanopowders. 
It is recommended that the implications of 
exposure to nanoparticles in the 
workplace are examined, and criteria 
developed to ensure robust safety 
assessment.
                                                
91 HSE, Review of the Adequacy of Current Regulatory Regimes to Secure Effective Regulation of Nanoparticles Created by Nanotechnology (HSE; 2006).
92 Health and Safety Laboratory, Literature Review: Explosion Hazards Associated with Nanopowders, HSL/2004/12 (HSe; 2004).
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substance or preparation falling 
within either subparagraph above.
‘Risk’ is defined as ‘the likelihood of a 
person’s safety being affected by 
harmful physical effects being caused to 
him from fire, explosion or other events 
arising from the hazardous properties of 
a dangerous substance in connection 
with work and also the extent of that 
harm’. 
II.  Employer 
responsibility 
and risk 
assessment
Regulation 3 of the Management of 
Health and Safety at Work Regulations 
1999 require an employer to conduct a 
risk assessment.  Regulation 5 of the 
Dangerous Substances and Explosive 
Atmospheres Regulations 2002 require 
employers to conduct an additional risk 
assessment where a dangerous 
substance is or may be present at the 
workplace.
Employers are required to eliminate or 
reduce risk so far as is reasonably 
practicable (Regulation 6(3)); to make 
arrangements for dealing with 
accidents, incidents and emergencies 
(Regulation 8); and to provide 
employees with precautionary 
information, instruction and training 
where a dangerous substance is 
present at the workplace (Regulation 9).
Incomplete knowledge base
See above.
Lacking data about workplace exposure to 
nanoparticles will have an impact on the 
accuracy of safety assessments.  See 
above.
Incomplete information will also have a 
bearing on the effectiveness of safety 
measures put un place according to 
employer obligations set out in 
Regulations 6, 8 and 9.
Linked 
Legislation
Chemical (Hazard Information and Packaging for Supply) Regulations 2002
Management of Health and Safety at Work Regulations 1999
Horizon 
Scanning
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Legislation: Health and Safety at Work etc. Act 1974 (as amended)93
Summary of Purpose: securing the health, safety and welfare of persons at work; protecting persons other than persons at work against risks to health 
or safety arising out of or in connection with the activities of persons at work; controlling the keeping and use of explosive or highly flammable or otherwise 
dangerous substances, and generally preventing the unlawful acquisition, possession and use of such substances; and controlling the emission into the 
atmosphere of noxious or offensive substances from premises of any class prescribed
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
Health, Safety 
and Welfare in 
connection with 
Work, and 
Control of 
Dangerous 
Substances and 
Certain 
Emissions into 
the 
Atmosphere.
Part I–
Interpretation.
The Act requires employers to ensure 
the health, safety and welfare of every 
employee at work as far as is 
reasonably practicable. The scope of 
employers’ duties range from 
maintaining plant and work systems, 
providing necessary information, 
instruction, training, and supervision to 
ensure safety at work, to the 
maintenance of employees’ working 
environment to make it safe and without 
risks to health.
Employers also have health, welfare 
and safety obligations to non-
employees.
Manufacturers, importers, or suppliers 
of articles and substances used at work 
are obliged to ensure that such articles 
or substances pose no risks to the 
health, welfare and safety of persons at 
work; and that necessary information be 
furnished on the use of and design of 
articles and substances.
     
Although the Act makes no direct allusion to 
nanoparticles, they are ostensibly covered by 
the definition of ‘substance’ as “…any natural 
or artificial substance (including micro-
organisms), whether in solid or liquid form or 
in the form of a gas or vapour”.94 It is 
desirable to have nanoparticles expressly 
mentioned in the definition of substance used 
in article or plant at work place due to their 
increasing industrial use.  
The term: “so far as is reasonably 
practicable” is used to qualify employers 
and manufacturers’ duty to ensure safety 
of employees and non-employees at work 
place. A higher level of responsibility 
might be desirable with regards to 
nanoparticles used in industrial settings 
due to the uniqueness of their properties 
and the potential dangers they pose to 
persons at work. 
Risk 
Management
The Act requires employers to provide 
and maintain safety equipment and safe 
systems of work, ensure materials used 
With current deficit of information, employers 
may not be able to comply with the necessary 
arrangements where information on how to 
                                                
93 Chapter 37
94 Section 53(1)
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are properly stored, handled, used and 
transported, provide information, 
training, instruction and supervision and 
ensure staff are aware of instructions 
provided by manufacturers and 
suppliers of equipment.
manage potential risks from the manufacture, 
supply and use of nanmaterials is not 
available.  However, as the Act includes the 
terms ‘so far as is reasonably practicable’ 
employees will not be held liable if their 
existing systems do not extend to the 
potentials risks from nanomaterials.
Schedule 3 –
Subject Matter 
of Health and 
Safety 
Regulations
Schedule 3 details the scope of 
prohibited acts as well as certain 
obligatory requirements with regards to 
handling of articles or substances at 
work place. These range from the 
manufacture, supply, importation, 
transportation, labelling, etc., of any 
article or substance.
Again there is no specific mention of 
nanoparticles. The definition of ‘substance’ as 
“any natural or artificial substance (including 
micro-organisms), whether in solid or liquid 
form or in the form of a gas or vapour”, would 
appear to cover nanoparticles.
Although the Executive or local authorities 
may appoint inspectors to enforce the 
provisions of the Act, there are no specific 
requirements on inspectors’ qualifications. 
It is even doubtful at this stage whether 
inspectors have enough qualifications or 
expertise for thorough assessments of 
dangers posed to health and safety by 
nanoparticles.   
Linked 
Legislation
The Agriculture (Safety, Health and Welfare Provisions) Act 1956; 
The Employment Medical Advisory Service Act, 1972; 
The Public Health Act 1961; 
The Factories Act, 1961; Management of Health and Safety at Work Regulations, 1999; 
Control of Substances Hazardous to Health Regulations 2002 (COSHH)
Horizon 
Scanning
Legislation: A m m o n i u m  N i t r a t e  M a t e r i a l s  ( H i g h  N i t r o g e n  C o n t e n t )  S a f e t y  R e g u l a t i o n s  2 0 0 3
Summary of Purpose: This prescribes activities for dealing with ammonium nitrate in solid form, where its nitrogen content is more that 28% of its 
weight. Includes action to be taken by manufacturers, importers, suppliers and enforcement authorities and the need to pass a detonation resistance test.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Scope Extends to the requirement of the need 
to satisfy a detonation resistance test 
for the manufacture of ammonium 
nitrate based fertiliser manufactured 
chemically and for safety controls for 
other ammonium nitrate material.
The manufacture of fertiliser is a current 
application for nanomaterials. The main focus 
of the Regulations is on the need to obtain a 
detonation resistance certificate and does not 
regulate any potential environmental hazards 
and risks associated with the use of these 
products.  It is possible that other 
environmental risks of nanomaterials would 
The scope of the regulations is very 
limited and it will not deal with any of the 
potential risks or effects that may arise 
from the use of nanomaterials in fertiliser.
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not be addressed for fertilisers and plant 
nutrients.
2. Risk 
Assessment
Risks identified and applicable 
management procedures deal with the 
potential for detonation.
There is no legal requirement for the provision 
of risk calculation and characterisation, other 
than for the explosion hazard of high nitrogen 
content fertilisers (where these include 
nanomaterials).  Therefore there is no 
assessment required of the potential risks of 
nanomaterials and as such no management 
procedures to deal with any impacts arising 
out of the risk assessment.
Linked 
Legislation
The Fertiliser Regulations 1991 - control the composition, labelling and packaging of fertilisers. The Regulations do not contain a 
definition of ‘fertiliser’, thus products can claim to supply “plant nutrients” without a statutory declaration and no indication of their 
nutrient content.
The Protection of Water Against Agricultural Nitrate Pollution (England and Wales) Regulations 1996 (as amended 2002)
Action Programme for Nitrate Vulnerable Zones (England & Wales) Regulations 1999 (as amended 2003)
Horizon 
Scanning
EC Regulation 2003/2003 for fertilisers- specifies the composition, labelling, traceability, safeguards and packaging of EC fertilisers. 
The Regulation was made on 13 October 2003, and repealed four earlier Council Directives covering EC fertilisers into a single legal 
instrument.
Legislation: Batteries and Accumulators (Containing Dangerous Substances) Regulations 1994 (as amended)95
Summary of Purpose: The Batteries and Accumulators (Containing Dangerous Substances) Regulations 1994 prohibit the marketing of certain types of 
alkaline batteries and accumulators containing more than the specified levels of ‘heavy metals’ (mercury, cadmium, and lead); establish design requirements 
for certain battery-powered equipment; and require that batteries covered by Directive 91/157/EEC carry the appropriate chemical symbol.  The Regulations 
cover the marketing, recovery and disposal of batteries and accumulators. 
Content for 
Analysis
Summary of regulations Gap or Potential Gap Comment/Impact
I. Definition Regulation 2(1) defines a ‘battery or Appropriateness of set thresholds It might be argued that the mercury limits 
                                                
95 Implementing Directive 91/157/EEC on batteries and accumulators containing certain dangerous substances; and the Directive 93/86/EEC on symbols to 
indicate the separate collection of batteries and accumulators containing more than specified levels of dangerous substances (‘the Marking Directive’).
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accumulator’ as:
‘a source of electrical energy generated 
by direct conversion of chemical energy 
and consisting of one or more primary 
(non-rechargeable) batteries or 
secondary (rechargeable) cells 
containing:
(a) either
(i) more than 25mg mercury 
per cell; or
(ii) in the case of alkaline 
manganese batteries, more 
than 0.025% mercury by 
weight;
(b) more than 0.025% cadmium by 
weight; or
(c) more than 0.4% lead by weight.
Regulation 3 stipulates that no person 
shall market a prohibited battery.  It 
goes on to define a ‘prohibited battery’ 
as:
(a) an alkaline manganese battery 
which contains more then 
0.025% mercury by weight; or
(b) in the case of an alkaline
manganese battery for 
prolonged use in extreme 
conditions, which contains 
more than 0.05% of mercury 
by weight.96
Commission Decision 98/101/EC 
subsequently reduced permissible 
levels of mercury in primary and 
secondary cells to 0.0005%, prohibiting 
It is expected that nanomaterials will be used 
in the manufacture of batteries or 
accumulators.  The Regulations do not make 
reference to the method of production, so 
batteries and accumulators produced using 
nanotechnology can be expected to fall within 
the Regulations’ ambit.  
The issue is whether the thresholds of heavy 
metals are appropriately set to cover potential 
risks arising from batteries and accumulators 
containing nanomaterials, and furthermore, 
whether new products containing nano-
engineered heavy metals will fall within the 
definition of ‘prohibited battery’ in Regulation 
3.
set at an inappropriately high level, given 
the possible implications of human and 
environmental exposure to nanomaterials.  
If this is the case, nanomaterials in 
batteries and accumulators can enter the 
lifecycle creating hazard implications 
downstream of manufacture.  The second
possibility is that new batteries and 
accumulators are deemed to be ‘new 
products’ that fall outside the scope of the 
Regulation 3 definition of ‘prohibited 
battery’.  In this case, it is advisable that a 
separate provision is drafted to prohibit 
batteries and accumulators containing 
levels of nanomaterials that are 
considered to pose a threat to human 
health or the environment.
                                                                                                                                                                                                                                         
96 Note that definition of ‘prohibited battery’ excludes alkaline manganese button cells or batteries composed of button cells.
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the marketing of batteries and 
accumulators that breach this threshold.
II.  Design and 
packaging 
requirements
Regulation 4 sets out specific labelling 
and packaging requirements.  Batteries 
and accumulators containing more than 
specified levels of dangerous 
substances must be given a separate 
collection mark and the relevant heavy 
metal content mark.  In relation to 
batteries or accumulators placed on the 
market in Great Britain for sale within 
the Community, the obligation to ensure 
correct marking rests with the 
manufacturer.  If this is not the case, the 
obligation rests with the manufacturer’s 
authorised representative in Great 
Britain.
The Regulations, which implement the 
Marking Directive 93/86/EEC, require 
that batteries and accumulators covered 
by Directive 91/157/EEC are collected 
separately from other household waste.
Appropriateness of set thresholds
If the heavy metal content thresholds 
established in Regulation 2 are 
inappropriately set with regard to potential 
risks posed by nanomaterials, batteries and 
accumulators containing nanomaterials and 
comprising of levels of heavy metals below 
those specified in Regulation 2 can be 
marketed without separate collection or 
content marks.  This will result in the entry of 
nanomaterials into municipal waste stream. 
It is recommended that the definition of 
‘batteries and accumulators’ contained in 
Regulation 2 is considered in relation to 
potential implications of human and 
environmental exposure to products that 
fail to satisfy the heavy metal thresholds 
and are this beyond the scope of the 1994 
Regulations.
III. Use of 
batteries or 
accumulators in 
appliances
Regulation 5(1) requires that 
manufacturers of batteries and 
accumulators ensure that those 
batteries or accumulators can be easily 
removed from consumer appliances in 
which they are used.  Regulation 5(2) 
imposes additional labelling 
requirements, stipulating that 
appliances excluded from Regulation 
5(1)  must be accompanied by 
instructions which inform users of the 
appliance content of environmentally 
hazardous batteries or accumulators 
contained therein; and which show how 
the batteries or accumulators can be 
safely removed.  Excluded appliances 
include reference cells in scientific and 
professional equipment; batteries and 
Narrow scope of ‘excluded appliances’
Although the list of excluded appliances 
contained in Schedule 1 to the Regulations 
potentially covers existing and future 
applications of nanotechnology, its scope is at 
present restricted.  
In order to reduce entry of nanomaterials 
into municipal waste stream and minimise 
environmental exposure, appliances 
containing batteries and accumulators 
comprising of nanomaterials should also 
be subject to the Regulation 5(2) 
requirement that appliances are labelled 
so as to inform users of environmentally 
hazardous content.
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accumulators placed in medical devices 
designed to maintain vital functions and 
in pacemakers, where uninterrupted 
functioning is essential; and portable 
appliances, where replacement of the 
batteries by unqualified persons could 
create a safety hazard to the user or 
could affect the operation of the 
appliance.
Linked 
Legislation
Hazardous Waste (England and Wales) Regulations 2005
List of Wastes (England) Regulations 2005
Horizon 
Scanning
In November 2003 the Commission adopted proposal to revise the Batteries Directive 91/157/EEC following consultation with Member States.  The 
proposed legislation applies to all batteries and accumulators,97 regardless of chemical composition, use, or size.  In July 2005 the European Council 
formerly adopted Common Position on proposed Batteries Directive.  Its key objectives include: improving separate collection and recycling of spent 
batteries; reducing disposal of spent batteries in municipal waste stream. The new Directive was agreed on in May 2006.  It is expected to come into 
force in the UK in 2008.
Legislation: Medical Devices Regulations 2002 (as amended)98
Summary of Purpose: The Medical Devices Regulations 2002 consolidates UK law on medical devices and implements three Directives: Directive 
93/42/EEC concerning medical devices; Directive 98/79/EC on in vitro diagnostic medical devices; and Directive 90/385/EEC on implantable medical devices.  
The Regulations stipulate that, subject to certain specified exceptions, no person shall place on the market or put into service a medical device unless that 
device meets essential requirements.
Content for 
Analysis
Summary of regulations Gap or Potential Gap Comment/Impact
I. Scope of Part II of the Regulations cover ‘general 
medical devices’.99  Section 8 of the 
 No gap identified. The placing on the market of medical 
devices falling outside the scope of the 
                                                
97 With the exception of those used in military applications.
98 Implementing Directive 90/385/EEC on the approximation of the laws of Member States relating to Active Implantable Medical Devices; Directive 
93/42/EEC concerning Medical Devices; Directive 98/79/EC on In Vitro Diagnostic Medical Devices.
99 A ‘medical device’ is defined in the Regulations as: ‘an instrument, apparatus, appliance, material or other article, whether used alone or in combination, 
together with any software necessary for its proper application, which: 
(a) is intended by the manufacturer to be used for human beings for the purpose of:
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Regulations Regulations stipulates that no person 
shall place on the market or put into 
service a medical device unless that 
device meets essential requirements 
set out in Annex I of Directive 
93/42/EEC.
Part III covers ‘active implantable 
medical devices’.100  Section 22 of the 
Regulations stipulates that no person 
shall place on the market or put into 
service a medical device unless that 
device meets essential requirements 
set out in Annex I of Directive 
definitions provided is likely to be covered 
by the General Product Safety 
Regulations 2005.
                                                                                                                                                                                                                                         
(i) diagnosis, prevention, monitoring, treatment or alleviation of disease;
(ii) diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap;
(iii) investigation, replacement or modification of the anatomy or of a physiological process; or
(iv) control of conception; and
(b) does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, even if it is assisted in its 
function by such means,
and includes devices intended to administer a medicinal product or which incorporate as an integral part a substance which, if used separately, would be a 
medicinal product and which is liable to act upon the body with action ancillary to that of the device.’
100 ‘Active implantable device’ is defined in the Regulations as ‘a medical device which:
(a) relies for its functioning on a source of electrical energy or a source of power other than that generated directly by the human body or by gravity; and
(b) is intended to be totally or partially introduced into the human body (whether surgically or medically, including being introduced into a natural orifice) and 
which is intended to remain in the human body after completion of the surgical or medical procedure during which it is introduced,
even if it is intended to administer a medicinal product or incorporates as an integral part a substance which, if used separately, would be a medicinal 
product’.
101 ‘In vitro diagnostic medical device’ is defined in the Regulations as ‘a medical device which:
(a) is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment or system, whether used alone or in combination; and
(b) is intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, 
solely or principally for the purpose of providing information –
(i) concerning a physiological or pathological state,
(ii) concerning a congenital abnormality,
(iii) to determine the safety and compatibility of donations, including blood and tissue donations, with potential recipients, or
(iv) to monitor therapeutic measures,
and includes a specimen receptacle but not a product for general laboratory use, unless that product, in view of its characteristics, is specifically intended by 
its manufacturer to be used for in vitro diagnostic examination’.
106
90/385/EEC.
Part IV applies to ‘in vitro diagnostic 
medical devices’.101  Section 34 
stipulates that no person shall place on 
the market or put into service a medical 
device unless that device meets 
essential requirements set out in Annex 
I of Directive 98/79/EC.
II.  Safety 
requirements
Annex I to Directive 93/42/EEC requires 
that medical devices are designed and 
manufactured in such as way as to 
guarantee the characteristics and 
performances referred to as ‘general 
requirements’ (Section I, Annex I).  As 
part of the ‘general requirements’, 
devices are designed and manufactured 
in such a way that:
‘when used under the conditions and for 
the purposes intended, they will not 
compromise the clinical condition or 
safety of patients, or the safety and 
health of users or, where applicable, 
other persons, provided that any risks 
which may be associated with their use 
constitutes acceptable risks when 
weighed against the benefits to the 
patient and are compatible with a high 
level of protection of health and safety.’
Annex I requires that particular attention 
is paid to the choice of materials used, 
particularly as regard toxicity.
Annex I to Directive 90/385/EEC also 
sets out general safety requirements, 
stipulating that active implantable 
medical devices must not present any 
risk to persons implanting them or, 
Incomplete knowledge base
It is recognised that knowledge about the 
implications of human exposure to 
nanoparticles is incomplete.  Despite the fact 
the each of the three Directives establish a 
general framework of safety, there remains, 
as with other current and future applications of 
nanotechnology, a paucity of information 
about the human health impact of exposure to 
nanomaterials.  
Although the specific requirement that the 
toxicity of materials used is taken into 
consideration on assessing safety might be 
expected to identify potential risks associated 
with nanoparticles, it is conceivable, given an 
incomplete knowledge base, that a thorough 
assessment of toxicity can be conducted.
Vigour of safety requirements
Annexes to Directives 93/42/EEC and 
90/385/EEC explicitly require that in 
assessing the safety of medical devices, 
attention must be paid to the choice of 
materials used and their toxicity.  Annex I to 
Directive 98/79/EC makes no reference to 
taking into account the toxicity of particular 
materials used in the design and manufacture 
of in vitro devices, although it is anticipated 
that in conducting safety assessments in 
general, material toxicity is a central 
It is recommended that the chemical 
properties and potential implications of 
uses of nanomaterials in the manufacture 
of medical devices are considered in 
further detail, and guidance issued.  
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where applicable, to other persons.  
Annex I goes on to note that in making 
a safety assessment, particular 
attention is to be paid to the materials 
used and their toxicity.
Annex I to Directive 98/79/EC 
stipulates, in its design and 
manufacturing requirements, that 
devices must be designed, 
manufactured and packed in such a 
way as to ‘reduce as far as possible the 
risk posed by product leakage, 
contaminants and residues to the 
persons involved in the transport, 
storage and use of the devices’.
consideration.
Linked 
Legislation
General Product Safety Regulations 2005
Medicines Act 1968
Horizon 
Scanning
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Legislation: Medicines for Human Use (Marketing Authorisations etc.) Regulations 1994 (as amended) 102
Summary of Purpose: The Medicines for Human Use (Marketing Authorisations etc.) Regulations 1994 implement a series of Community provisions 
relating to the marketing of medicinal products.  A manufacturer is prohibited from placing on the market any medicinal product unless marketing has been 
authorised by the competent authority in each Member State.  In the UK, the competent authority is the Medicines and Healthcare products Regulatory 
Agency (MHRA).  
Content for 
Analysis
Summary of regulations Gap or Potential Gap Comment/Impact
I. Definition Regulation 3 provides that no ‘relevant 
medical product’ shall be placed on the 
market or distributed by way of 
wholesale dealing unless prior 
authorisation has been granted by the 
licensing authority (MHRA) or the 
European Commission.
‘Relevant medical product’ is defined 
as:
‘a medicinal product for human use to 
which Chapters II to V of Council 
Directive 65/65/EEC apply, and 
accordingly includes the industrially 
produced medicinal products mentioned 
in Article 2.2 of that Directive’.
Whether incorporation of nanomaterials into 
existing product would require additional 
authorisation
Although it is foreseen that nanomaterials will 
be used in the production of medicinal 
products (brining new products containing 
nanomaterials within the scope of the 
Regulations), determining whether the 
marketing of existing products containing 
nanomaterials is covered by previously 
granted authorisation attached to the 
production question might be open to dispute.  
The addition of nanomaterials to products in 
relation to which authorisation has been 
granted raises questions about the extent to 
which a product must be modified before 
requiring separate authorisation.  This is 
further dealt with in relation to application 
procedure, below.
Medicinal products for research and 
development
The Regulations do not extend to cover 
medicinal products intended for research and 
development trials.  This creates a potential 
gap in the regulation of potential risks 
See below.
Note that the List of Wastes (England) 
Regulations 2005 includes ‘waste from 
human or animal health care and/or 
related research’ as hazardous waste for 
the purposes of the Hazardous Waste 
(England and Wales) Regulations 2005.
                                                
102 Implementing Directive 2001/83/EC on the Community Code relating to medicinal products for human use (as amended); Directive 65/65/EEC; Directive 
75/318/EEC; Chapters I to II and V to VI of Council Directive 75/319/EEC and any Regulation adopted by the Commission under Article 15 of that Directive; 
Directive 89/342/EEC; Directive 89/343/EEC; Directive 89/381/EEC; Directive 92/26/EEC; Directive 92/27/EEC; Directive 92/73/EEC; Regulation (EEC) No. 
2309/93 and any Regulations adopted by the Commission under Article 15.4 or 22.1 of that Regulation.
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associated with nanomaterials, relating in 
particular to the subsequent disposal of 
products and downstream environmental 
exposure to potentially hazardous 
substances.
II.  Application 
procedure
Applications for the grant, renewal, or 
variation of a marketing authorisation 
must be made in accordance with 
Community provisions.
Article 8 of Directive 2001/83 requires 
that an application includes information 
such as: the name of the medicinal 
product; description of manufacturing 
method; method and route of 
administration; description of control 
measures employed by the 
manufacturer; and results of physico-
chemical, biological or microbiological 
tests, toxicological and pharmacological 
tests, and clinical trials.
Article 10 provides that an applicant is 
not required to provide results of 
toxicological, pharmacological tests or 
clinical trials if he can demonstrate that:
i. That the medicinal product is 
essentially similar to a 
medicinal product authorised in 
the Member State concerned 
and that the holder of the 
marketing authorisation for the 
original product has consented 
to the toxicological, 
pharmacological and/or clinical 
references contained in the file 
Interpretation of ‘essentially similar’
The interpretation of ‘essentially similar’ will 
determine whether a new medicinal product 
falling within the broad scope of the definition 
of ‘relevant medicinal product’ provided in 
Regulation 3 requires separate authorisation 
prior to marketing.  One of the principal 
concerns with nanomaterials is their higher 
toxicity, relative to that found in their non-
nanomaterial equivalents.  In the event that a 
medicinal product is deemed to be ‘essentially 
similar’ to a marketed medicinal product (the 
implication being that there is no requirement 
that the applicant provides toxicological, 
pharmacological, or clinical trial test results),  
it is conceivable that medicinal products 
containing nanomaterials will enter onto the 
market without a  sufficiently robust safety 
assessment.
Adequacy of information base of safety 
assessment
In the event that medicinal products 
containing nanomaterials are not deemed to 
be ‘essentially similar’ to marketed products, 
and thus subject to separate safety 
assessment testing, the appropriateness of 
existing testing procedures under Directive 
2001/83/EC for testing the safety of 
nanomaterials in medicinal products might be 
questioned.  The application procedure set 
out in Article 8 of Directive 2001/83 requires 
In the interests of the protection of human 
health, it is recommended that medicinal 
products containing nanomaterials are 
distinguished from products already 
placed on the market pursuant to Directive 
2001/83.
                                                
103 Directive 87/22/EEC of 22 December 1986 on the approximation of national measures relating to the placing on the market of high-technology medicinal 
products, particularly those derived from biotechnology.
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on the original medicinal 
product being used for the 
purpose of examining the 
application in question; or
ii. That the constituent or 
constituents of the medicinal 
product have a well established 
medicinal use, with recognised 
efficacy and an acceptable level 
of safety; or
iii. That the medicinal product is 
essentially similar to a 
medicinal product which has 
been authorised in accordance 
with Community provisions in 
force, for not less than six years 
and is marketed in the Member 
State for which the application 
is made.  This period is 
extended to 10 years in the 
case of high-technology 
medicinal products having been 
authorised under Article 2(5) of 
Directive 87/22/EEC.103
that an applicant provides the competent 
authority with information including a 
qualitative and quantitative analysis of the 
constituents and of the finished product, the 
presence of heavy metals, biological and 
toxicological test results.  Given the novelty of 
applications of nanotechnology, it is likely that 
the data required in order to conduct thorough 
safety assessments is lacking.
Linked 
Legislation
 Veterinary Medicines Regulations 2005
 Medicines Act 1968: A number of independent advisory committees are established under the Medicines Act 1968, including the 
Medicines Commission (MC), and the Committee on the Safety of Medicines (CSM).  The MC is established under section 2 of the 
1968 Act.  In addition to providing advice to the UK Licensing Authority on policy issues relating to drug regulation, the MC acts as 
an appellate body for proposals to revoke or suspend a national marketing authorisation or to refuse applications to vary a 
marketing authorisation, and for appeals for human and veterinary use marketing authorisation applications that have been refused 
by the licensing authority on the basis of advice from the CSM or the Veterinary Products Committee.  The CSM is established 
pursuant to section 4 of the 1968 Act.  Its principal functions include considering applications for marketing authorisations, and 
advising Ministers and the UK Licensing Authority on the quality, efficacy and safety of medicines to ensure the maintenance of 
public health safety standards.
Horizon 
Scanning
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Legislation: Motor Fuel (Composition and Content) Regulations 1999 (as amended)104
Summary of Purpose: The 1999 Regulations implement Directive 98/70/EC relating to the quality of petrol and diesel fuels.  The Directive sets technical 
specifications on health and environmental grounds for fuels to be used for vehicles equipped with positive ignition and compression ignition engines.
Content for 
Analysis
Summary of regulations Gap or Potential Gap Comment/Impact
I. Environmental 
specifications
Annexes I to IV set out environmental 
specifications for market fuels to be 
used for vehicles equipped with positive 
ignition and compression ignition 
engines.  Specifications are set out in 
relation to a number of listed 
parameters, including:
 Oxygen content
 Lead content
 Sulphur content
 Hydrocarbon analysis
 Polycyclic aromatic hydrocarbons
 Cetane number
 Research octane number
 Motor octane number
Parameter limits (minimum and 
maximum) are set according to weight, 
temperature, percentage concentration, 
pressure, or volume, depending on the 
parameter in question.
Appropriateness of parameter limits
The issue is whether the parameter limits are 
set at appropriate levels to prevent the 
materialisation of potential risks to human 
health or the environment posed by 
nanoparticles in motor fuel.  The limits set in 
Annexes I to IV do not refer to particle size.  It 
is conceivable that the present limits would fail 
to capture potential threats arising from the 
use of nanomaterials in this context. 
The overarching safety framework 
established by the General Product Safety 
Regulations 2005 applies, should the 
parameter limits fail to capture potential 
risks arising from the placing on the 
market of fuel containing nanoparticles.
Linked 
Legislation
General Product Safety Regulations 2005
Horizon 
Scanning
Legislation: E n d  o f  L i f e  V e h i c l e s  R e g u l a t i o n s  2 0 0 3  ( E L V ) 105
                                                
104 Implementing Directive 98/70/EC relating to the quality of petrol and diesel fuels.
112
Summary of Purpose: The regulation is an example of extended producer responsibility (EPR), which requires that vehicles put on the market after July 
2003 may not contain lead, cadmium or hexavalent chromium.  Integral to the concept of EPR is that waste management is seen as part of the product 
lifecycle.  The regulation also requires that all ELVs are only treated by authorised dismantlers, a concentration on reuse, recovery and recycling as the 
preferred disposal means and that vehicles are de-polluted before recycling.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Scope The Regulations apply to new and end 
of life vehicles106 and their materials and 
components, irrespective of how the 
vehicle is serviced or repaired. A central 
aim is to reduce the amount of waste 
from vehicles and to encourage reuse, 
recovery and recycling.
The process involved in disposal, destruction 
or recycling of components containing 
nanomaterials may pose an increased 
potential risk of exposure to workers in 
recycling and disposal industry and to the 
environment.  Further information on the 
impacts will be required.
The concept behind EPR applies equally 
to nanomaterials, requiring producers or 
manufacturers to minimise human and 
environmental exposure to free 
nanoparticles at all stages of the lifecycle 
and should also form an integral part of 
the innovation and design process.  If 
nanomaterials are accurately classified 
and increased information on potential 
impacts become available these 
regulations should ensure that 
nanomaterials are captured and managed 
appropriately.
2.Hazardous 
Substance*
The regulations require that hazardous 
materials are removed before a vehicle 
is dismantled. It is defined as any 
substance which is considered to be 
dangerous under Directive on 
Dangerous Substances107  and as such 
on the Approved Supply List108^.  
Where a hazardous material is 
permitted it must be labelled.
Currently, no ‘existing’ nanomaterial 
substances appear on this list.  Operators 
potentially dependent on classification of ELV 
waste by waste generator or disposer - the 
lack of data available may mean that 
substances in nanosized form will not be 
classed as a dangerous substance.  (See also 
potential gaps in List of Waste/CHIPs 
regulations).
If classed as ‘hazardous’?
It is recommended that due to the lack of 
available scientific information on the 
impacts of nanomaterials, wastes resulting 
from the development, manufacture, 
supply and use of nanoparticles are 
classed as hazardous.  This will require 
producer guidance.
                                                                                                                                                                                                                                         
105 End-of-Life Vehicles (Producer Responsibility) Regulations 2005 SI 263 - The Regulations require a producer to register with the Secretary of State and 
declare responsibility for those vehicles which he has placed on the market.  A producer is required  to submit to the Secretary of State an application for 
approval of the system he has established to collect vehicles for which he is responsible and the system for collection must contain sufficient capacity to treat 
those end-of-life vehicles for which he is responsible.   The regulations introduce reuse, recovery and recycling targets for end-of-life vehicles treated at 
authorised treatment facilities.
106 End-of-Life vehicle means a vehicle which is waste within the meaning of Article 1(a) of the Waste Directive.
107 Directive 67/548/EEC – Annex I lists about 5,000 substances with their classification and labelling.
108 Is the document entitled "Information Approved for the Classification and Labelling of Dangerous Substances and Dangerous Preparations (Eighth 
Edition)" approved by the Health and Safety Commission on 26 July 2005
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Hazardous components are removed from 
waste vehicle and segregated, thereby 
reducing the potential for contamination.  
Nanomaterials identified as hazardous and 
permitted will therefore be labelled.  However, 
if applying List of Wastes – there is no 
hazardous code for e.g. plastics and therefore 
plastics containing nanomaterials would either 
have to be coded without identification to 
plastic or not be identified as hazardous, 
however plastic components must be 
identified by the use of standard component 
codes.
If not classed as ‘hazardous’?
Component containing nanomaterials may not 
be segregated and may be incorrectly 
disposed via a means which may result in 
higher exposure.
3. Heavy Metals Producers must ensure that materials 
and components of vehicles put on the 
market do not contain lead, mercury, 
cadmium or hexavalent chromium 
except in the cases listed in Schedule 1.
The issue will be whether the prohibited 
materials will have a nano equivalent.  If they 
do whether the nano equivalent is classed as 
an ‘existing’ substance – if it is a potential gap 
may arise if the nano form is assessed on the
same principles as the macro form.
If the nano form is classed as a ‘new’ 
substance and therefore assessed on its own 
potential risks, a gap may arise if the new 
substance falls out of the scope of the 
regulations.
4. Information 1. Coding Standards: Producers must 
use standard component codes to 
identify any parts, which contain plastics 
or rubbers to facilitate recycling
2. Dismantling Information: The 
dismantling information shall identify, in 
so far as it is needed by treatment 
facilities, the different materials and 
components of the vehicle, and the 
location of all hazardous substances in 
1. Plastics & rubbers are a leading potential 
area for nanotechnology applications – codes 
may need to be reassessed to differentiate 
between plastics and rubber with and without 
nanomaterials – particularly if the presence of 
nanomaterials causes the components to 
react differently to treatment.
2. Main potential issue is the lack of available 
data on nanomaterials to allow a producer to 
As more information becomes available 
about the potential risk presented by 
releases at end of life, it may be 
necessary to consider whether this 
regulation needs to be modified to set out 
how such materials should be managed.
114
the vehicle
3. Reporting: including information on 
the environmentally sound treatment of 
ELV
provide the necessary information to comply 
with this regulation.  This will include the 
necessary information on how nanomaterials 
should be managed e.g. whether ELV waste 
containing nanomaterials is suitable for reuse, 
recovery or recycling. 
3. As per (2) above, the issue is the lack of 
available data required to comply with this 
particular regulation.
5. Technical 
Requirements for 
keeping and 
treating
Sets down a number of minimal 
technical requirements at treatment site 
including the need for impermeable 
surfaces and provided with spillage 
collection facilities, decanters and 
cleanser-degreasers.
These minimal technical requirements may 
need to be reconsidered in light of information 
on the management requirements for 
nanomaterials.
Linked 
Legislation
^ - Dangerous Substances Directive –Annex I of this Directive, chemicals examined under NONS, ESR or BPR will have the 
classification and labelling agreed at the EU level and entered into Annex I – this is implemented in the UK as the Approved Supply 
List - Currently no substances at nanosized form listed under the Approved Supply List.
* - Chemical (Hazard Information & Packing for Supply) Regulations 2002 – Identification and classification of nanomaterials will 
be the responsibility of suppliers under CHIP, this initial classification can be used by subsequent users who will also rely on the 
information provided in ‘Safety Data Sheets’.
* - List of Waste Regulations 2005 – Will assist in the identification of hazardous waste components 
Horizon 
Scanning
EC Communication “Towards a European Strategy for Nanotechnology” - In that communication, the EC stressed that 
nanotechnology must be developed in a safe and responsible manner. As such, the EC urged that any potential public health, safety, 
environmental and consumer risks be addressed up front by generating the data needed for risk assessment, integrating risk 
assessment into every step of the lifecycle of nanotechnology-based products, and adapting existing methodologies (and, as 
necessary, developing new ones) for the regulation of nanomaterials.  The explicit mention of ‘lifecycle’ approach leads to the 
important conclusion that products containing nanomaterials must be managed after use to ensure that none of these materials can 
escape into the environment.
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Legislation: R e s t r i c t i o n  o f  t h e  U s e  o f  C e r t a i n  H a z a r d o u s  S u b s t a n c e s  i n  E l e c t r i c a l  
a n d  E l e c t r o n i c  E q u i p m e n t  R e g u l a t i o n s  2 0 0 5  ( R o H S )
Summary of Purpose: The RoHS Regulations ban the putting on the EU market of new Electrical and Electronic Equipment (EEE) containing more than 
the permitted levels of lead, cadmium, mercury, hexavalent chromium and both polybrominated biphenyl (PBB) and polybrominated diphenyl ether (PBDE) 
flame retardants from 1 July 2006. There are a number of exempted applications for these substances.  The regulations extend to the product, components 
and subassemblies of such products.  RoHs falls under the extended producer responsibility (EPR) regime.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Hazardous 
Substances
"Hazardous substance" means lead, 
mercury, cadmium, hexavalent 
chromium, polybrominated biphenyls or 
polybrominated diphenyl ethers in 
quantities exceeding the maximum 
concentration value levels (0.1% by 
weight).  It extends to 8 classes of 
EEE*.
The regulations also include a list of 
exempt applications – Schedule 2.
1. The definition of hazardous substances 
under the Restriction of Hazardous 
Substances (RoHS) Directive does not 
include nanomaterials; there is the potential 
for some of these hazardous substances to 
also be available at the nanoscale e.g. 
cadmium-based quantum dots.  This is not a 
complete ban on these substances only on 
products not containing more than the 
permitted level of restricted substance.  The 
concentration level has been derived from 
information of the impacts of these restricted 
substances at the macro level and therefore 
the availability at the nanoscale may require 
reassessment of appropriate concentration 
value levels. 
2. If nanomaterials are classed as new 
substances under NONS** and eventually 
under REACH, the definition in these 
regulations may need to be altered to ensure 
capture of any new nanosized form of the 
macro substance.
3. If nanoscale form classed as ‘existing’ 
substance danger that risk assessment based 
on macro substance and not the unique 
properties of the nano form.
Any potential gaps again will be 
dependent on the availability of data on 
the potential impacts of the nanoscale 
component in contrast to the macro scale 
component – as a consequence 
regulations may need to be adapted 
particularly in terms of concentration 
values for any identified nanoscale 
substances falling under the regulations’ 
definition of hazardous substance.
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Linked 
Legislation
* - Directive on Waste Electrical and Electronic Equipment (WEEE) – categories of EEE identified in RoHS comply with the same 
8 categories identified in Annex I of WEEE.
** - Notification of New Substances – new nanosized form substances derived from the macro scale substance may be classed as 
new substance under NONS.
Horizon 
Scanning
Legislation: D i r e c t i v e  2 0 0 2 / 9 6 / E C  o n  W a s t e  E l e c t r i c a l  a n d  E l e c t r o n i c  E q u i p m e n t  
( W E E E )
Summary of Purpose: The Directive aims to reduce the amount of WEEE being disposed to landfill by reducing the amount of WEEE produced, 
encouraging re-use and recycling by encouraging its separate collection and subsequent treatment.  It also aims to improve the environmental performance of 
producers by encouraging a lifecycle approach to the production of electrical and electronic equipment, including placing the responsibility of reuse and 
recycling on the producer.  It does not cover all electrical and electronic goods and a list is supplied.  The Directive is under consultation and is not expected 
to be implemented into UK legislation until 2007.  The Directive is an example of extended producer responsibility (EPR).
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Scope within the 
UK
The UK will introduce the requirements 
via the WEEE Regulations, currently not 
in force. In the UK it is likely that the 
Secretary of State will have powers to 
prepare and issue a code of practice for 
the purpose of providing practical 
guidance on the standards that must be 
met by the operator of a designated 
collection facility.
When information on the impacts and 
effects of nanomaterials becomes 
available, it may become necessary to 
readdress the methods of treating such 
components; this power could fill any 
potential gap if nanomaterials are 
captured by the intended UK regulations.
2. Removal of 
substances, 
preparations and 
components Annex 
II
The purpose of the Directive is at a 
minimum to remove from any 
separately collected WEEE a number of 
identified substances, preparations and 
components.  Those identified are to be 
disposed or recovered in accordance 
with the Waste Framework Directive*.
This list does not include any specific 
nanomaterials however as this is a non-
exhaustive list other substances can be added 
to this list, thereby providing for the inclusion 
in the future for any new substances which 
may pose a particular concern.
3. Re-use and 
treatment 
information 
Member States should make provisions 
for producers to provide reuse and
treatment information to reuse centres 
and treatment and recycling facilities for 
each new type of electrical and 
electronic equipment put on the market, 
At the current time, there is not the relevant 
level of nanomaterial data available to allow 
producers to comply fully with this provision.  
However, once this information becomes 
available this requirement will assist with 
the disposal of WEEE containing 
nanomaterials.
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including the location of dangerous 
substances and preparations.
4. Dangerous 
Substances & 
Preparations
Current definition of dangerous 
substances is any substance which is 
considered to be dangerous under 
Directive on Dangerous Substances109, 
in the UK this will be any substance on 
the Approved Supply List
There is the potential for identifying products 
containing nanomaterials.  However, this will 
be dependent on whether nanomaterials are 
classed as dangerous substances and 
therefore hazardous.  At present no ‘existing’ 
nanomaterial substance on this list.  If not 
classed as a dangerous substance or is 
incorrectly classed as non-hazardous, these 
substances may not be managed by the best 
available treatment, recovery and recycling 
techniques and thereby reducing any potential 
damage to human health and/or the 
environment.
This may also extend to the handling of any 
WEEE with employers not providing the 
adequate health and safety measures for 
employees and thereby not complying with 
COSHH110.
With the lack of available data on the 
potential risks posed by nanomaterials, it 
is advisable to apply the precautionary 
principle and class nanomaterials as 
hazardous thereby reducing any gaps that 
may occur throughout the regulatory 
framework.
5. Treatment 
Methods
1. The Directive requires that operators 
ensure that appropriate systems are 
available to provide for the treatment of 
WEEE using the best available 
treatment, recovery and recycling 
techniques.
2. The Directive also seeks to 
encourage the integration of recycled 
materials in new equipment.
1. None of the current specified treatment 
methods are intended to address the potential 
risks of nanomaterials.
2. With the lack of information on the reaction 
of nanomaterials to various processes, 
treatment methods may need to consider this 
requirement and additional research may be 
required.
This may need to be readdressed in time.
6. Private 
Household WEEE
1. The introduction of a take back 
scheme for EEE from domestic use to 
producer.
1. Potential gap may exist depending on the 
extent of the scheme if exemptions apply and 
the level of information available to the public 
to secure its effectiveness.
1. This should capture domestic WEEE, 
which may contain nanomaterials, this 
system is a step forward for domestic 
waste to reduce the amount of domestic 
waste containing nanomaterials being 
sent to landfill.
                                                
109 Directive 67/548/EEC – Annex I lists about 5,000 substances with their classification and labelling.
110 Control of Substances Hazardous to Health Regulations 2002
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2. Information – Distributor responsible 
for supplying information on the 
potential effects on human health and 
on the environment caused by the 
presence of hazardous substances in 
EEE.
2. With the current level of available 
information on nanomaterials it seems unlikely 
that distributors will be able to comply with this 
condition, resulting in a lack of available 
information being passed on to the public.
2. EPR may provide a step forward in 
closing the information gap loop, e.g. 
producers with a responsibility for 
ensuring the appropriate disposal of their 
products will also be responsible for 
providing the relevant reuse and treatment 
information.
Linked 
Legislation
* - Waste Framework Directive111 - The essential objective of all provisions relating to waste disposal must be the protection of 
human health and the environment against harmful effects caused by the collection, transport, treatment, storage and tipping of waste 
– central to this is the reduction of the amount of waste disposed to landfill.
Control of Substances Hazardous to Health Regulations 2002 – These will be applicable to the health and safety conditions of 
treatment facilities.
List of Waste Regulations 2005 – identification and coding of WEEE included in the list of wastes, WEEE arriving at sites will be 
classified using these codes – to date none accommodate identification of nanotechnologies but if identified as hazardous should be 
covered by the list, however list may need to be revised due to the introduction of nanomaterials as a potential contaminant.
Horizon 
Scanning
EC Communication “Towards a European Strategy for Nanotechnology” - In that communication, the EC stressed that 
nanotechnology must be developed in a safe and responsible manner. As such, the EC urged that any potential public health, safety, 
environmental and consumer risks be addressed up front by generating the data needed for risk assessment, integrating risk 
assessment into every step of the lifecycle of nanotechnology-based products, and adapting existing methodologies (and, as 
necessary, developing new ones) for the regulation of nanomaterials and nanoproducts.  The explicit mention of ‘lifecycle’ approach 
leads to the important conclusion that products containing nanomaterials must be managed after use to ensure that none of these 
substances are disposed in a manner which results in damage to human health or the environment.
Thematic Strategy on the prevention and recycling of Waste by the European Commission – seeks to encourage the use of waste 
as a resource and therefore increased recycling.
Legislation: P a c k a g i n g  ( E s s e n t i a l  R e q u i r e m e n t s )  R e g u l a t i o n s  2 0 0 3 112
Summary of Purpose: The main requirement of the regulation is that no person who is responsible for packing or filling products into packaging or 
importing packed or filled packaging into the United Kingdom may place that packaging on the market unless that packaging fulfils the Essential 
Requirements^ and is within the Heavy Metal concentration limits.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Essential 
Requirement –
Manufacturing and 
1. Design, production and 
commercialisation of packaging 
facilitates the potential to reuse, recover 
and recycle and should minimise the 
1. This provision is sufficiently flexible to 
extend to any packaging containing 
nanomaterials.  Nanomaterials are likely to be 
utilised in a number of packaging materials 
Due to the scope of materials covered by 
the regulations there are a number of 
significant applications for 
nanotechnology.
                                                
111 Council Directive 75/442/EEC
112 As amended 2004 (SI 1188) and 2006 (SI 1492)
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composition impact on the environment when 
packaging waste or residues from 
packaging waste management 
operations is finally disposed.
2. The presence of noxious and 
hazardous substances and materials 
are minimised with regard to their 
presence in emissions, ash or leachate 
when packaging or residues from waste 
management are incinerated or sent to 
landfill113.
e.g. plastic and nanomaterials whether 
classed as hazardous or not should be 
assessed as to their effectiveness to be 
disposed of via the waste management 
methods identified.  
2. The aim of the regulations and the 
Packaging Directive is to reduce the amount 
of noxious metals and other substances as 
well as the potential toxicity of packaging 
waste and to limit their environmental impact.  
Nanomaterials are likely to be captured under 
this regulation if they are classed as a 
hazardous substance or material and if so any 
emissions will be minimised.   As the 
regulations extend throughout the lifecycle of 
packaging including manufacturing; 
manufacturers will rely on information 
supplied to them by chemical suppliers who in 
turn will rely on data provided under NONS* 
notification.  Potential gaps at these stages 
will therefore impact on other users. 
Hazardous packaging waste will be coded 
under the List of Waste Regulations 2005**.
In applying a lifecycle analysis approach 
the design, production and 
commercialisation requirements should 
ensure that the impact on the environment 
and human health are limited even where 
there are likely emissions and/or
discharges*** as a result of the recovery 
process and the end disposal of any 
wastes resulting from the recovery.  
Currently, the lack of scientific information 
on the impacts of nanomaterials on 
human health and the environment is 
likely to prohibit a full lifecycle approach 
and as such to limit any potential harm 
from nanomaterials, it is recommended 
that they are classed as hazardous 
substances.
2. Regulated 
Metals
Aggregate heavy metal limits apply to 
cadmium, mercury, lead and hexavalent 
chromium in packaging or packaging 
components subject to some 
exceptions.
In the UK one of the main applications of 
nanotechnology is within metals and metal 
oxides – it is however, unlikely that the 
regulations do extend to metal components in 
their nanoform, particularly in terms of the 
applicable concentration values.  If the nano-
equivalent is classed as an ‘existing’ 
substance there is then the risk that the 
potential impacts will not be identified at the 
nanoscale but at the macro equivalent, 
thereby resulting in a gap in risk assessment 
and risk management.  If the nano-equivalent 
is classed as a ‘new’ substance it may not be 
If data indicated that the nanoscale form 
of heavy metals should be covered, this 
would be a simple alteration to the 
regulations.
                                                                                                                                                                                                                                         
113 Under the provisions of the Hazardous Waste (England & Wales) Landfill Regulations 2005 – any hazardous packaging sent to landfill must be sent to one 
designated to receive hazardous waste.
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covered by the regulations.
3. Exemption 
Criteria
The concentration levels of regulated 
metals shall not apply to plastic crates 
or plastic pallets on or before 4 March 
2009 provided certain requirements are 
fulfilled.
This limits the entry of external materials into 
the recycling process to that which is 
technically feasible to control and that no 
regulated material shall be intentionally 
introduced.  The technical specifications are 
unlikely to include any that are capable of 
addressing the identification of nanomaterials 
and the definition of intentionally introduced 
does not extend to the use of recycled 
material as feedstock where the recycled 
materials contains amounts of regulated 
metal.  The exemption criteria are therefore 
unlikely to capture nanomaterials, which could 
be contained in recycled material.
Linked 
Legislation
^ - as outlined in Annex II of Directive 94/62/EC of the European Parliament and the Council on packaging and packaging 
waste
* - Notification of New Substances Regulations 1993 – Determination of new substances and the hazard information necessary to 
reduce risks during use and disposal.
** - List of Waste (England & Wales) Regulations 2005 – Currently only two  hazardous codes available for contaminated 
packaging with one identified as a ‘mirror’ code requiring thresholds for hazardous properties to be met, as a consequence the 
threshold levels may be too high to ensure that packaging containing nanoparticles is identified as hazardous. 
Pollution Prevention and Control (England & Wales) Regulations 2000 - Operators of the potentially most polluting processes 
('prescribed processes' which are specified in the amended Environmental Protection (Prescribed Processes and Substances) 
Regulations 1991/472) have to apply for prior authorisation from the Environment Agency to operate the process. PPC requires 
operators to consider the total impact of all releases to air, water and land when making an application
Consumer Protection Act 1987  
Horizon 
Scanning
Legislation: P r o d u c e r  R e s p o n s i b i l i t y  O b l i g a t i o n s  ( P a c k a g i n g  W a s t e )  R e g u l a t i o n s  
2 0 0 5 114
Summary of Purpose: The 2005 Regulations place obligations on certain businesses to register with the relevant competent authority in each 
jurisdiction within the UK or via a ‘compliance scheme’, to recover and recycle specified tonnages of packaging waste each year and to certify that this 
recovery and recycling has been achieved. Some businesses must also provide certain information about recycling to consumers.  The UK has set a series of 
targets to be achieved each year to 2010.  The obligation is placed on any business which handles more than 50 tonnes of packaging per annum and has a 
turnover of more than £2 million per annum if it is involved in manufacturing raw materials for packaging, converting raw materials into packaging, filling 
                                                
114  Implementing Council Directive 94/62/EC on packaging and packaging waste as amended Council Directive 2004/12/EC and 2005/20/EC
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packaging, selling packaged goods as a service provider or importer.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Scope The primary aim is to reduce the overall 
quantity of packaging waste that is 
subject to final disposal and priority is 
given to the prevention of packaging 
waste and to reuse where possible.
The scope of the regulations is limited as they 
only apply to producers with a turnover of 
£2,000,000 and handled in aggregate more 
than 50 tonnes of packaging or packaging 
materials.  Small producers using 
nanomaterials will not be covered by the 
regulations and if nanomaterials are not 
classed as hazardous substances, the 
packaging can be disposed to landfill.
Irrespective of whether packaging 
contains nanomaterials, the purpose of 
the regulations is to reduce the amount of 
packaging being disposed to landfill and 
as such offers a means of reducing any 
potential impacts on the environment and 
human health from the final disposal of 
nanomaterials.
2. Recovery and 
Recycling 
Obligations
Producers are required to take 
reasonable steps to carry out specified 
tonnages of recovery & recycling of 
packaging waste.  Recovery includes 
recycling, composting and energy 
recovery****.
Many of the packaging materials listed are 
capable of being composed of nanomaterials 
– with the lack of available information on the 
potential impacts of nanomaterials it may be 
necessary to consider the potential impacts of 
the various disposal methods for this type of 
packaging materials if the nanomaterials are 
not classed as hazardous under the 
Dangerous Substances Directive**.  Any 
emissions levels will require to be controlled 
under the PPC*** regulations, which include 
waste management facilities as specified 
activity, as long as they fulfil the tonnage 
requirements. Small waste management 
facilities may not be covered by the PPC 
regulations if they do not meet the tonnage 
levels.
There is little scope for classifying 
packaging waste as hazardous with only 
‘mirror’ entry codes being available, which 
means that there is a scope for assessing 
whether the hazardous substance in terms 
of concentration thresholds and it is 
unlikely that nanomaterials will be 
captured by these concentration 
thresholds^.
3. Application for 
accreditation
Person seeking accreditation must 
provide information on the development 
of capacity for the collection and 
reprocessing of packaging waste and 
the development of new markets for 
materials or goods which have been 
made from recycled packaging waste 
and arrangements for the collection and 
separation of packaging.
Unlikely, in the present that such capacity will 
extend to the handling of nanomaterials or for 
the potential utilisation of recycled feedstock 
containing nanomaterials. At present it is 
unlikely that sufficient technical methods exist 
to separate nanomaterials from packaging.
Linked Packaging (Essential Requirements) Regulations 2003 – The regulations provide a list of essential requirements for all packaging 
and provide concentration levels for regulated metals.
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Legislation ** - Dangerous Substances Directive - List I and List II substances contained in the Dangerous Substances Directive 
(76/464/EEC), however as part of the ongoing restructuring of the Community water policy, the Directive on Dangerous Substances
is now integrated in the Water Framework Directive (2000/60/EC) which was adopted in September 2000, and Directive 76/464/EEC 
will be fully repealed in 2013. Directive 76/464/EEC has been codified as Directive 2006/11/EC on pollution caused by certain 
dangerous substances discharged into the aquatic environment of the Community.
*** - Pollution Prevention and Control (England & Wales) Regulations 2000 - Operators of the potentially most polluting 
processes ('prescribed processes' which are specified in the amended Environmental Protection (Prescribed Processes and 
Substances) Regulations 1991/472) have to apply for prior authorisation from the Environment Agency to operate the process. PPC 
requires operators to consider the total impact of all releases to air, water and land when making an application.  Limited to specific 
processes.
**** - Waste Framework Directive Annex II – Provides a list of recovery methods acceptable under the Directive.
Environment Act 1995 introduces the producer responsibility obligations. 
Waste Management Licensing Regulations 1994
^ - List of Waste (England & Wales) Regulations 2005 - Identifies substances as either ‘Absolute’ or ‘Mirror’ wastes.  Absolute 
wastes are always hazardous.  Mirror wastes may be hazardous or non-hazardous dependent on the concentration of dangerous 
substances.
Horizon 
Scanning
Thematic Strategy on the Prevention and Recycling of Waste by the European Commission – seeks to encourage the use of 
waste as a resource and therefore increased recycling.
Legislation: Control of Pesticides Regulations 1986
Summary of Purpose: The Control of Pesticides Regulations 1986 sets out an approval scheme for non-agricultural pesticides.  In 2001, Directive 
98/8/EC (which establishes a regulated single European market in biocides based on risk evaluation and harmonised authorisation) was transposed in the 
Biocidal Products Regulations 2001.  The Biocidal Products Regulations 2001 will replace the Control of Pesticides Regulations 1986, although the 1986 
Regulations will remain in force until the safety of substances has been assessed under the 2001 Regulations.  Currently most pesticides are regulated under 
the Control of Pesticides Regulations 1986.  The 1986 Regulations prohibit the advertisement, sale, supply, storage and use of pesticides without an approval 
and a consent.
Content for 
Analysis
Summary of regulations Gap or Potential Gap Comment/Impact
I. Definition and 
scope
Regulation 3 provides that the 
Regulations apply to:
- any pesticide; or
- any substance, preparation or 
organism prepared or used for any 
of the following purposes, as if it 
Note exemption in relation to R&D:
The Regulations do not apply to …
‘substances, preparations or organisms used 
in laboratories for the purpose of the micro 
propagation of plants or substances, 
It is foreseen that nanomaterials will be 
used in the manufacture of pesticides 
falling within the Regulation 3.
The Regulation 3(2)(f) exemption creates 
the possibility that nanomaterials will be 
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were a pesticide:
 protecting plants or wood or 
other plant products from 
harmful organisms;
 regulating the growth of 
plants;
 giving protection against 
harmful creatures;
 rendering such creatures
harmless;
 controlling organisms with 
harmful or unwanted effects 
on water systems;
 protecting animals against 
ectoparasites.
‘Pesticide’ is given the meaning 
assigned to it in section 16(15) of the 
Food and Environment Act 1985.
preparations or organisms used in the 
production of novel food’ (3(2)(f)).
used specifically in relation to novel food 
R&D without prior approval (Regulation 5) 
or consent (Regulation 6).  This has 
potential implications regarding workplace 
and environmental exposure to 
nanoparticles.  
II.  Approval and 
consent
Regulation 4 prohibits the 
advertisement, sale, supply, storage, 
and use of a pesticide without prior 
approval (Regulation 5) and consent 
Regulation 6).
Regulation 5(3) provides that ‘[e]ach 
approval may authorise the use, supply 
and storage of the pesticide to which it 
relates’. 
The question is whether the inclusion of 
nanoparticles in pesticides requires a new 
approval and consent irrespective of the fact 
that its non-nano form has already been 
authorised.  
If the inclusion of nanoparticles alters the 
nature of the pesticide to such an extent that it 
may be considered a ‘new’ pesticide for the 
purposes of the Regulations, separate 
approval and consent will be required.  
Regulation 5(2) provides that approval may be 
‘experimental’ to enable further testing to be 
conducted to produce additional safety data 
before provisional/full approval is granted.  
If the inclusion of nanoparticles has no 
bearing on the nature of the pesticide so that 
it is still deemed to be the same pesticide 
product for the purposes of the Regulations, 
no new approval or consent will be required.  
The upshot is that nanoparticles might enter 
The Biocidal Products Regulations 2001, 
which will replace the 1986 Control of 
Pesticides Regulations, establish a 
rigorous mechanism for risk assessment 
based on the toxicity of substances.
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onto the market without consideration of 
safety aspects specific to nanomaterials.
III. Safety The advertisement, sale, supply, 
storage and use of pesticides are 
prohibited unless conditions of consent 
set out in the Schedules to the Control 
Of Pesticides Regulations 1986 are 
met.
- Schedule 1 (conditions relating to 
consent to advertisement of 
pesticides)
- Schedule 2 (conditions relating to 
consent to sale, supply and storage 
of pesticides)
- Schedule 3 (conditions relating to 
consent to use of pesticides)
- Schedule 4 conditions relating to 
consent of use of pesticides by 
aerial application)
Each of the Schedules sets out a 
number of safety requirements.  
Schedules 2 and 3, for example, set out 
a general safety requirement that any 
person who sells, supplies or stores a 
pesticide shall take all reasonable 
precautions, particularly with regard to 
storage and transport, to protect the 
health of human beings, creatures and 
plants, safeguard the environment and 
in particular avoid the pollution of water.
Before a pesticide can be approved for 
sale and use, evidence is required of its 
The question is whether current forms of risk 
assessment are designed to address the sort 
of risks posed by human/environmental 
exposure to pesticides containing 
nanoparticles.
It is likely that safety requirements are 
sufficiently broad to encompass potential 
risks associated with human or 
environmental exposure to pesticides.
The Advisory Committee on Pesticides 
maintains that a precautionary approach 
to pesticide approval is adopted.116  
Pesticides in use are periodically 
reviewed, and companies are required to 
notify registration authorities if any new 
information becomes available raising 
safety concerns.
                                                
115 See Advisory Committee on Pesticides (ACP), A Guide to Pesticide Regulation in the UK and the Role of the Advisory Committee on Pesticides, (DEFRA 
& HSE; London; 2003).
116 Advisory Committee on Pesticides (ACP), A Guide to Pesticide Regulation in the UK and the Role of the Advisory Committee on Pesticides, (DEFRA & 
HSE; London; 2003).
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efficacy and that it will not pose an 
unacceptable risk to human health or 
the environment.  Companies seeking 
approval must submit scientific data, 
which would usually include information 
about the physico-chemical properties 
of the pesticide, its potential toxicity in 
humans, exposure to operators and 
workers, and ecotoxicology.115
Linked 
Legislation
Food and Environment Protection Act 1985 – established overarching legal framework for the control of pesticides in Great Britain 
which implemented through the Control of Pesticides Regulations 1986. 
Biocidal Products Regulations 2001 – establishes a framework addressing the hazardous properties of non-agricultural pesticides 
and their classification, labelling, and risk management procedures.
Plant Protection Products Regulations 2005
Pesticides (Maximum Residue Levels in Crops, Food and Feeding Stuffs (England and Wales) Regulations 1999
Chemicals (Hazard Information & Packaging for Supply) Regulations 2002
Control of Substances Hazardous to Health Regulations 2002
Horizon 
Scanning
Legislation: Detergents Regulations 2005117
Summary of Purpose: The Detergents Regulations 2005 introduce measures to implement Regulation 648/2004 and establish a competent authority 
(‘Pesticides Safety Directorate’) in charge of enforcement.  Regulation 648/2004 aims to improve the free market of detergents, modernise the detergents
regime, improve environmental protection, and provide specific information to consumers on the content of detergents.  It extends and tightens the testing of 
surfactant biodegradability, and requires the provision of more detailed information on detergent labels.  It is an offence to place a detergent on the market in 
contravention with the Regulation.  
Content for 
Analysis
Summary of regulations Gap or Potential Gap Comment/Impact
I. Definition of 
‘controlled 
product’
 Regulation 2(1) 
Detergent 
Regulation 2(1) of the Detergent 
Regulations 2005 is defined as ‘a 
detergent or a surfactant’.
Article 2 to Regulation 648/2004 defines 
‘detergent’ as:
 No gap identified.
                                                
117 Enforcing the Detergents Regulation (EC) No.648/2004.
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Regulations 
2005
 Article 2 
Regulation 
648/2004
‘any substance or preparation 
containing soaps and/or other 
surfactants intended for washing and 
cleaning processes.  Detergents may 
be in any form (liquid, powder, paste, 
bar, cake, moulded piece, shape, etc.) 
and marketed for or used in household, 
or institutional or industrial purposes.’
Auxiliary washing preparations, laundry 
fabric-softener, domestic cleaning 
preparations, and other cleaning and 
washing preparations also fall within the 
definition of ‘detergent’.
‘Surfactant’ is defined as:
‘any organic substance and/or 
preparation used in detergents, which 
has surface-active properties and which 
consists of one or more hydrophilic and 
one or more hydrophobic groups of 
such a nature and size that it is capable 
of reducing the surface tension of water, 
and of forming spreading or adsorption 
monolayers at the water-air interface, 
and of forming emulsions and/or 
microemulsions and/or micelles, and of 
adsorption at water-solid interfaces.’
II.  Protection of 
human health, 
animal health 
and the 
environment
 Article 2 
Regulation 
The use of surfactants can only be 
authorised if they pass certain 
biodegradability tests.118  Regulation 
648/2004 introduces a two-tier system 
of safety testing: primary testing and 
ultimate testing.  
Article 2 to Regulation 648/2004 defines 
Stringency of safety assessment
The use of nanotechnology is expected to 
heavily impact the manufacture of detergents.  
It is likely that the use of nanomaterials in this 
context would not be precluded by the 
definitions of ‘detergent’ and ‘surfactant’ 
provided in Article 2 to Regulation 648/2004.  
The issue is whether the safety provisions set 
Article 15 to Regulation 648/2004 
establishes a safeguard clause to protect 
against unforeseen dangers.  It enables 
Member States to impose provisional 
restrictions or prohibitions on the sale 
and/or use of a specific detergent if there 
are justifiable grounds for believing that 
the detergent poses a potential risk to 
                                                
118 Tests must be conducted in accordance with Article 10(5) of Regulation (EC) No.793/93.
127
648/2004 ‘primary biodegradation’ as:
‘the structural change (transformation) 
of a surfactant by micro-organisms 
resulting in the loss of its surface-active 
properties due to the degradation of the 
parent substance and consequential 
loss of the surface-active property’.
‘Ultimate biodegradation’ is defined as:
‘the level of biodegradation achieved 
when the surfactant is totally used by 
micro-organisms in the presence of 
oxygen resulting in its breakdown to 
carbon dioxide, water and mineral salts 
of any other elements present 
(mineralisation)’.
Primary testing is measured by a series 
of tests set out in Annex II to the 
Regulation.  Ultimate testing is set out 
in Annex III to the Regulation.  
Manufacturers wishing to place on the 
market surfactants or detergents 
containing surfactants that fail the 
ultimate biodegradability test but pass a 
primary biodegradability test are 
required to submit a derogation 
application pursuant to Articles 4 and 5 
of Regulation 648/2004.  An application 
for derogation must be accompanied by 
a technical file supplying information 
necessary for evaluating the safety of 
the surfactant in question, results of 
tests conducted pursuant to Annexes II 
and III, and a complementary risk 
assessment in accordance with 
stipulations in Annex IV.
out in the Regulation are capable of 
identifying potential risks associated with 
exposure to nanomaterials.  The provisions in 
Annex IV require that the molecular and 
structural formula, and the composition of a 
surfactant are taking into consideration in an 
assessment of safety.  It is likely that the 
Annex IV requirements are sufficiently 
thorough to identify possible threats arising 
from the use of nanomaterials.  However, a 
complementary risk assessment is only 
required in relation to surfactants that fail the 
ultimate biodegradability test set out in Annex 
III.  It is conceivable that primary and ultimate 
biodegradability testing fails to detect potential 
risks associated with exposure to 
nanomaterials which might be expected to be 
identified by a complementary risk 
assessment.  
human or animal health, or to the 
environment.
The safety requirements established 
under the overarching framework of the 
General Product Safety Regulations 2005 
also applies to the placing on the market 
of detergents.
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Annex IV requires that a
complementary risk assessment 
includes information regarding the 
societal value of the application, 
conditions of use, the availability and 
suitability of alternatives, and its 
environmental impact.
Linked 
Legislation
General Product Safety Regulations 2004
Horizon 
Scanning
Legislation: C o s m e t i c  P r o d u c t s  ( S a f e t y )  R e g u l a t i o n s  2 0 0 4  ( a s  a m e n d e d ) 119
Summary of Purpose: The principle aim of the Cosmetic Products (Safety) Regulations 2004 is to safeguard public health.  Cosmetic products are only 
permitted to contain safe ingredients.  The Regulations set out a number of requirements in relation to conditions of use, the manufacture and supply of 
products, prohibitions and restrictions on ingredients, animal testing, and ingredient labelling and information.  The regulatory regime works from the premise 
that a product cannot be marketed unless it is deemed to be safe not only under normal but also under reasonably foreseeable conditions of use.  The 
Regulations contain lists of ingredients which are either prohibited or restricted, or positively listed as acceptable subject to certain conditions.  The 
manufacturer (or person responsible for placing the product on the market in the EC) is responsible for ensuring that cosmetic products do not cause damage 
to human health.  A safety assessment must be conducted by a suitably qualified person in relation to all cosmetic products before they are placed on the 
market, and the results made available to enforcing authorise.  Specific safety assessment procedures must be adhered to in relation to cosmetic products 
intended for use by children under the age of three years and for cosmetic products intended for external intimate hygiene.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
I. Definition
Regulation 3(1)
The definition of a ‘cosmetic product’ 
comprises two parts, both of which must 
be satisfied.  The definition is set out in 
Regulation 3(1).  First, in order to fall 
within the definition, a substance or 
preparation must have one of the 
following six functions: (i) to clean; (ii) to 
No gap identified. It is likely that the definition of ‘cosmetic 
product’ pursuant to Regulation 3(1) is 
sufficiently broad to capture current and 
future uses of nanomaterials in the 
cosmetics sector.  Products supplied to 
consumers that fall outside the scope of 
the Regulation 3(1) definition are likely to 
                                                
119 Implementing Cosmetics Directive 76/768/EEC (as amended).
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perfume; (iii) to change the appearance; 
(iv) to protect; (v) to keep in good 
condition; or (vi) to correct body odours.  
Secondly, the field of application of the 
said substance or preparation must 
include one or more of the following: (i) 
the epidermis; (ii) the hair system; (iii) 
the nails; (iv) the lips; (v) the external 
genital organs; (vi) the teeth; or (vii) the 
mucous membranes of the oral cavity.
A ‘cosmetic ingredient’ is defined as any 
substance or preparation of synthetic or 
natural origin used in the composition of 
a cosmetic product.
fall within the scope of the General 
Product Safety Regulations 2005120 which 
establishes a framework for ensuring that 
intended for or likely to be used by 
consumers under normal or foreseeable 
conditions are safe. 
II. General 
Safety 
Requirement
Regulation 4
The supply of a cosmetic product liable 
to cause damage to human health 
under normal or reasonably foreseeable
conditions of use is prohibited.  This 
safety requirement does not cover the 
misuse of a cosmetic product.  
No gap identified in relation to damage to 
human health.
The general safety requirement is limited 
to an assessment of risk in relation to 
human health.  Normal or reasonably 
foreseeable uses of cosmetic products 
containing nanoparticles posing little or no 
threat to human health might at the same 
time create potential hazards at other 
stages of the lifecycle – for example, to 
the environment following product 
disposal.  
II. Prohibited 
and Restricted 
Ingredients
Regulations 5
Regulations 5(1) and 5(2) prohibit or 
restrict the use of groups of cosmetic 
ingredients listed in Schedules 3 to 7:
Schedule 3
Prohibited substances
Schedule 4
Restricted substances
Whether Schedules of prohibited or restricted 
substances cover substances containing 
nanomaterials
Prohibition or restriction in Schedules 3 to 7 is 
based on the type of substance rather than 
their method of production. Determining if 
substances containing nanoparticles fall within 
It is recommended that the list of 
prohibited and restricted substances, and 
weight and concentration thresholds of 
restricted substances, contained in 
Schedules 3 to 7 are examined with 
reference to specific characteristics of 
nanoparticles.
                                                                                                                                                                                                                                         
120 ‘Product’ is defined by the General Product Safety Regulations 2005 as ‘a product which is intended for consumers or likely, under reasonably foreseeable 
conditions, to be used by consumers even if not intended for them and which is supplied or made available, whether for consideration or not, in the course of 
a commercial activity and whether it is new, used or reconditioned and includes a product that is supplied or made available to consumers for their own use in 
the context of providing a service.’
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Schedule 5
Hair colourants subject to restrictions
Schedule 6
Preservatives subject to restrictions
Schedule 7
UV filters subject to restrictions
Schedules 4 to 7 stipulate the maximum 
weight and concentration of substances 
permitted in cosmetic products.
Regulation 5(15) prohibits the supply of 
cosmetic products containing 
carcinogens, mutagens or as 
substances toxic to reproduction.  
Regulation 6 sets out procedures for 
obtaining authorisation for use of 
ingredients not listed in the Schedules.  
Colouring agents (excluding hair dyes), 
antimicrobial preservatives, and UV 
filters can only be used if they are 
positively listed in Schedules 5, 6 or 7.  
If a manufacturer wishes to use a 
cosmetic ingredient which is normally 
subject to positive listing but which is 
not listed in the Schedules to the 
Regulations, authorisation (‘Prior 
National Approval’) must be obtained.  
the scope Schedules 3 to 7 depends on 
whether listed substances and those 
containing nanoparticles can be considered to 
be equivalent for the purposes of the 
Regulations. 
If substances containing nanomaterials are 
deemed to be equivalent to their non-
nanomaterial counterpart whose use is 
restricted, the issue is whether the weight and 
concentration limits specified are 
appropriately set to account for risks 
associated with human/environmental 
exposure to nanoparticles.  It is conceivable 
that nanoparticles have the same chemical 
composition as ingredients whose use is 
permitted absolutely (by virtue being positively 
listed under Regulation 6) or partially (owing 
to restrictions imposed by the Schedules to 
the Regulations) but whose toxicity profile is 
markedly different thus posing a greater threat 
to human health and the environment.    
If the inclusion of nanoparticles in substances 
listed in the Schedules in some way alters the 
chemical structure of that substance, it is 
conceivable that the use of the substance in 
cosmetic products will not be covered by 
Schedule 3 to 7.  
III. Safety 
Assessment
Regulations 
9(1)(d) and (e) 
The manufacturer of cosmetic products 
is obliged to keep information on its 
products readily accessible to the 
competent authorities.
Regulation 9(1)(d) requires that a safety 
Incomplete knowledge base
The safety assessment requirement raises the 
most issues in relation to nanomaterials.  The 
Scientific Committee on Cosmetic Products 
and Non-Food Products Intended for 
Consumers (SCCNFP),121 which advises the 
It is recommended that detailed guidelines 
are developed on the risk assessment of 
nanomaterials in the light of paucity of 
information in a number of key areas.
Should the Regulation 9 risk assessment 
                                                
121 Committee has since been replaced by Scientific Committee on Consumer Products (SCCP), Scientific Committee on Health and Environmental Risks 
(SCHER), and Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR).
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assessment is conducted in relation to 
the finished product and made available 
to the competent authority.  Regulation 
9(1)(e) sets out the same requirement 
in relation to products intended for use 
on children under the age of three and 
to cosmetic products intended 
exclusively for use in external intimate 
hygiene.  Regulation 9(2) stipulates that 
safety assessments must be conducted 
in accordance with principles of good 
laboratory practice referred to in Article 
1 Directive 2004/10/EC, taking into 
account:
 the general toxicological profile 
of each ingredient used;
 the chemical structure of each 
ingredient;
  the level of exposure of each 
ingredient;
 the specific exposure 
characteristics of the areas on 
which the cosmetic product will 
be applied; and
 the specific exposure 
characteristics of the class of 
individuals for whom the 
cosmetic product is intended.
European Commission, has stipulated in its 
Guidance Notes122 that the precise chemical 
nature of the ingredient and its structural  
formula, if known, should be identified in the 
safety assessment file.  The evaluation of a 
cosmetic ingredient should be conducted in 
relation to its physical, chemical, and physio-
chemical properties.  Although there are no 
specific requirements relating to 
nanomaterials in cosmetic products, it is 
unlikely, given incomplete information about 
the implications of human/environmental 
exposure to nanomaterials, that a full safety 
evaluation could be conducted on cosmetic 
products containing nanoparticles.  The 
Scientific Committee on Emerging and Newly 
Identified Health Risks (SCENIHR) has noted 
that existing methods for assessing the 
toxicity of substances might not be sufficiently 
robust to cover potential hazards arising from 
the use of nanomaterials.123  In particular, 
information necessary for the risk assessment 
of dermal exposure to nanoparticles is 
lacking.
It is conceivable that the use of nanomaterials 
in cosmetic products will be authorised in line 
with the safety requirements set out in 
Regulation 9, notwithstanding the fact that 
relatively little is known about the toxicological 
profile of nanoparticulate ingredients and 
exposure characteristics.       
requirement fail to identify threats to 
human health posed by nanomaterials 
contained in a cosmetic product, and 
evidence of this risk becomes available 
once the product has been placed on the 
market, Regulation 9 of the General 
Product Safety Regulations 2005 require 
producers or distributors to notify the 
competent authority of the said risk.
                                                                                                                                                                                                                                         
122 Notes of Guidance for the Testing of Cosmetic Ingredients and Their Safety Evaluation Should Contain Specific Safety Evaluation Procedures for 
Nanomaterials (SCCNFP/0690/03.
123 SCENIHR, Opinion on the Appropriateness of Existing Methodologies to Assess the Potential Risks Associated with Engineered and Adventitious 
Products of Nanotechnologies, SCENIHR/002/05.
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IV. Animal 
Testing Ban
Regulations 5(7) 
to 5(13)
The Regulations introduce a two-stage 
ban on the testing of cosmetic 
ingredients on animals.  This ban 
applies to any testing undertaken in 
order to satisfy compliance with the 
Cosmetics Directive 76/769/EEC or with 
the Regulations.
 Prior to 2009 it will be illegal to test 
any cosmetic ingredient on animals in 
order to satisfy requirements of the 
Regulations if an alternative test 
method exists and has been validated 
at Community level.
 After 2009 it will be illegal to test any 
cosmetic ingredient on animals 
irrespective of whether an alternative 
test method exists.
Animal testing ban restricts level to which 
ingredients can be tested for safety
There is concern that certain toxicological 
conclusions could not be drawn without the 
testing of cosmetic ingredients on animals.124  
It is worth noting, however, that the REACH 
regulations specify the use of animals for 
testing. 
Linked 
Legislation
General Product Safety Regulations 2005
Horizon 
Scanning
                                                
124 See Oral Evidence (23 February 2004) presented to the Royal Society and the Royal Academy of Engineering (Report: Nanoscience and 
Nanotechnologies: Opportunities and Uncertainties), Dr. Ian White (Chairman at the time of the Scientific Committee on Cosmetic and Non-Food Products) 
(http://www.nanotec.org.uk/evidence/WhiteIWcomments.pdf, accessed October 2006).
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Legislation: General Product Safety Regulations 2005125
Summary of Purpose:  The General Product Safety Regulations 2005 implement the General Product Safety Directive 2001/95/EC, and are designed 
to ensure the safety of all products intended for consumer use.  They are complementary to specific sector provisions with safety requirements.  The 
Regulations came into force on 1 October 2005, replacing the General Product Safety Regulations 1994.  The 2005 Regulations ensure consumer product 
safety by requiring that products placed on the market or supplied by producers and distributors are deemed to be safe and establishing a framework for 
safety assessment.  The Regulations cover the supply of all new and second-hand products,126 including clothing, medicines, machinery, tools and 
equipment, household goods, chemicals and pesticides, and motor vehicles.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
I. Definition
Regulation 2
A ‘product’ is defined by the 
Regulations as a product which is 
intended for consumer use or likely, 
under reasonably foreseeable 
conditions, to be supplied or made 
available for consumer use.
The Regulations also cover products 
that were originally intended for 
professional use, but have since 
‘migrated’ to the consumer market.
A ‘safe product’ is defined as a product 
which, under normal or reasonably 
foreseeable conditions of use does not 
present any risk or only the minimum 
risks compatible with the product's use, 
considered to be acceptable and 
consistent with a high level of protection 
for the health and safety of consumers. 
Definition of risk
The Regulations do not provide a clear 
definition of ‘risk’ in this context.127  This has 
potential implications for the assessment of 
product safety, discussed below.
The Regulations apply to consumer 
products irrespective of whether a product 
contains nanoparticles.  The Regulation’s 
definition of ‘product’ can be held to be 
sufficiently broad to cover current and 
potential applications of nanotechnology in 
consumer goods. 
Although there is no legal definition of 
‘risk’, it is clear that the Regulations only 
extend to cover risks to human health and 
safety.  Potential environmental risks fall 
outside the scope of the Regulations.
II. General 
Safety 
Requirement
Regulation 5
Regulation 5 provides that no producer 
shall supply or place a product on the 
market unless the product is deemed to 
be safe. 
Adequacy of safety standards
The question is whether the methods of safety 
assessment adequately deal with potential 
dangers posed by the use of nanoparticles in 
Compliance with voluntary standards does 
not guarantee that a product will be 
deemed to be safe if it fails to establish 
appropriate safety levels in respect of 
                                                
125 Implementing Directive 2001/95/EC on General Product Safety.
126 Although note that the following are excluded: (i) products supplied for repair or reconditioning prior to use; and (ii) the sale of antiques.
127 Although note that ‘serious risk’ is defined by Regulation 2 as a serious risk, including one the effects of which are not immediate, requiring rapid 
intervention.
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An assessment of the safety of a 
product is made on the basis of a 
number of factors, including its 
characteristics; packaging; instructions 
for assembly and maintenance, use and 
disposal; effect on other products with 
which it might be use; labelling and 
other information provided for the 
consumer; and categories of consumers 
at risk.  Specific product regulations or 
national safety laws are also taken into 
account in determining safety.  Where 
there are no applicable product or 
national regulations, safety is assessed 
according to voluntary EU ‘harmonised’ 
standards;128 Community technical 
specifications; national standards; 
industry codes of practice; and the state 
of the art and technology.
consumer products.  The Regulations 
introduce a presumption of conformity with the 
general safety requirement if a product 
conforms with the UK transposition of a 
voluntary European standard insofar as the 
risk is covered by that standard.129
Harmonised standards are European 
standards, adopted by CEN, CENELEC, or 
ETSI following the issuing of a mandate by 
the European Commission after Member 
State consultation.  Standards published to 
date include those relating to a number of 
sectors of current and potential  applications 
of nanotechnology, including: active 
implantable medical devices; in vitro 
diagnostic medical devices; medical devices; 
radio and telecom terminal equipment; 
machinery; toy safety; construction products; 
and packaging and packaging waste.  
Compliance with harmonised standards, 
however, remains voluntary.  
nanomaterials.  Standards, therefore, can 
be seen to provide a de minimis threshold 
of safety.  It is recommended that 
harmonised standards that take into 
account the characteristics of 
nanoparticles are developed.
Note also the RAPEX (Community Rapid 
Information System) procedure set out in
Regulation 33.  An obligation is placed on 
producers and distributors to notify the 
enforcement authority of a product (other 
than a pharmaceutical product) posing a 
serious risk to consumers which requires 
urgent action.  
Linked 
Legislation
                                                                                                                                                                                                                                         
128 Council Resolution, 7 May 1985, ‘New Approach to Technical Harmonization and Standards’.
129 For a list of standards, see Official Journal of the European Union, European Commission website: 
http://ec.europa.eu/enterprise/newapproach/standardization/harmstds/reflist.html, accessed October 2006.
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Horizon 
Scanning
In April 2006 the European Commission called for the establishment of CEN Technical Committee on 
nanotechnologies based on business plan set out by CEN Technical Board Working Group 166 and emphasised 
need to ensure cooperation with CENELEC.130
Consumer Policy Committee of the International Organization for Standardization is call ing for the development of 
an International Standard that would provide guidance on how to identify, assess and eliminate or reduce risks 
associated with consumer products to all those involved in the supply chain.  ISO Technical Committee 229 has 
been set up to promote standardisation in the field of nanotechnologies, specif ically in relation to classif ication, 
terminology and nomenclature, basic metrology, characterisation, including calibration and certif ication, risk and 
environmental issues. [Change font style/colour]
Legislation: Contaminants in Food (England) Regulations 2006131
Summary of Purpose: Legislation on contaminants in foodstuffs is made under the overarching framework established by Regulation (EC) No.315/93.  
The Regulation sets out procedures for contaminants in food, and applies to contaminants which are not covered by other specific Community provisions.  
Regulation (EC) No.466/2001 was enacted under Regulation 315/93 as a measure to harmonise the setting of maximum quantities of contaminants in 
foodstuffs across Member States, facilitate trade by removing competition distortion, and achieve greater levels of consumer protection.  Regulation 466/2001 
is enforced by separate, parallel provisions in each of the devolved administrations of the UK.  Regulation 3 of the Contaminants in Food (England) 
Regulations 2006 make it an offence to place on the market food breaching requirements of Regulation 315/93.
Content for 
Analysis
Summary of regulations Gap or Potential Gap Comment/Impact
I. Definition of 
‘contaminant’
 Article 1(1) 
Regulation 
(EC) No.315/93
Article 1(1) to Regulation 315/93 
defines a contaminant as:
‘any substance not intentionally added 
to food which is present in such food as 
a result of the production (including 
operations carried out in crop 
husbandry, animal husbandry and 
veterinary medicine), manufacturing, 
processing, preparation, treatment, 
packing, packaging, transport or holding 
of such food, or as a result of 
No gap identified. It is likely that the definition of contaminant 
provided in Article 1(1) will cover a wide 
range of applications of nanotechnology in 
food manufacturing.  
                                                
130 European Commission (Enterprise and Industry Directorate-General) Action Plan for European Standardisation, April 2006, final, 
http://ec.europa.eu/enterprise/standards_policy/action_plan/doc/standardisation_action_plan.pdf, accessed October 2006.
131 Implementing Regulation (EC) No. 466/2001 setting maximum levels for certain contaminants in foodstuffs.
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environmental contamination.  
Extraneous matter, such as, for 
example, insect fragments, animal hair, 
etc., is not covered by this definition.’
II. Maximum 
contaminant 
thresholds
 Article 2 
Regulation 
(EC) 315/93
 Article 1 
Regulation 
(EC) 
No.466/2001
 Regulation 3 
Contaminants 
in Food 
(England) 
Regulations 
2006
Article 2 to Regulation 315/93 stipulates 
that food containing a contaminant in 
quantities that pose an unacceptable
threat to public health must not be 
placed on the market. 
Article 1 to Regulation 466/2001 
requires that foodstuffs indicated in 
Annex I must not, when placed on the 
market, contain contaminant levels 
higher than those specified in the 
Annex.
Regulation 3 of the Contaminants in 
Food (England) Regulations 2006 
makes it an offence to place on the 
market foodstuffs containing 
contaminants specified in Regulation 
466/2001 at levels exceeding those 
specified.
Appropriateness of threshold levels
It is unclear whether the thresholds specified 
in the Annex to Regulation 466/2001 are set 
at appropriate levels to control potential risks 
arising from applications of nanotechnology in 
this context.  Taking into account recognised 
properties of nanomaterials, such as 
increased toxicity, it is conceivable that the 
maximum level thresholds specified provide 
inadequate protection to consumer health.  
The toxicology of contaminants is 
continually evaluated by the Commission 
in cooperation with Member States to 
review the limits set.  The flexibility of the 
regime is reflected by the fact that 
Regulation 466/2001 has undergone a 
number of amendments.  Maximum 
thresholds can be adjusted, should it 
transpire that the migration of 
nanomaterials to foodstuffs results in 
unacceptable levels of contaminant.
Furthermore, Part I of the Food and 
Environment Protection Act 1985 enables 
Ministers to make emergency orders 
where they consider that circumstances 
exist, or may exist, which are likely to 
create a risk to human health through the 
consumption of contaminated food.
The regulatory regime relating to 
contaminants in food is underpinned by 
more general frameworks that establish 
basic safety principles, such as Regulation 
(EC) No.178/2002 and the Food Safety 
Act 1990.  Foodstuffs also fall within the 
scope of the General Product Safety 
Regulations 2005.
Linked 
Legislation
Regulation (EC) No.466/2001 setting maximum levels for certain contaminants in foodstuffs
General Principles of Food Law Regulation (EC) 178/2002
Food Safety Act 1990
General Product Safety Regulations 2005
Horizon 
Scanning
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Legislation:  F o o d  A d d i t i v e s  D i r e c t i v e  8 9 / 1 0 7 / E E C 132
Summary of Purpose: Broadly speaking, the regulatory regime in relation to food additives sets out lists of permitted additives, the food products in 
which they can be used, and maximum levels of use.  The Food Additives Directive 89/107/EEC establishes an overarching framework for the authorization of 
the use of additives in food products.  Only those food additives listed in the Directive may be used in the manufacture or preparation of foodstuffs and only 
under specified conditions of use.  The Directive, which provides the umbrella framework of food additive regulation, is supplemented by a number of other 
specific provisions.*
Content for 
Analysis
Summary of regulations Gap or Potential Gap Comment/Impact
I. Definitional 
Aspects
Article 1 and 
Annex I
A ‘food additive’ is defined by Article 1 
of Directive 89/107/EEC* as:
‘any substance not normally consumed 
as a food in itself and not normally used 
as a characteristic ingredient of food 
whether or not it has nutritive value, the 
intentional addition of which to food for 
a technological purpose in the 
manufacture, processing, preparation, 
treatment, packaging, transport or 
storage of such food results, or may be 
reasonably expected to result, in it or its 
by-products becoming directly or 
indirectly a component of such foods’.
Accordingly, food additives are used (or 
intended to be used) as ingredients 
during the manufacture or preparation 
No gap identified. It is likely that current applications of 
nanotechnology in the manufacture of 
food additives will fall within the definition 
of ‘food additive’ in Article 1 and the 
categories set out in Annex I.  
                                                
132 Directive 89/107/EEC on the approximation of the laws of Member States concerning food additives authorised for use in foodstuffs intended for human 
consumption (as amended).
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of food product and are present in the 
final product, even if in altered form.133  
Annex I of the Directive lists the 
following categories of food additives 
which may be used in the manufacture 
or preparation of foodstuffs:
 Colour
 Preservative
 Anti-oxidant
 Emulsifier
 Emulsifying salt
 Thickener
 Gelling agent
 Stabiliser
 Flavour enhancer
 Acid
 Acidity regulator
 Anti-caking agent
 Modified starch
 Sweetener
 Raising agent
 Anti-foaming agent
 Glazing agent
 Flour treatment agent
 Firming agent
 Humectant
 Sequestrant
 Enzyme
 Bulking agent
 Propellent gas and packing gas
II.  Safety 
Assessment
Article 2 and 
Annex II
Annex II sets out general criteria for the 
use of food additives.  In addition to 
other requirements, it stipulates that 
additives must not present a hazard to 
consumer health at level of use 
No specific assessment of additives 
containing nanomaterials
Safety assessment requirements make no 
reference to nanomaterials, or indeed to 
particle size.  The question is whether, on the 
Despite the fact that the Directive does se 
out specific criteria for the assessment of 
nanomaterials, it is likely that the 
provisions are sufficiently broad to protect 
consumer health from potential dangers 
                                                                                                                                                                                                                                         
133 Note that the Directive does not cover: (i) processing aids; (ii) substances used in the protection of plants and plant products in conformity with Community 
rules relating to plant health; (iii) flavourings for use in foodstuffs, which fall within the scope of Directive 88/388/EEC; and (iv) substances added to foodstuffs 
as nutrients.
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proposed, so far as can be judged on 
the scientific evidence available.  It 
goes on the note that:
‘To assess the possible harmful effects 
of a food additive or derivatives thereof, 
it must be subjected to appropriate 
toxicological testing and evaluation.  
The evaluation should also take into 
account, for example, any cumulative, 
synergistic or potentiating effect of its 
use and the phenomenon of human 
intolerance to substances foreign to the 
body.’
basis of the criteria given, the effect of 
nanoparticles is likely to be covered by the 
Directive.
arising from applications of 
nanotechnology.  The Directive itself 
contains a number of ‘safety net’ 
provisions:
 Annex II provides that all food additives 
must be continually observed and re-
evaluated whenever necessary in the 
light of changing conditions of use and 
new scientific information.
 Annex II stipulates that authorisation of 
food additives must be limited to the 
lowest level of use necessary to achieve 
the desired effect (Annex II).
 Article 5 states that when granted, 
authorisation is limited to period of two 
years.
 Article 4 enables a Member State to 
temporarily suspend or restrict the 
application of provisions should it have 
grounds to believe that, as a result of 
new information or re-evaluation of 
existing information, an additive poses a 
potential risk to human health.
Linked 
Legislation
* Sweeteners in Food Regulations 1995 (as amended);134 Colours in Food Regulations 1995 (as amended);135 Miscellaneous Food 
Additives Regulations 1995 (as amended);136 Smoke Flavourings (England) Regulations 2005.137
Horizon 
Scanning
                                                
134 Implementing Directive 94/35/EC on sweeteners for use in foodstuffs and Directive 95/31/EC laying down specific criteria of purity concerning sweeteners 
for use in foodstuffs.
135 Implementing Directive 94/36/EC on colours for use in foodstuffs (as amended).
136 Implementing Directive 95/2/EC on food additives other than colours and sweeteners (as amended) (which has to be read with Directive 89/107/EEC on 
the approximation of the laws of the Member States concerning food additives authorised for use in foodstuffs intended for human consumption).
137 Implementing Regulation (EC) No. 2065/2003 of the European Parliament and of the Council on smoke flavourings used or intended for use in or on 
foods.
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Legislation:
 Food Additives Regulations:
 S w e e t e n e r s  i n  F o o d  R e g u l a t i o n s  1 9 9 5  ( a s  a m e n d e d ) 138
 C o l o u r s  i n  F o o d  R e g u l a t i o n s  1 9 9 5  ( a s  a m e n d e d ) 139
 M i s c e l l a n e o u s  F o o d  A d d i t i v e s  R e g u l a t i o n s  1 9 9 5  ( a s  a m e n d e d ) 140
Summary of Purpose: In 1995, three sets of Regulations were adopted under the broad framework of the Food Additives Directive 89/107/EEC and the 
Food Safety Act 1990 to control the use of principal categories of food additives.  This group of Regulations operates under the broad framework of the Food 
Additives Directive* controlling the use of specific substances as additives in foodstuffs.  Each of the three Regulations implement a Community Directive 
which lists permitted food additives and their conditions of use.  In addition, they implement Directives setting out purity criteria for the additives listed.  They 
establish a pre-market approval regime which requires that all additives positively listed undergo safety assessment.
Content for 
Analysis
Summary of regulations Gap or Potential Gap Comment/Impact
I. Scope of 
Regulations
Directive 89/109/EEC does not extend 
to cover:
 Flavourings;**
 Extraction solvents.***
The Sweeteners in Food Regulations 
1995 define ‘sweetener’ as any food 
additive which is used or intended to be 
used (a) to impart a sweet taste to food, 
or (b) as a table-top sweetener.  It goes 
on to define ‘food additive’ as:
‘any substance not normally consumed 
as a food in itself and not normally used 
as a characteristic ingredient of food, 
whether or not it has nutritive value, the 
intentional addition of which to food for 
Use of nanomaterials as additives in 
categories falling outside scope of specific 
Regulations
It is conceivable that nanomaterials will be 
used in the manufacture of types of food 
additives falling outside the scope of the three 
specific Regulations cited.  Although it is 
difficult to predict future applications of 
nanotechnology, evidence from research and 
development suggests that uses of 
nanomaterials will feature heavily in food 
production.
Should the use of nanomaterials in 
foodstuffs fall outside the definitions 
provided in the aforementioned 
Regulations, it is likely that the Food 
Additives Directive* is sufficiently broad to 
encompass all known, and likely future, 
applications of nanotechnology in this 
context.
The use of flavourings and extraction 
solvents as food additives is covered by 
separate, specific provisions (see ** and 
***).
The broad framework established General 
Product Safety Regulations 2005 extends 
to cover food products placed on the 
                                                
138 Implementing Directive 94/35/EC on sweeteners for use in foodstuffs and Directive 95/31/EC laying down specific criteria of purity concerning sweeteners 
for use in foodstuffs.
139 Implementing Directive 94/36/EC on colours for use in foodstuffs (as amended) and Directives 95/45/EC and 2001/50/EC laying down specific purity 
criteria concerning colours for use in foodstuffs.
140 Implementing Directive 95/2/EC on food additives other than colours and sweeteners (as amended) (which has to be read with Directive 89/107/EEC on 
the approximation of the laws of the Member States concerning food additives authorised for use in foodstuffs intended for human consumption); Directive 
2001/5/EC on food additives other than colours and sweeteners; and Directives 96/77/EC and 2001/30/EC laying down specific purity criteria on food 
additives other than colours and sweeteners.  
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a technological purpose in the 
manufacture, processing, preparation, 
treatment, packaging, transport or 
storage of such food results, or may 
reasonably be expected to result, in it or 
its by-products becoming directly or 
indirectly a component of such foods’.
The Colours in Food Regulations 1995
covers any food additive which is used 
or intended to be used for the primary 
purpose of adding or restoring colouring 
in a food.  The crucial test for 
determining whether a substance is a 
‘colour’ for the purposes of the 
Regulations is set out in Regulation 
2(1)(b).  The substance must have 
undergone ‘selective extraction’ for the 
prime function of colouring.
The Miscellaneous Food Additives 
Regulations 1995 cover food additives 
other than colours and sweeteners 
(‘miscellaneous additives’) that perform 
one or more of the following functions, 
set out in Regulation 2(1).  A 
‘miscellaneous food additive’ is defined 
as:
‘any food additive which is used or 
intended to be used primarily as an 
acid, acidity regulator, anti-caking 
agent, anti-foaming agent, antioxidant, 
bulking agent, carrier, carrier solvent, 
emulsifier, emulsifying salt, firming 
agent, flavour enhancer, foaming agent, 
gelling agent, glazing agent, humectant, 
modified starch, packaging gas, 
preservative, propellant, raising agent, 
sequestrant, stabiliser or thickener, but 
does not include any processing aid’.
market for consumer use.
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II.  Purity 
Criteria
Each of the three Regulations stipulate 
that specific purity criteria must be 
satisfied before an additive is used in 
foodstuffs.
Directive 95/31/EC sets out purity 
criteria in relation to additives falling 
within the scope of the Sweeteners in 
Food Regulations 1995.
Directives 95/45/EC and 2001/50/EC 
set out purity criteria in relation to the 
Colours in Food Regulations 1995.
Directives 96/77/EC and 2001/30/EC 
set out purity criteria in relation to the 
Miscellaneous Food Additives 
Regulations 1995.
Limited restriction of small particles in 
additives
The only additives whose use in food or food 
ingredient is restricted on the basis of particle 
size is microcrystalline cellulose141 and 
powdered cellulose.142  This restriction is set 
out in Directive 96/77/EC, and so applies only 
to miscellaneous food additives.  The use of 
small microcrystalline cellulose and powdered 
cellulose (not less than 5μm) is limited 
because their safety is uncertain. 
It is recommended that particle size is 
included in the purity criteria as standard 
practice.  By refining safety assessment 
tools to allow for consideration of the 
effects of small particles, threats posed by 
nanomaterials are likely to be identified 
and managed prior to marketing.  This 
anticipatory approach is consistent with 
the precautionary principle, which is cited 
by the General Principles of Food Law 
Regulation**** as a central element of 
food safety. 
Should nanomaterials satisfy the purity 
criteria (owing to their failure to assess 
impact of particle size), but still pose a 
danger to human health, the Food 
Additives Directive* establishes a 
sufficiently broad safeguards.  The 
Directive imposes an overarching 
obligation to ensure that additives present 
no hazard to consumer health at the level 
of use proposed, so far as can be judged 
on the scientific evidence available.  
Linked 
Legislation
* Directive 89/107/EEC on the approximation of the laws of Member States concerning food additives authorised for use in foodstuffs 
intended for human consumption (as amended).
** Flavourings in Food Regulations 1992143
*** Extraction Solvents in Food Regulations 1993144
**** General Principles of Food Law Regulation (EC) 178/2002
General Product Safety Regulations 2005
Horizon 
Scanning
The Food Standards Agency has called for an assessment  consumer safety and regulatory implications of potential applications of 
nanotechnology in the manufacture of food additives and other novel food ingredients.145
Directive 2004/19/EC (amending Directive 2002/72/EC) requires the creation of a positive list of additives permitted in the 
                                                
141 Defined in Directive 96/77/EC as ‘purified, partally depolymerised cellulose prepared by treating alpha-cellulose, obtained as a pulp from natural strains of 
fibrous plant material, with mineral acids’.
142 Defined in Directive 96/77/EC as ‘purified, mechanically disintegrated celluslose prepared by processing alpha-cellulose obtained as a pulp from natural 
strains of fibrous plant materials’.
143 Implementing Directive 88/388/EEC concerning flavourings for use in foodstuffs.
144 Implementing Directive 88/344/EEC on extraction solvents used in the production of foodstuffs.
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manufacture of food contact plastics.  The Commission is required by 31 December 2007 to confirm when the list of additives will 
become a positive list.  
Legislation: Food Safety Act 1990
Summary of Purpose: The Food Safety Act 1990 is principally an enabling piece of legislation establishing a consumer protection regime ensuring the 
safety of products including (i) drinks; (ii) articles and substances of no nutritional value which are used for human consumption; (iii) chewing gum and other 
products or a like nature and use; (iv) and articles and substances used as ingredients in the preparation of food.  The Food Safety Act 1990 (Amendment) 
Regulations 2005 enacted under the European Communities Act 1972 align the definition of ‘food’ with that in the General Principles of Food Law Regulation 
178/2002.  The Food Safety Act 1990 sets out general enforcement provisions, and creates specific offences and penalties.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
I. Food safety Section 7 establishes that it is an 
offence to render injurious to health 
food intended to be sold for human 
consumption.  ‘Injury’ is defined in this 
section as including any impairment, 
whether permanent or temporary.
Section 18 provides that Ministers may 
by regulations make provision for 
prohibiting the carrying out of 
commercial operations with respect to 
novel foods, or food sources from which 
such foods are intended to be derived.
A ‘novel food’ is defined as any food 
which has not previously been used for 
human consumption in Great Britain, or 
has been so used only to a very limited 
extent.
Food safety obligations extend to those 
working in the production, processing, 
storage, distribution and sale of food.  
The Food Safety Act 1990 sets out a 
Meaning of ‘novel food’
It is unclear whether the uses of 
nanomaterials in foodstuffs will bring the food 
product within the meaning of ‘novel food’.  
Given that reference is made to the novelty of 
the food product rather than to its process of 
manufacture or composition, it is conceivable 
that the production of foodstuffs using 
nanotechnology is insufficient to render it 
‘novel’ for the purposes of section 18 of the 
Act.
Even if food products were to fall outside 
the scope of section 18, the regime 
established by the Food Safety Act 1990 
is still sufficiently broad to cover potential 
dangers arising from the use 
nanotechnology in relation to foodstuffs in 
general.  Products falling outside the 
definition of ‘food’ set out in section 1 will 
be caught by overarching frameworks 
such as the General Principles of Food 
Law Regulation (EC) No.178/2002 and the 
General Product Safety Regulations 2005.
                                                                                                                                                                                                                                         
145 FSA, Draft Report of FSA Regulatory Review, March 2006.
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general responsibility to take 
precautions to ensure compliance with 
its provisions.  See also industry 
standards relating to Good 
Manufacturing Practices, and Hazard 
Analysis and Critical Control Point, for 
example.
Linked 
Legislation
General Principles of Food Law Regulation (EC) No.178/2002
General Food Regulations 2004
General Product Safety Regulations 2005
Horizon 
Scanning
Legislation: General Principles of Food Law Regulation (EC) 178/2002
Summary of Purpose: The Regulation sets out general principles and requirements of food law, and lays down procedures relating to food safety.  Its 
primary objective is to ensure the protection of human health.  Regulation 178/2002 is enforced by the General Food Regulations 2004.  
Content for 
Analysis
Summary of regulations Gap or Potential Gap Comment/Impact
I.  Safety 
Assessment
Paragraph 18 of the Preamble 
emphasises the centrality of scientific 
risk assessment in decision-making.  It 
stipulates that:
‘[i]n order for there to be confidence in 
the scientific basis of food law, risk 
assessments should be undertaken in 
an independent, objective and 
transparent manner, on the basis of the 
available scientific information and 
data.’
Article 6 also makes reference to the 
scientific underpinnings of risk analysis. 
The scientific and technical basis to of 
Community legislation relating to food 
Incomplete information base
The most significant problem arising from the 
Regulation’s emphasis on scientific risk 
assessment is the lack of knowledge in 
relation to the implications of nanotechnology 
on food safety.  The upshot is that safety 
assessments of nanomaterials in food 
products are based on incomplete 
information, and might not accurately reflect 
the likely effect of nanotechnology.  It is likely 
that applications of nanotechnology will be 
deemed to represent an ‘emerging risk’ 
pursuant to Article 50.  Given the novelty of 
nanotechnology and the lack of complete 
knowledge about its implications, the 
feasibility of thorough risk assessment is 
thwarted by scientific uncertainty.
The Regulation establishes a broad 
framework of food safety that will extend 
to cover threats posed by applications of 
nanotechnology in foodstuffs.  In 
particular, the Regulation makes reference 
to situations in which lacking information 
renders it is impossible to conduct a full 
scientific risk assessment.  The 
precautionary principle is cited as the 
primary guiding tool to decision-making.
Paragraph 19 of the Preamble:
‘It is recognised that scientific risk 
assessment alone cannot, in some cases, 
provide all the information on which a risk 
management decision should be based, 
and that other factors relevant to the 
matter under consideration should 
145
safety is bolstered by the setting up of 
the European Food Safety Authority 
(EFSA), pursuant to the Regulation. 
Paragraph 50 of the Preamble:
‘Improved identification of emerging 
risks may in the long term be a major 
preventive instrument at the disposal of 
Member States and the Community in 
the exercise of its policy.  It is therefore 
necessary to assign to the Authority an 
anticipatory task of collecting 
information ad exercising vigilance and 
providing evaluation of and information 
on emerging risks with a view to their 
prevention.’ 
In making an assessment of food 
safety, Article 14 requires that the 
following factors are taken into account:
 Normal conditions of use by the 
consumer and at stages of 
production, processing and 
distribution;
 Information available to the 
consumers concerning the avoidance 
of specific adverse health effects from 
a particular food;
 Probable immediate and/or short-term 
and/or long-term effects of a particular 
food on the health of the person 
consuming it and on subsequent 
generations;
 Probable cumulative toxic effects;
 Particular health sensitivities of a 
specific category of consumers where 
a food is intended for that category of 
consumers.
Article 34 deals specifically with the 
identification of emerging risks.  It states 
legitimately be taken into account 
including societal, economic, traditional, 
ethical and environmental factors and the 
feasibility of controls.’
Paragraph 21 of the Preamble:
‘In those specific circumstances where a 
risk to life or health exists but scientific 
uncertainty persists, the precautionary 
principle provides a mechanism for 
determining risk management measures 
or other actions in order to ensure the high 
level of health protection chosen in the 
Community.’
Article 7 reiterates the significance of the 
precautionary principle in situations 
where, following an assessment of 
available information, the possibility of 
harmful effects on health is identified but 
‘scientific uncertainty persists’.
Article 17 extends safety requirements to 
all stages of production, processing and 
distribution, requiring that Member States 
monitor and verify that the relevant 
requirements of food law are fulfilled by 
food and feed business operators.
It is anticipated that threats posed by 
nanotechnology will be adequately 
managed under the broad safety 
framework established by the Regulation.  
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that EFSA shall establish monitoring 
procedures for searching for, collating 
and analysing information in order to 
identify emerging risks in relation of 
foodstuffs.
Linked 
Legislation
General Food Regulations 2004
Horizon 
Scanning
Legislation:  M a t e r i a l s  a n d  A r t i c l e s  i n  C o n t a c t  w i t h  F o o d  ( E n g l a n d )  R e g u l a t i o n s  2 0 0 5 146
Summary of Purpose:  Regulation 4 of the Materials and Articles in Contact with Food (England) Regulation provides for the enforcement of Regulation 
(EC) No. 1935/2004 which sets out a general framework of consumer protection.  Regulation 1935/2004, amongst other things, requires that materials and 
articles are manufactured in compliance with good manufacturing practice so that, under normal or foreseeable conditions of use, they do not transfer their 
constituents to food in quantities which could endanger human health.  National regulations in each of the devolved administrations of the UK through enforce 
the Regulation.  Regulation 1935/2004 revoked the previous framework Directive 89/109/EEC147 and the Materials and Articles in Contact with Food 
Regulations 1987.  Some parts of the 1987 Regulations which implemented Directive 78/142/EEC on vinyl chloride monomer and Directive 93/10/EEC on 
regenerated cellulose film148 remain in force. 
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
I. Definition
Articles 1 and 2 
Regulation (EC) 
No.1935/2004
Article 1 provides that the Regulation 
applies to materials and articles, 
including active and intelligent food 
contact materials, which in their finished 
state:
 Are intended to be brought into 
contact with food; or
 Are already in contact with food and 
were intended for that purpose; or
 Can reasonably be expected to be 
brought into contact with food or to 
No gap identified. The Regulation extends to the application 
of new technologies in food contact 
materials in the form of ‘active’ and 
‘intelligent’ systems.  This is significant 
because it is anticipated that 
nanotechnology will be used in this 
context to develop active and intelligent 
materials and articles.  
                                                
146 Implementing the Materials and Articles in Contact with Food Regulation (EC) No. 1935/2004.
147 Directive 89/109/EEC on the approximation of the laws of the Member States relating to materials and articles intended to come into contact with 
foodstuffs.
148 Directive 93/10/EEC has since been amended by Directive 2004/14/EC.
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transfer their constituents to food 
under normal or foreseeable 
conditions of use.
‘Active food contact materials and 
articles’ is defined in Article 2 as 
materials and articles that are intended 
to extend the shelf-life or to maintain or 
improve the condition of packaged food.
‘Intelligent food contact and articles’ is 
defined in Article 2 as materials and 
articles which monitor the conditions of 
packaged food or the environment 
surrounding the food.
II. Active and 
Intelligent 
Materials and 
Articles
Article 4 
Regulation (EC) 
No.1935/2004
The intended migration of constituents 
from active and intelligent food contact 
materials and articles is permitted, 
provided that safeguards are complied 
with.  Article 4 sets out special 
requirements in relation to these 
categories of food contact material.  It 
notes that active and intelligent 
materials may bring about changes in 
the composition or organoleptic 
characteristics of food, provided that 
those changes comply with other 
Community provision relating to food 
safety.
Migration of nanomaterials to foodstuffs
Given that it is anticipated that nanomaterials 
will be used in the manufacture of active and 
intelligent materials and articles, the migration 
of nanomaterials to foodstuffs is likely.
Although the migration of nano-
constituents to foodstuffs is potentially 
permitted by the Regulation, Article 4 
requires pre-market authorisation of 
substances deliberately incorporated into 
active materials and articles to be 
released into food or the environment 
surrounding food shall be authorised and 
used in accordance with the relevant 
Community provisions relating to food 
safety.  A safety assessment is required 
as part of the authorisation application 
(see safety assessment, below).
III. 
Authorisation 
and safety 
assessment
Articles 8 and 9 
Regulation (EC) 
No.1935/2004
Article 8 provides that no substance 
shall be authorised unless it has been 
demonstrated that, when used under 
the conditions set in specific measures, 
the final material or article satisfies 
requirements of Article 3 (general 
requirements), and where they apply, 
Article 4 (special requirements for active 
and intelligent materials and articles, 
Incomplete knowledge base about migration 
of nano-constituents
Given that there are recognised knowledge 
gaps relating to the effect of nanomaterials on 
food safety, comprehensive safety 
assessments are likely to be difficult to 
conduct.  Under the 2001 Scientific 
Committee on Food Guidelines, the 
toxicological dataset required to determine 
It is unlikely that full safety assessments 
are possible in relation to the migration of 
nanomaterials to foodstuffs.  The General 
Principles of Food Law Regulation (EC) 
178/2002 framework, however, imposes 
an overarching obligation to adopt a 
precautionary approach to scientifically 
uncertain risk. 
                                                
149 Guidance published by the European Food Safety Authority can be found at: http://www.efsa.europa.eu/en/science/afc/afc_guidance/722.html
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see above).
Article 3 requires that materials and 
articles, including active and intelligent 
materials and articles, shall be 
manufactured in compliance with good
manufacturing practice so that, under 
normal or foreseeable conditions of use, 
they do not transfer their constituents to
food in quantities which could endanger 
human health.
Article 9 sets out requirements for 
application for authorisation of new 
substances.  As part of the application 
procedure, an applicant must submit to 
the competent authority a technical 
dossier containing information specific 
in the guidelines for the safety 
assessment of a substance.149  An 
assessment of both the toxicological 
data indicating the potential hazard and 
the likely human exposure data is 
required.150  Furthermore, an application 
for authorisation must include 
information on the identity of the 
substance in question, its physical, 
chemical and microbiological properties, 
and intended use.
Guidelines of the Scientific Committee 
on Food published in 2001151 state that, 
as a general principle, the greater the 
safety depend on migration values. It is 
conceivable, given the novelty of applications 
of nanotechnology, datasets are insufficiently 
‘extensive’ to establish the safety of food 
contact materials containing nanoparticles 
falling within the ‘high migration’ category.  
Establishing the safety of food contact 
materials containing nanoparticles falling 
within the ‘low migration’ category, however, 
poses less of an evidential challenge.  Given 
that only a limited dataset is required in 
relation to low migration constituents, it is 
conceivable that materials and articles 
containing nanoparticles are deemed to be 
‘safe’ and marketed before more robust 
datasets on human and environmental 
exposure are developed.
The Scientific Committee on Food Guidelines 
do not consider environmental impact of food 
contact materials. 
Furthermore, Article 18 of Regulation 
1935/2004 establishes safeguard 
measures that enable a Member State, 
following the receipt of new information or 
a re-evaluation of existing information that 
leads it to conclude that the use of a 
material or article endangers human 
health, to temporarily suspend or restrict 
the application of the Regulation.
                                                                                                                                                                                                                                         
150 See also Scientific Committee on Food, Guidelines of the Scientific Committee on Food for the presentation of an application for safety assessment of a 
substance to be used in food contact materials prior to its authorisation, SCF/CS/PLEN/GEN/100 Final, 19 December 2001.  
151 See also Scientific Committee on Food, Guidelines of the Scientific Committee on Food for the presentation of an application for safety assessment of a 
substance to be used in food contact materials prior to its authorisation, SCF/CS/PLEN/GEN/100 Final, 19 December 2001.  
152 See also Scientific Committee on Food, Guidelines of the Scientific Committee on Food for the presentation of an application for safety assessment of a 
substance to be used in food contact materials prior to its authorisation, SCF/CS/PLEN/GEN/100 Final, 19 December 2001, at pages 2-3.
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exposure through migration, the more 
toxicological information will be 
required. 152  In relation to high 
migration (5-60mg/kg/food), an 
extensive data set is required in order to 
establish safety.  In relation to migration 
between 0.05-5mg/kg/food, a reduced 
data set may be sufficient.  In relation to 
low migration (<0.05mg/kg/food), only a 
limited data set is required. 
Linked 
Legislation
General Principles of Food Law Regulation (EC) 178/2002
Food Contact Ceramics Directive 2005/31/EC153
Horizon 
Scanning
In December 2005 the Department of Trade and Industry published a consultation document on proposals to implement Directive 
2005/31/EC.  The Directive will replace the Ceramic Ware (Safety) Regulations 1988.  Draft Regulations are being made pursuant to 
the Food Safety Act 1990, ensuring consistency with other specific provisions on food contact materials and articles.  The consultation 
closed in February 2006.  The DTI is currently in the throes of implementing the Directive.
                                                
153 Directive 2005/31/EC amending Directive 84/500/EEC as regards a declaration of compliance and performance criteria of the analytical method for 
ceramic articles intended to come into contact with foodstuffs.
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Legislation:  N o v e l  F o o d s  a n d  N o v e l  F o o d  I n g r e d i e n t s  R e g u l a t i o n s  1 9 9 7 154
Summary of Purpose: The Novel Foods Regulations 1997 establishes an approval system for all novel foods and processes before the food or food 
ingredient is placed on the market.  Novel foods and food ingredients are those that have not been used within the European Community to any significant 
degree before 15 May 1997.  Before being placed on the market in the Community, novel food and novel food ingredients are subject to a single safety 
assessment through Community procedure.  If, however, if a food falling within certain categories set out in the Regulations they are ‘substantially equivalent’ 
to food already on the market, they are subject to a simplified procedure of assessment.  Applications for the placing on the market of a novel food or food 
ingredient must be made to the Food Standards Agency (FSA).  The FSA will consult the independent Advisory Committee on Novel Foods and Processes, 
DEFRA, the Department of Health, and other relevant departments on product safety, and consumer and ethical concerns.  The overriding objective is to 
protect human health.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
I. Definition
Regulation 2 
(Novel Food and 
‘Novel food’ and ‘novel food ingredients’ 
are defined in Article 1 of Regulation 
(EC) No.258/97 as food and food 
ingredients:
Whether use of nanotechnology in food and 
ingredients satisfies ‘novelty’ threshold
It is conceivable that the use of nanoparticles 
in foods already on the market will fail to 
It is likely that applications of 
nanotechnology in food production will 
satisfy the novelty test set out in part (e) 
opposite.  Should applications of 
                                                
154 Implementing the Novel Foods Regulation (EC) 258/97.
155 Except for foods and food ingredients obtained by traditional propagating or breeding practices and having a history of safe food use.
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Novel Food 
Ingredients 
Regulations 
1997);
Article 1 
(Regulation (EC) 
No.258/97)
a. produced from, but not containing, 
genetically modified organisms;
b. which present a new or intentionally 
modified primary molecular 
structure; 
c. which consist of micro-organisms, 
fungi or algae; 155
d. which consist of or are isolated from 
plants or isolated from animals; and
e. to which a production process not 
currently used has been applied, 
and where that process gives rise to 
significant changes in their 
composition or structure.
Regulation 3 stipulates that the 
marketing of food or food ingredients 
falling within the scope of the 
Regulations must be authorised.  An 
application must be submitted to the 
Member State in which the product is to 
be placed on the market for the first 
time (see III below).
satisfy the novelty test set out in Article 1.  It is 
unlikely that the novelty threshold has been 
tested in relation to the use of nanomaterials 
in food, given that nanotechnologies in this 
context are still in the research and 
development stage.156  The question is 
whether the use of nanoparticles in existing 
products render those products ‘novel’ and 
requiring authorisation before being marketed. 
nanotechnology in this context fall outside 
scope of Regulations, they will be caught 
by the EC Regulation on General 
Principles of Food Law* which establishes 
mechanisms to ensure the safety of food 
placed on the market.
II. Substantial 
equivalence
Article 3(4) 
(Regulation (EC) 
No.258/97)
The concept of ‘substantial equivalence’ 
was introduced by WHO and OECD, 
with particular reference to foods 
produced by modern biotechnology.  
Commission Recommendation 
97/618/EC notes that:
‘If a new food or food component is 
found to be substantially equivalent to 
an existing food or food component, it 
can be treated in the same manner with 
respect to safety, keeping in mind that 
establishment of substantial 
equivalence is not a safety or nutritional 
assessment in itself, but an approach to 
Whether food or food ingredients produced 
using nanomaterials are ‘substantially 
equivalent’ to those already on market
It is conceivable that a food or ingredient 
produced using nanotechnology will be 
deemed to be ‘substantially equivalent’ to food 
products that have a history of consumer use.
Article 3(4) notes that the substantial 
equivalence test applies only in relation to 
certain categories of food and food 
ingredients:
 foods and food ingredients produced from, 
but not containing, genetically modified 
It is unlikely that current and potential 
applications of nanotechnology identified 
will fall into any of these categories to 
which Article 3(4) applies.
                                                                                                                                                                                                                                         
156 See Food and Drink Federation, Response to FSA Draft Report of Regulatory Review of the Use of Nanotechnologies in Relation to Food 
http://www.fdf.org.uk/responses/fdf_response_nano.pdf, accessed October 2006.
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compare a potential new food with its 
conventional counterpart.’ (paragraph 
3.3)
Accordingly, the substantial equivalence 
test can be extended to assess foods 
from novel sources and processes.
Analysis of the composition of a novel 
food or ingredient is essential to the 
substantial equivalence evaluation. 
organisms;
 foods and food ingredients consisting of or 
isolated from micro-organisms, fungi or 
algae; and
 foods and food ingredients consisting of or 
isolated from plants and food ingredients 
isolated from animals, except for foods and 
food ingredients obtained by traditional 
propagating or breeding practices and 
having a history of safe food use.
III. Safety 
Assessment
Regulation 3 
(Novel Food and 
Novel Food 
Ingredients 
Regulations 
1997)
Articles 4, 6 and 
7 (Regulation 
(EC) No.258/97) 
Manufacturers wishing to place a novel 
food or novel food ingredient on the 
market are required to submit an 
application in accordance with 
Commission Recommendation 
97/618/EC concerning the scientific 
aspects and the presentation of 
information necessary to support 
applications for the placing on the 
market of novel foods and novel food 
ingredients and the preparation of initial 
assessment reports.  Amongst other 
things, the application must contain 
information to demonstrate that the 
following conditions (as set out in Article 
3(1)) are satisfied.  Foods and food 
ingredients falling within the scope of 
the Regulation must not:
 present a danger for the consumer;
  mislead the consumer;
 differ from foods or food ingredients 
which they are intended to replace to 
such an extent that their normal 
consumption would be nutritionally 
disadvantageous for the consumer.
Article 6 provides that, upon receipt of 
application, the Member State shall 
ensure that an initial safety assessment 
No specific assessment criteria for 
nanomaterials
The Regulations do not explicitly set out 
specific criteria to assess the safety of novel 
foods on the basis of particle size.  
A finding of ‘substantial’ or ‘partial’ 
equivalence has implications for safety 
assessment requirements.  In the case of the 
former, no further toxicological testing is 
required.  In the case of the latter, 
toxicological testing required only in relation to 
novel traits.  
It is likely that safety assessment 
requirements are sufficiently broad to 
cover potential risks arising from food 
products manufactured using 
nanomaterials.  Commission 
Recommendation 97/618/EC, however, 
requires that a compositional and 
toxicological analysis is conducted in an 
assessment of safety, with reference to 
the identity, chemical structure and 
physico-chemical properties of the novel 
food, as well as aspects such as source, 
composition, potential intake based on the 
proposed use in the general diet, potential 
exposure of particularly vulnerable 
population groups, and the likely effects of 
processing.
A finding of substantial (or partial) 
equivalence would create a potential 
loophole for the safety assessment of 
foods containing nanomaterials, although 
as noted above, it is unlikely that current 
applications of nanotechnology in this 
context fall within Article 3(4).
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is conducted by the competent food 
assessment body.  In the UK, this 
function is carried out by the Food 
Standards Agency.  In the event that an 
additional assessment is required 
pursuant to Article 7, the Commission, 
together with the Standing Committee 
for Foodstuffs, shall decide whether to 
authorise the food or ingredient in 
question by having regard to:
 the conditions of use of the food or 
food ingredient;
 the designation of the food or food 
ingredient, and its specification,
 specific labelling requirements.
Linked 
Legislation
* Regulation (EC) No.178/2002 on General Principles of Food Law
Horizon 
Scanning
 European Commission launched consultation in June 2006 on the revision of Novel Food Regulation (EC) No.258/97.  The consultation seeks input 
from the public, stakeholders, and Member States in order to conduct an impact assessment for a future revision to the Regulation.  The principal 
objectives of the consultation include: to develop a more streamlined authorisation procedure and a more adjusted safety assessment system; and to 
clarify the definition of ‘novel’ and the scope of the Regulation.  One of the main issues open to discussion was whether the Regulation should 
continue to employ uniform criteria for the safety assessment of all types of food or whether specific criteria should be developed for specific types of 
food that are proportionate to the potential risks posed.  Arguments for specific safety criteria might have particular resonance in relation to the use of 
nanotechnology in food.  The consultation closed on 1 August 2006.  
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Legislation: Plastic Materials and Articles in Contact with Food (England) Regulations 2006157
Summary of Purpose: The Plastic Materials and Articles in Contact with Food (England) Regulations 2006 revoke the Plastic Materials and Articles in 
Contact with Food Regulations 1998.  The 2006 Regulations prohibit specified activities in relation to any plastic material or article which fails to meet the 
appropriate required standards set out in the Regulations, and specify the required standard relating to overall migration limits from plastic materials or 
articles to food.  The Regulations implement a number of Directives relating to food contact materials.  Directive 2002/72/EC establishes the overarching 
framework in relation to plastic materials and articles intended to come into contact with foodstuffs.
Content for 
Analysis
Summary of regulations Gap or Potential Gap Comment/Impact
I. Definitional 
Aspects
Article 1 Directive 
2002/72/EC
Article 1 of the Directive defines 
‘plastics’ as:
‘the organic macromolecular 
compounds obtained by polymerisation, 
polycondensation, polyaddition or any 
other similar process from molecules 
with a lower molecular weight or by 
chemical alteration of natural 
macromolecules.’
The following substances are not 
regarded as ‘plastics’ for the purpose of 
the Directive:
 varnished or unvarnished regenerated 
cellulose film, covered by Commission 
Directive 93/10/EEC;
 elastomers and natural and synthetic 
rubber;
 paper and paperboard, whether 
modified or not by the addition of 
plastics; 
Use of nanomaterials in categories falling 
outside definition of ‘plastics’
It is anticipated that certain uses of 
nanomaterials in the manufacture of food 
contact materials will fall outside the scope of 
‘plastics’ as defined in Article 1.  A scoping 
exercise of current and future applications that 
nanotechnology will be used to produce 
rubber, paper, and surface coatings, particular 
in the food packaging field.  These 
applications are not covered by the consumer 
protection afforded by Directive 
2002/72/EC.158
Whilst it is conceivable that certain 
materials falling outside the Article 1 
definition of ‘plastics’ could pose a threat 
to human health, this potential gap is 
covered by the general framework 
established by Regulation 1935/2004* 
which stipulates that materials and articles 
shall be manufactured in compliance with 
good manufacturing practice so that they 
do not transfer their constituents to food in 
quantities which could endanger human 
health (Article 3).
                                                
157 Implementing Directive 82/711/EEC laying down the basic rules necessary for testing migration of the constituents of plastic materials and articles 
intended to come into contact with foodstuffs; Directive 85/572/EEC laying down the list of stimulants to be used for testing migration of constituents of plastic 
materials and articles intended to come into contact with foodstuffs; and Directive 2002/72/EC relating to plastic materials and articles intended to come into 
contact with foodstuffs.  The 2006 Regulations also provide for the enforcement of Regulation (EC) No.1895/2005 on the restriction of use of certain epoxy 
derivatives in materials and articles intended to come into contact with food.
158 This is confirmed by Directive 2004/19/EC.
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 surface coatings obtained from: (i) 
paraffin waxes, including synthetic 
paraffin waxes, and/or micro-
crystalline waxes, or (ii) mixtures of 
the waxes listed in the first indent with 
each other and/or with plastics,
 ion-exchange resins;
 silicones.
Regulation (EC) No.1895/2005** 
provides that ‘material and articles’ are:
 materials and articles made of any 
type of plastics; 
 materials and articles covered by 
surface coatings; and
 adhesives.
II. Restricted 
migration of 
constituents
Regulation 9
Regulation 3 prohibits specified 
activities in relation to any plastic 
material or article which fails to meet 
the appropriate required standards set 
out in the Regulations.
The Regulations stipulate that plastic 
materials and articles shall not transfer 
their constituents in quantities 
exceeding specific limits.  
Regulation 9 sets standards relating to 
overall migration limits.  It stipulates that 
the overall migration must not exceed  
60 milligrams of constituents released 
per kilogram of food in the case of any 
plastic material or article comprising:
 an article which is a container or 
comparable to a container or can be 
filled, with a capacity of not less than 
500 millilitres and not more than 10 
litres;
 an article which can be filled and for 
Whether migration thresholds are sufficient to 
manage potential dangers posed by 
nanomaterials
Given that the Regulations not differentiate 
between nanomaterials and materials and 
articles produced by ‘traditional’ means, it is 
uncertain whether this migration threshold 
would provide adequate protection against 
threats posed by nanoparticles. 
Even if the thresholds are inappropriately 
set in respect of nanomaterials, the 
overarching framework of consumer 
safety established by Regulation 
1935/2004* and the General Product 
Safety Regulations 2004 apply.  
If the maximum thresholds are set at too 
high a level, thus enabling potentially toxic 
plastic materials and articles containing 
nanoparticles to enter onto the market, a 
number of waste provisions might apply.  
If the plastic materials and articles are 
used in the manufacture of packaging, the 
Packaging (Essential Requirements) 
Regulations 2003 and the Producer 
Responsibility Obligations (Packaging 
Waste) Regulations 2005 might apply.  
Packaging waste is also listed as 
‘hazardous waste’ by the List of Wastes 
(England) Regulations 2005 for the 
purposes of the Hazardous Waste 
(England and Wales) Regulations 2005.
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which it is impracticable to estimate 
the surface area in contact with food; 
or
 cap, gasket, stopper or similar device 
for sealing.
In the case of any other plastic material 
or article, the overall migration limit is 
set at 10 milligrams per square 
decimetre of the surface area of the 
plastic material or article.
III. Restriction 
of use of certain 
substances
Regulations 4 
and 5
Regulation 4 restricts the use of 
monomers in the manufacture of plastic 
materials and articles.  Schedule 1 to 
the Regulations lists restricted 
monomers, and stipulates maximum 
permitted quantities and migration 
thresholds.
Regulation 5 restricts with use of 
additives in the manufacture of plastic 
materials and articles.  Schedule 2 to 
the Regulations list restricted additives, 
and stipulates maximum permitted 
quantities and migration thresholds. 
Regulation 10 and Schedule 4 set out 
similar provisions in relation to the 
migration of primary aromatic amines.
Appropriateness of set thresholds
Thresholds set in Schedules 1, 2, and 4 are 
based on weight or percentage concentration.  
It is unclear whether the maximum limits 
specified provide adequate protection against 
potential risks associated with exposure to 
nanoparticles.
See above.
Linked 
Legislation
* Materials and Articles in Contact with Food Regulation (EC) No.1935/2004
** Regulation (EC) No.1895/2005 on the restriction of use of certain epoxy derivatives in materials and articles intended to come into 
contact with food
Contaminants in Food Regulation (EC) No. 315/93
Packaging (Essential Requirements) Regulations 2003
Producer Responsibility Obligations (Packaging Waste) Regulations 2005
Hazardous Waste (England and Wales) Regulations 2005
List of Wastes (England) Regulations 2005
Horizon 
Scanning
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Legislation: E n v i r o n m e n t a l  P r o t e c t i o n  A c t  1 9 9 0 159^
Summary of Purpose:  Provides the main statutory framework for environmental protection including the management of waste, statutory nuisance and 
contaminated land^.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1.  Waste Disposal
- Duty of Care*
Section 34 provides that a ‘duty of care’ 
applies to any person who produces, 
imports, carries, keeps, treats or 
disposes of controlled waste.  Any 
person subject to the duty has to take 
reasonable steps to: Prevent any other 
person contravening section 33 (i.e. the 
law relating to the unauthorised deposit, 
keeping, treatment or disposal of 
controlled waste); prevent the escape of 
waste; ensure that the waste is 
transferred only to an authorised 
person; and ensure that an adequate 
written description of the waste is given 
to anyone to whom the waste is 
transferred.
1. Potential gaps exist in the regulating of 
nanomaterials, in particular in understanding 
the potential risks posed by waste products 
containing nanomaterial, in assessing the 
most effective form of management/disposal; 
and if specialised management/disposal is 
required, identifying waste products 
containing nanomaterials amongst other 
waste streams e.g. domestic, commercial and 
industrial.
2. Under the Environmental Protection 
(Duty of Care) Regulations 1991* (as 
amended), there must be a transfer note 
when waste is transferred, for example from 
the waste producer to a carrier.  This transfer 
note must identify the waste, along with other 
details.  However, identification of waste is via 
the List of Waste Regulations 2005 and no 
codes exist that will specifically identify 
nanomaterials.  In addition a number of the 
potential applications for nanomaterials, e.g. 
food production, have no available hazardous 
waste code, if nanomaterials are classed as 
dangerous substances and therefore 
hazardous no current code under this Chapter 
will provide identification of the hazardous 
properties.
To ensure the proper disposal of
nanomaterials further information is 
required on the most appropriate 
methods, which will result in the least 
amount of damage to human health and 
the environment.
It is recommended that due to the lack of 
available scientific information on the 
impacts of nanomaterials, wastes resulting 
from the development, manufacture, 
supply and use of nanoparticles are 
classed as hazardous.
3. Contaminated 
Land**
1. Part IIA provides a definition of 
contaminated land and how it is to be 
identified and dealt with:
Potential problems relating to the role of 
nanomaterials in contaminated land is the 
availability of appropriate scientific and 
The current lack of knowledge on the 
health and environmental impacts of 
nanomaterials means that land where 
                                                
159 As amended Environment Act 1995 and Waste Management (England & Wales) Regulations 2006
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“any land which appears to the local 
authority in whose area it is situated to 
be in such a condition, by reason of 
substances in, on or under the land, 
that (a) significant harm is being caused 
or there is a significant possibility of 
such harm being caused; or (b) 
pollution of controlled waters is being, 
or is likely to be, caused”. 
2. Remediation
technical assessment of all the relevant and 
available evidence; and on the basis of that 
assessment, it is satisfied on the balance of 
probabilities that significant harm is being 
caused.
It is unlikely that because of the nanoscale 
properties, nanomaterials in contaminated 
land will satisfy the definition and criteria for 
assessing significant harm.
nanomaterials are released is likely to fall 
outside the Part IIA regime, pending future 
developments in scientific knowledge.
4. Control of 
Substances
Power to prohibit or restrict the 
importation, use, supply or storage of 
injurious substances or articles if it is 
considered that such prohibition or 
restriction will prevent the cause of 
pollution of the environment or damage 
to human health.
No gap identified. This power can be use to introduce 
regulations where it may be necessary to 
control identified nanomaterial, if it is 
considered that certain nanomaterials are 
considered to impose a particular 
pressure on the environment or damage 
human health.  
5. Hazardous 
Substances
Powers to obtain information about 
potentially hazardous substances for 
the purpose of assessing their potential 
for causing pollution of the environment 
or harm to human health.
This may be a valuable power for the 
regulator allowing the relevant authority to 
collect information on products or articles 
containing prescribed substances, the 
requirement to conduct tests of substances 
and furnish results from the tests.
However, at present owing to current 
scientific and technical limitations it is 
unlikely sufficient information and 
assessment capability is available to 
comply with any regulations implemented 
under this power. 
Linked 
Legislation
^ - Environment Act 1995 – amends the EPA, establishes the relevant environment protection agencies in the UK and introduces 
into the EPA Part IIB on contaminated land and also producer responsibility obligations e.g. Producer Responsibility Obligations 
(Packaging Waste) Regulations 2005
Waste Management (England & Wales) Regulations 2006 – amends certain sections of Part II of the EPA.
Pollution Prevention and Control (England & Wales) Regulations 2000 – replaces the pollution control regime established under 
Part 1 of the EPA.
* - Waste (Household Waste Duty of Care) Regulations 2005 – Householders must ensure that any waste disposal is collected by 
an authorised waste collector.
** - Contaminated Land (England) Regulations 2000 - deal with various procedural details such as the description of special sites, 
public registers, remediation notices and appeals.
 Waste Management Licensing Regulations 1994 – These regulations in combination with Part II of the EPA transposed the Waste 
Framework Directive160
Groundwater Regulations 1998 – covers the disposal of substances covered under the Regulation in cases where a waste 
management licence under Part II of the EPA is not already required.
                                                
160 Directive 75/442/EEC
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Water Industry Act 1991 - Where a process regulated under Part I of the Environmental Protection Act 1990 proposes to discharge 
trade effluent into a sewer, it also requires a discharge consent from the competent body, discharge consents are regulated under the 
Water Industry Act.
Horizon 
Scanning
Directive 2004/35/EC on Environmental Liability – covers environmental damage from activities, it includes damage to land and 
soil where there is serious harm to health and water pollution leading to a decline in water quality. There may be defences for damage 
caused by an act of armed conflict, natural phenomenon, or from compliance with a permit, and emissions which at the time they were 
authorised were not considered to be harmful.  Consequently any damage from nanomaterials assessed according to the best 
available scientific and technical knowledge would not be covered if they were classed as non-harmful. 
Legislation: P o l l u t i o n  P r e v e n t i o n  a n d  C o n t r o l  ( E n g l a n d  a n d  W a l e s )  R e g u l a t i o n s  
2 0 0 0 161( P P C ) ^
Summary of Purpose: The Regulations implement into the UK the Directive 96/61/EC on Integrated Pollution Prevention and Control, which sets down 
measures to either prevent or reduce emissions to air, water and land from prescribed activities.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Scope 1. Scope extends to traditional unit 
operations and unit processes.
2. Threshold Capacity – Activities are 
subject to a capacity before IPPC 
permits are required. For example, 
plants for the pre-treatment or dyeing of 
1. Such is the innovative nature of 
nanotechnology production that they may not 
meet the IPPC activity descriptions. For 
example, in the PPC Regulations, chemical 
industry activities must involve the production 
of chemicals ‘in a chemical plant by chemical 
processing for commercial purposes’ and this 
would exclude nanomaterials  produced using 
solely by physical production routes162. 
2. Many of the sectors under which 
nanomaterials may be produced are unlikely 
to meet these thresholds and therefore be 
exempted under the Regulations.  These 
thresholds mean that small scale sites, as well 
However, even if the production of 
nanomaterials does not fall under the 
Regulations, it is also likely that the listed 
activities will incorporate the use of 
nanomaterials.
                                                
161 As amended 2001 (SI 503), 2002 (SI 275 & SI 1702), 2003 (SI 1699 & SI 3296), 2006 (SI 2311), Pollution Prevention and Control (England and Wales) 
(Amendment) and Connected Provisions Regulations 2004 SI 3276, Pollution Prevention and Control (Unauthorised Part B Processes) (England and Wales) 
Regulations 2004, SI 434 and Pollution Prevention and Control (Public Participation)(England and Wales) Regulations 2005 SI 1448
162 A scoping study to identify gaps in environmental regulation for the product and application of nanotechnologies, Final Report, DEFRA, 200
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fibres or textiles are excluded where the 
treatment capacity is below 10 tonnes 
per day.  
as all research and development activities, 
are not covered by the IPPC Directive and 
national legislation.
2. Definition -
pollutant
Is any substance, vibration, heat or 
noise released as the result of an 
emission which may be harmful to 
human health or quality of the 
environment and which may damage 
material property or impair or interfere 
with amenities.
A substance is defined as a chemical 
element and its compounds and any 
biological entity or micro-organism.
Are nanomaterials ‘pollutants’?
May depend on a number of factors including 
whether the nanomaterial has been classed 
as a new substance or as an existing one in 
terms of its macro equivalent*.   There is no 
requirement in the definition for a substance 
to be a dangerous substance** merely that as 
a result of an emission it may be harmful –
consequently, nanomaterials if classed as a 
new substance could be captured whether or 
not it was considered dangerous.  However, a 
list of pollutants is provided and nanomaterials 
if classed as new substances* are not 
captured under this list.   If classed as an 
existing substance, any analysis may be 
based on the impacts of the macro scale form, 
which is likely to be inappropriate for the 
nanoscale form of the substance.
This will impact on the means of 
assessing the likely risks and the methods 
used for evaluating the appropriate 
emission level values.
3. Emission Level 
Values (ELV)
1. May be set in permit for all pollutants 
likely to be released
2. ELVs to apply when pollutants are 
likely to be emitted in significant 
quantity?
If considered an existing substance – ELV 
estimated on the basis of the environmental 
risks of the macro equivalent, which may be 
different from the nanomaterial due to the 
different reactions of materials at the 
nanoscale.  
If not considered an existing substance - the 
term ‘significant quantities’ may exclude 
consideration of nanomaterial emissions, 
unless it was assessed in relation to the 
environmental significance of the 
nanomaterial itself.
2. What is significant quantity?
It is unlikely that nanomaterials will satisfy any 
‘significant quantity’ threshold, as what is 
significant at the macro scale is not 
comparable to that at the nanoscale.
As the regulations provide for reviewing 
the emission levels, as new information 
becomes available and the scientific 
knowledge on the impact of nanomaterials 
is collected and collated, new levels can 
be set which are applicable to 
nanomaterial emissions.
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3. Levels to be based on the best 
available techniques for the type of 
installation.
3. Best Available Technique?
With the lack of scientific data available, 
nanomaterials may escape capture under this 
method of assessing emissions, however, 
there is scope for stricter limits to be set under 
the regulations and nanomaterials may need 
to be covered under this standard.
4. Permit 
Information
A permit application must include a 
description of the nature and quantities 
of foreseeable emissions from the 
installation into each medium as well as 
identification of significant effects of the 
emissions on the environment.
Given the current uncertainty in relation to the 
potential impacts of nanomaterials on human 
health and/or the environment in relation both 
to the potential effects and the level at which 
these effects might occur, it may not be 
possible to assess the impacts of many 
nanomaterials. Based on current scientific 
knowledge, there may be a number of issues 
in determining an acceptable level of 
emissions, the appropriate preventative 
measures or the Best Available Technology 
(BAT).  The general lack of scientific 
knowledge on the management of 
nanomaterials may itself mean that the 
definition of BAT cannot extend to 
nanomaterials.
The regulations do provide for conditions 
which are supplemental or incidental to 
other conditions to be applied to a permit, 
there is the potential to capture 
nanomaterials via these supplemental 
conditions.  Whilst the Secretary of State 
has the power to ask for specific 
conditions to be included in a permit. 
5. Environmental 
Assessment Levels
ELVs are set so that environmental 
assessment levels (EALs) are not 
exceeded.
The majority of EALs for air have been 
extrapolated from occupational exposure 
limits (OELs) using suitable uncertainty 
factors, which allow for the differences 
between occupational exposure to chemicals 
and the exposure of the general population to 
the pollutant in ambient air. It is not known 
whether such limit values will be revised 
although it is unlikely that this will happen in 
the short term. The absence of this hierarchy 
of information could cause difficulties in 
setting appropriate EAL/ELVs
6. Monitoring Assuming that ELVs could be 
established, it would be necessary to 
monitor industrial emissions for 
nanomaterials to ensure compliance.
Based on current evidence about the relative 
toxicity of nanomaterials compared with the 
same material at the macro scale, it is 
possible that ELVs relevant to nanoparticles 
would, on a mass basis, be much lower. 
As commented in the Defra scoping study 
report - while methodologies to measure 
these parameters are available, they have 
not yet been applied to stack 
measurement. It is unlikely, that the 
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However, the current means of measuring 
and monitoring the emissions is unlikely to be 
applicable to monitoring any emissions 
resulting from nanomaterial pollutants.  It is 
possible that they could be based on an 
alternative metric such as particle number or 
surface area within an appropriate size range. 
It is likely that similar problems will arise in 
monitoring nanomaterials in effluent 
discharges.
systems as currently available would be 
well suited to this type of environment, 
particularly in terms of robustness and 
ability to tolerate temperature extremes163.
Linked 
Legislation
^ - Environment Protection Act 1990 (EPA) – PPC Regulations replaces the pollution and control regime established under Part 1 
of the EPA.
* - Notification of New Substances Regulations  - requires standardised testing of hazardous properties of new chemical 
substances, those substances identified as new feed into EU level and Annex I of the Dangerous Substances Directive
** - Directive 2006/11/EC on pollution caused by certain dangerous substances discharged into the aquatic environment of the 
Community, this directive codifies and replaces Directive on Dangerous Substances 76/464/EEC, which provided a list of List I and 
II substances 
** - Environment Protection (Prescribed Processes and Substances) Regulations 1991 - lists a number of List I substances 
whose releases to water are prescribed for Integrated Pollution Control.  PPC Regulations will revoke the prescribed process 
regulation following full implementation of the PPC regime.
Packaging (Essential Requirements) Regulations 2003
Producer Responsibility Obligations (Packaging Waste) Regulations 2005
Control of Major Accident Hazard Regulations 1999
Groundwater Regulations 1998 –
Urban Waste Water Treatment (England & Wales) Regulations 1994
Water Resources Act 1991
Hazardous Waste (England & Wales) Regulations 2005
Landfill (England & Wales) Regulations 2002
Waste Incineration (England) Regulations 2002
Horizon 
Scanning
Regulation (EC) No 166/2006 concerning the establishment of a European Pollutant Release and Transfer Register and 
amending Council Directives 91/689/EEC and 96/61/EC - tool for encouraging improvements in environmental performance, for 
providing public access to information on releases of pollutants and off-site transfers of pollutants and waste, and for use in tracking 
trends, demonstrating progress in pollution reduction, monitoring compliance with certain international agreements, setting priorities 
and evaluating progress achieved through Community and national environmental policies and programmes.  Applies to any 
chemical element and its compounds and applies to any introduction of pollutants into the environment as a result of any human 
activity, whether deliberate or accidental, routine or non-routine, including spilling, emitting, discharging, injecting, disposing or 
dumping, or through sewer systems without final waste-water treatment.  Directive applies to a list of prescribed activities as well as 
a list of prescribed substances with specific thresholds.   It is likely that the thresholds have been set at a level too high to cover the 
                                                
163 A scoping study to identify gaps in environmental regulation for the product and application of nanotechnologies, Final Report, DEFRA, 200
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release of nanomaterials.
Legislation: Air  Qual i ty (England) Regulat ions 2000 164 & Air  Qual i ty Limit  Values Regulations 2003 165
Summary of Purpose: The purpose of these regulations is to protect human health and the environment by restricting or preventing the potential harm
from pollutants being released into the air.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Scope Regulations relate to a prescribed list of 
pollutants including: sulphur dioxide, 
nitrogen dioxide, fine particulate matter 
(PM10), suspended particulate matter, 
lead, benzene, carbon monoxide, 
polycyclic aromatic hydrocarbons 
(PAHs) (benzo-a-pyrene as indicator), 
cadmium, arsenic, nickel compounds 
and mercury.
For each of these pollutants, the effects on 
human health and the environment are 
known, hence the reasons for their control as 
such it is unlikely that these regulations will 
extend to nanomaterials given that the effects 
on human health and the environment are at 
present generally unknown.   A potential gap 
exists as the regulations are unlikely to extend 
to the nanoscale form.
The regulations oblige industry to reduce 
the quantity of dust, fumes, acid gases 
and volatile organic compounds emitted to 
the atmosphere.  The general intention is 
that industry will achieve this either by 
altering procedures or by installing 
appropriate treatment or separation 
systems.  On a practical level even if 
nanomaterials were covered by the 
relevant regulations, the relevant technical 
systems may not currently exist.
2. Limit Values The 2003 Regulations provide 
prescribed limit values for each of the 
prescribed pollutants.
Again the limit values are set at a level based 
on the specific knowledge of the effects of the 
prescribed pollutants and do not relate to any 
potential impacts from the nanoscale form.   
Even if the nanoscale form was covered 
under the prescribed list, a potential gap is 
likely to arise as a result of the specific limit 
values.
3. Testing Requirement to assess ambient air 
quality via measuring stations supplying 
representative data on concentrations.
As identified against other regulations, the 
main issue will be whether current testing 
methods can be adapted to measure the 
presence of nanomaterials.   At present it is 
unlikely that current testing standards and 
methods are likely to be able to detect the 
nanoscale form of substances.
                                                
164 As amended 2002 (SI 3043)
165 As amended 2004 (SI 2888)
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Linked 
Legislation
Pollution Prevention and Control (England & Wales) Regulations 2000 – controls industrial emissions to air from prescribed 
substances emitted from prescribed activities.
Clean Air Act 1993 – consolidated existing legislation which control smoke emissions, the intallation of furnaces and the height of 
chimneys.
Horizon 
Scanning
Commission’s Thematic Strategy on Air Pollution 2005 - The strategy focuses on reducing emissions from five key pollutants as 
well as ground-level ozone by 2020 including particulate matter (PM) with a diameter of 2.5, which the Strategy recognises for 
particular attention as there is insufficient evidence to determine a safe level of human exposure to particulates and in practical terms 
all increases in PM levels should be regarded as harmful.
Proposed Ambient Air Quality Directive - would require reductions in average PM2.5 concentrations throughout each Member State 
and set a cap on concentrations in the most polluted areas.
Legislation: C o n t r o l  o f  P o l l u t i o n  ( O i l  S t o r a g e )  ( E n g l a n d )  R e g u l a t i o n s  2 0 0 1
Summary of Purpose: The Regulations apply to industrial, commercial and institutional (residential and non-residential) premises storing more than 200 
litres of oil.  They require a person having custody or control of oil to carry out certain works and take certain precautions and other steps for preventing 
pollution of any waters which are controlled waters for the purposes of Part III of the Water Resources Act 1991*.  Oil shall be stored in a container which is of 
sufficient strength and structural integrity to ensure that it is unlikely to burst or leak in its ordinary use.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Scope Regulations apply to oil of any kind 
except waste oil as defined in the 
Waste Management Licensing 
Regulations, within any kind of 
container which is being used and 
stored above ground and situated 
outside a building and on any premises 
except those specifically listed.
The aim of the regulations is to reduce the 
number of significant oil pollution incidents by 
50%166 - this target may need to be reviewed 
in light of the presence of nanomaterials if it is 
discovered that the potential polluting impacts 
are increased due to the presence of these 
nanoscale materials.
There are a number of potential 
applications for nanotechnology in the 
manufacture and supply of oil products 
e.g. frying oil and motor fuel and synthetic 
oils.
2. Design
Requirements
The Regulations set minimum design 
standards for all new and existing 
above ground oil storage facilities. The 
key requirement is the provision of 
secondary containment (a ‘bund’ or ‘drip 
tray’) to ensure that any leaking or
spilt oil cannot enter controlled waters.
There may need to be a requirement to 
ensure that the minimum design standards 
are sufficient for oils containing nanoscale 
substances or materials e.g. the base of 
containers must be impermeable to water and 
oil – however nanomaterials may react 
differently.
The regulations as a whole should provide 
sufficient flexibility to ensure that oils 
containing nanomaterials are regulated in 
a way so as to prevent pollution resulting 
from any escape.
                                                
166 Environment Agency http://www.environment-agency.gov.uk/ourviews/857255/880418/?version=1&lang=_e
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3. Risks A notice may be served on a person 
with custody or control of oil, requiring 
person to carry out works, take 
precautions or other such action to 
minimise the risk of oil-related water 
pollution.
Where oil contains nanomaterials, which may 
(depending on available research) cause a 
potential risk, person with custody or control 
will be reliant on the available safety data 
provided by supplier under CHIP**, if said 
nanomaterials have been classed as 
hazardous.  Persons with obligations under 
these regulations will only be in a position to 
take precautions or minimise potential risk if 
they are supplied with the appropriate hazard 
data. 
New potential risks may also need to be 
considered particularly in terms of the 
potential hazards from heat exposure or 
fire.
Linked 
Legislation
* - Water Resources Act 1991 – outlines those water courses considered to be controlled water for the purposes of the Act.
** - Chemical (Hazard Information & Packaging Supply) Regulations - CHIP requires suppliers of chemicals to decide whether 
they are 'dangerous' and in what way, and then provide information to their customers in the form of warning labels and safety data 
sheets. The chemicals must also be packaged properly.
The Building Regulations 1991 - may be amended to include provisions for pollution prevention measures at new build private 
dwellings, similar to the new oil storage regulations. The EA can use existing anti-pollution powers to tackle individual existing private 
dwellings heating oil storage tanks where pollution of controlled waters is likely to occur.
Horizon 
Scanning
Legislation: C o n t r o l  o f  P o l l u t i o n  ( S i l a g e ,  S l u r r y  a n d  A g r i c u l t u r a l  F u e l  O i l )  R e g u l a t i o n s  
1 9 9 1 167
Summary of Purpose: These Regulations require persons with custody or control of a crop being made into silage, livestock slurry or certain fuel oil to 
carry out works and take precautions and other steps for preventing pollution of waters which are controlled waters.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Agricultural Fuel 
Oil
A person who has the custody or 
control of agricultural fuel oil must store 
it in a prescribed manner under the 
regulations as contained in Schedule 3.  
The design requirements for the bund 
and base of storage must be 
impermeable and designed to a quality 
that with proper maintenance will have 
The regulations introduce a secondary 
containment system (a bund) which should 
cover the control of pollution from agricultural 
fuel oil whether nanomaterials are present or 
not.  However, they are minimum prescriptive 
standards and only capture those that store 
over 1,500 litres of fuel.  
                                                
167 As amended in 1996 (SI 2044), 1997 (SI 547).  The regulations were implemented under Section 92 of the Water Resources Act 1991.
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a life span of 20 years.  No part of the 
fuel storage area should be within 10 
metres of any inland or coastal waters.
Linked 
Legislation
Water Resources Act 1991 – regulations were implemented under Section 92 of this Act.
Control of Pollution (Oil Storage)(England) Regulations 2001 - apply to industrial, commercial and institutional (residential and 
non-residential) premises storing more than 200 litres of oil.  
The Protection of Water Against Agricultural Nitrate Pollution (England and Wales) Regulations 1996
Action Programme for Nitrate Vulnerable Zones (England & Wales) Regulations 1999
Protection of Water Against Agricultural Nitrate Pollution (England and Wales) (Amendment) Regulations 2006, SI 1289
Horizon 
Scanning
Legislation: E n v i r o n m e n t a l  P r o t e c t i o n  ( P r e s c r i b e d  P r o c e s s e s  a n d  S u b s t a n c e s )  R e g u l a t i o n s  
1 9 9 1 168
Summary of Purpose: list a number of List I substances whose releases to water are prescribed for Integrated Pollution Control
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Prescribed 
Processes
Extends to the processes and activities 
covered by the Pollution, Prevention 
and Control Regulations.
The production and manufacture of 
nanomaterials are unlikely to meet the IPPC 
activity descriptions, generally because the 
activities fall under the tradition unit process.
Whilst the production may not fall under 
the prescribed processes, those 
processes that are identified are likely to 
utilise nanomaterial substances in their 
production process.
2. Prescribed 
Substances 
Three different lists of prescribed 
substances for water, air and land must 
be prevented or restricted.
Will nanomaterials be classed as a prescribed 
substance?
Whether nanomaterials will be covered by the 
regulations will depend on whether they can 
be classed as a prescribed substance.
1. Water
It is unlikely that nanomaterials are at present 
included under the identified substances but 
there is the potential to include nanomaterials 
In relation to nanomaterials, it is of interest 
that the only metals regulated in this way 
are mercury and cadmium and their 
compounds (which are not generally used 
as nanomaterials).  Some nanomaterials 
may need to be considered independently 
of the macro equivalent due to unknown 
effects of nanoscale form.
However, any potential to be captured 
                                                
168 As amended 1992 (SI 614), 1993 (SI 1749 & SI 2405), 1994 (SI 1271 & SI 1329), 1995 (SI 3247), Environmental Protection (Prescribed Processes and 
Substances) (Amendment) (Hazardous Waste Incineration) Regulations 1998, SI 767 and Environmental Protection (Prescribed Processes and Substances 
Etc.) (Amendment) (Petrol Vapour Recovery) Regulations 1996, SI 2678.
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in particular metal and its compounds if they 
are classed as existing substances169 – which 
means that the nanoscale substance is 
measured and assessed to the same 
standards as the macro, which may fail to 
identify the specific issues of the nanoscale.  
However, other nanomaterials will not be 
covered.
1. Air
The list could include nanomaterials but as 
outlined above much will depend on whether 
nanoscale is considered as an existing or a 
new substance.  Again potential for a number 
of nanomaterials not to be covered by the 
regulations if the macro scale equivalent does 
not require inclusion on the list.
3. Land
A number of the listed substances have the 
potential to include nanomaterials in particular 
pesticides.
under the lists will be if the nanomaterial is 
classed as an existing substance. To 
ensure a consistent approach to 
nanomaterials and to ensure assessment 
of their particular risks and effects, it has 
been recommended in other assessments 
that nanomaterials are classed as new 
substances and as such there is the 
potential gap that they will not be covered 
by the lists of prescribed substances.
Linked 
Legislation
* As part of the ongoing restructuring of the Community water policy, the Directive 76/464/EEC on Dangerous Substances is now 
integrated in the Water Framework Directive (2000/60/EC) which was adopted in September 2000, and Directive 76/464/EEC will be 
fully repealed in 2013. Directive 76/464/EEC has been codified as 2006/11/EC on pollution caused by certain dangerous substances 
discharged into the aquatic environment of the community.
Pollution Prevention and Control (England & Wales) Regulations - Operators of the potentially most polluting processes 
('prescribed processes' which are specified in the amended Environmental Protection (Prescribed Processes and Substances) 
Regulations 1991/472) have to apply for prior authorisation from the Environment Agency to operate the process. PPC requires 
operators to consider the total impact of all releases to air, water and land when making an application. These Regulations revoke the 
prescribed process regulation following full implementation of the PPC regime.
Water Industry Act 1991 - occupiers of trade premises may not discharge any trade effluents into a public sewerage unless 
authorised by the competent body.
Horizon 
Scanning
                                                                                                                                                                                                                                         
169 An "existing substance" is defined as one that is listed in the European Inventory of Existing Commercial Chemical Substances (EINECS).
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Legislation: G r o u n d w a t e r  R e g u l a t i o n s  1 9 9 8 170
Summary of Purpose:  The regulations require the relevant authority to prevent the direct or indirect discharge of list I substances to groundwater and to 
control pollution resulting from the direct or indirect discharge of list II substances, this is achieved via a requirement for an authorisation for the disposal, or 
tipping for the purposes of disposal, of list I or II substances in cases where a waste management licence under Part II of the Environmental Protection Act 
1990 is not already required.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Definition –
pollution
The Regulations place a duty on the 
Environment Agency (the relevant 
authority in England) to protect 
groundwater, in effect by prohibiting 
discharges of List I substances to 
groundwater, and preventing pollution 
of groundwater by List II substances.* 
Pollution is defined as discharge 
substances, directly or indirectly into 
groundwater which can result in 
damage to human health, water 
supplies, living resources or aquatic 
ecosystem.
Will nanomaterials be classed as a substance 
under the regulation?
Whether nanomaterials will be covered by the 
regulations will depend on whether they can 
be classed as a List I or List II substance. 
1. If they are classed as a List I substance 
systems will be required to prohibit their 
discharge into groundwater.  It is unlikely that 
nanomaterials are at present included under 
the identified substances in List I. Substances 
in List I do have the potential to include 
nanomaterials in particular metal and its 
compounds, if they are classed as existing
substances – meaning that the nanoscale 
substance is measured and assessed to the 
same standards as the existing macro 
substance identified on the List.  Such a 
comparison may fail to identify the specific 
impacts and/or effects of a material at the 
nanoscale.  In addition, the majority of the 
remaining nanomaterials will not be covered.   
If the nanoscale substance is classed as a 
‘new substance’ – this raises a new issue as 
In general nanomaterials are currently unlikely 
to fall under either of the Lists and even if 
some can be captured due to comparison with 
the macro equivalent – any risk assessments 
derived from the effects of the macro scale 
are unlikely to capture the potential risk 
effects of the nanoscale form.   To ensure a 
consistent approach to nanomaterials and to 
ensure assessment of their particular risks 
and effects, it has been recommended in 
other assessments that nanomaterials are 
classed as new substances and as such 
would not be included in the Lists.
It is foreseeable that due to the purpose of the 
introduction of the lists, e.g. List I is to cover 
pollutants which were selected because of 
their persistence, toxicity and bioaccumulation 
– any nanomaterials which fulfil these 
requirements can be added to the list.
                                                
170 Implements Council Directive 80/68/EEC^ as amended by Directive 91/692/EEC.
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to whether a new substance at the nanoscale 
is still covered by the regulation.
2. A number of the substances in List II are 
available at the nanoscale.  Again it will 
depend on whether they are classed as 
existing substances and subject to the same 
issues outlined in terms of List I. 
2.  Exception Even if nanomaterials were captured 
under List I or List II, the regulations 
include exceptions, which extend to 
discharge of substances in list I and II 
but in very small quantities and 
concentrations.
This is not a numeric standard and the 
European Court has held that were quantity of 
substances in List I or II contained in 
discharges of other substances is such that 
the threat of pollution cannot automatically be 
excluded, the Directive is applicable171.  It is 
likely that nanomaterials discharged will be in 
small quantities, however with the lack of 
scientific knowledge on the potential impacts, 
it may be necessary to consider including 
them under the regulations by considering 
them as pollutants which constitute a 
pressure.  However, this will require adequate 
monitoring tools to capture the presence of 
nanomaterials.
The introduction of the proposed Directive on 
Groundwater+ is likely to introduce threshold 
values for all pollutants identified as putting 
groundwater at potential risk. Thresholds in 
other legislation (e.g. REACH) have generally 
been set at a level too high to include 
nanomaterials and this may need to be 
addressed at an early stage.  Pollutants for 
which limits must be set include: ammonium, 
arsenic, cadmium, sulphate, trichloroethylene 
and tetrachloroethylene. 
3. Risk 
Assessment & 
Information 
1. Prior to granting authorisations to 
permit certain discharges, the 
Environment Agency must assess the 
risk of the discharge polluting or altering 
the quality of the groundwater.
2. Assess the purifying powers of soil & 
subsoil and the risk of pollution and 
alteration of the quality of the 
groundwater
1. This may be assessed by using current 
techniques and these standard tests may not 
capture the different level of pressures, effects 
and potential risks introduced by 
nanomaterials.
2. Again this will be dependent on current 
scientific knowledge, where this is not 
available it may not be possible to assess the 
reaction of soil and subsoil to effluents 
containing nanomaterials.
Does not extend to List I substances, the 
discharge of which cannot be authorised, 
except where this is permitted under the 
regulations. 
4. Terms of 
Authorisation 
Authorisations will include the essential 
precaution required for the potential 
substance that may be present in the 
effluent and the maximum quantity of 
It is unlikely that due to the lack of available 
scientific data that the relevant precautions 
can be evaluated and this lack of information 
can extend to the maximum quantity of any 
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such substance. nanoscale substance that may be permitted to 
be discharged.
Linked 
Legislation
^ -Directive 80/68/EEC – directive on pollution caused by certain dangerous substances discharged into groundwater, this amended 
Directive 76/464/EEC, by removing the protection of groundwater from its remit.
- List I and List II substances contained in the Dangerous Substances Directive (76/464/EEC), however as part of the ongoing 
restructuring of the Community water policy, the Directive on Dangerous Substances is now integrated in the Water Framework 
Directive (2000/60/EC) which was adopted in September 2000, and Directive 76/464/EEC will be fully repealed in 2013. Directive 
76/464/EEC has been codified as Directive 2006/11/EC on pollution caused by certain dangerous substances discharged into the aquatic 
environment of the Community.
Environment Protection (Prescribed Processes and Substances) Regulations 1991 - lists a number of List I substances whose 
releases to water are prescribed for Integrated Pollution Control.  
Water Resources Act 1991 - provides the power to modify discharge consents
Pollution Prevention and Control (England & Wales) Regulations 2000 - Operators of the potentially most polluting processes 
('prescribed processes' which are specified in the amended Environmental Protection (Prescribed Processes and Substances) 
Regulations 1991/472) have to apply for prior authorisation from the Environment Agency to operate the process. PPC requires operators 
to consider the total impact of all releases to air, water and land when making an application.
Horizon 
Scanning
+ - Groundwater protection against pollution under the Water Framework Directive - The European Commission adopted a proposal for a 
new Directive to protect groundwater from pollution on 19th September 2003 (COM(2003)550). Based on an EU-wide approach, the 
proposed Directive introduces, for the first time, quality objectives, obliging Member States to monitor and assess groundwater quality on 
the basis of common criteria and to identify and reverse trends in groundwater pollution. A final text was agreed in October 2006.  
On 17 July 2006, the Commission adopted a proposed Directive (Surface Water Protection against Pollution under the Water 
Framework Directive) setting environmental quality standards for the priority substances which Member States must achieve by 2015, to 
ensure "good chemical surface water status". The proposal also requires progressive reduction of emissions, losses and discharges of all 
priority substances, and phase-out or cessation of emissions, losses and discharges of priority hazardous substances within 20 years.
Legislation: S u r f a c e  W a t e r s  ( D a n g e r o u s  S u b s t a n c e s )  ( C l a s s i f i c a t i o n )  R e g u l a t i o n s  1 9 9 7  &  1 9 9 8
Summary of Purpose: These Regulations prescribe a system for classifying the quality of inland freshwaters, coastal waters and relevant territorial 
waters with a view to reducing the pollution of those waters by the dangerous substances.  The regulations establish water quality objectives.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
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1. Dangerous 
Substances
The substances listed in both 
regulations are substances within List II 
of the Dangerous Substances 
Directive*.
A number of the substances in List II are
available at the nanoscale.  Again it will 
depend on whether they are classed as 
existing substances172 - which means that the 
nanoscale substance is measured and 
assessed to the same standards as the 
macro.  Such a comparison may fail to identify 
the specific issues of the nanoscale 
substance.  In addition, other nanomaterials 
will not be covered.
To ensure a consistent approach to 
nanomaterials and to ensure assessment 
of their particular risks and effects, it has 
been recommended in other assessments 
that nanomaterials are classed as new 
substances and as such would not be 
included in the Lists.
2. Limits An annual mean concentration for each 
dangerous substance is listed in both 
regulations.  The mean concentration 
assists in the classification of the water 
source ensuring that the concentration 
of the dangerous substance does not 
exceed that listed.
With the low levels associated with 
nanomaterials it is foreseeable that in a 
number of occasions, they will, if classed as a 
dangerous substance, fall below these 
threshold limits.
New concentrations limits may need to be 
considered in light of nanomaterials and 
this would support a need for them to be 
considered as new substances.
3. Sampling The Environment Agency is required 
under the regulations to monitor the 
effects on the designated waters of 
discharges containing the prescribed 
dangerous substances.
It is likely that the current standards for 
monitoring and sampling techniques of water 
status will not capture the pressures 
introduced by nanomaterials.
Linked 
Legislation
* - List II substances contained in the Dangerous Substances Directive (76/464/EEC), however as part of the ongoing restructuring 
of the Community water policy, the Directive on Dangerous Substances is now integrated in the Water Framework Directive
(2000/60/EC) which was adopted in September 2000, and Directive 76/464/EEC will be fully repealed in 2013. Directive 76/464/EEC 
has been codified as Directive 2006/11/EC on pollution caused by certain dangerous substances discharged into the aquatic
Horizon 
Scanning
On 17 July 2006, the Commission adopted a proposed Directive (Surface Water Protection against Pollution under the Water 
Framework Directive) setting environmental quality standards for the priority substances which Member States must achieve by 
2015, to ensure "good chemical surface water status". The proposal also requires progressive reduction of emissions, losses and 
discharges of all priority substances, and phase-out or cessation of emissions, losses and discharges of priority hazardous 
substances within 20 years.
                                                
172 An "existing substance" is defined as one that is listed in the European Inventory of Existing Commercial Chemical Substances (EINECS).
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Legislation: T r a d e  E f f l u e n t s  ( P r e s c r i b e d  P r o c e s s e s  a n d  S u b s t a n c e s )  R e g u l a t i o n s  1 9 8 9 173
Summary of Purpose: These regulations specify two categories of trade effluent, which is any effluent (liquid waste) that is discharged from any 
premises used for carrying on a trade or industry.  Consent must be obtained to permit any discharge of trade effluent.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Prescribed 
Substances
Prescribed substances as contained in 
Section 1 are controlled if present in 
prescribed concentrations.
Potential for nanomaterial to be covered 
under the list, however much will depend on 
whether the nanoscale form is classed as an 
existing or new substance.  If an existing 
substance174, it might be categorised as a 
prescribed substance but would then be 
assessed against the same standards as the 
macro, which may fail to identify the specific 
issues of the nanoscale.  Nanomaterials, 
which do not fall under the prescribed 
substances list, will not be captured.
Trade effluent can include waste 
chemicals, including oils, liquid process 
wastes, detergents, condensate water 
from compressed air installations, cooling 
water, biodegradable liquids, wash water, 
liquid wastes or wash waters, other than 
domestic sewage, discharged using sinks, 
basins or toilets, and contaminated mine 
or quarry water.  It therefore, has a high 
likelihood of containing nanomaterials
2. Prescribed 
Processes
Trade effluent that derives from a 
prescribed process as contained in 
Section 2, which contains asbestos or 
chloroform if present in prescribed 
concentrations.
Potential for inclusion in the list but subject to 
the same issues discussed above.
To ensure a consistent approach to 
nanomaterials and to ensure assessment 
of their potential risks and effects, it has 
been recommended in other assessments 
that nanomaterials are classed as new 
substances and as such there is the 
potential gap that they will not be covered 
by the lists of prescribed substances.
Linked 
Legislation
Water Act 1989 –  Section 74 provides for the control of exercise of trade effluent functions as applied in these regulations.
Environmental Protection (Duty of Care) (England & Wales) Regulations 2000 - Any effluents that the Sewerage Undertaker will 
not permit you to discharge to the foul sewer will be classed as Waste or Hazardous Waste. Wastes must be handled and disposed of 
according to the duty of care regulations.
Water Industry Act – Definition of trade effluent - “...any liquid, either with or without particles of matter in suspension in the liquid, 
which is wholly or partly produced in the course of any trade or industry carried on at a trade premises..”  Occupiers of trade premises 
may not discharge any trade effluents into a public sewerage unless authorised by the sewerage undertaker. An application to 
discharge should include details of the effluent, quantity to be discharged in any one day, and the highest rate at which it is proposed 
to discharge. The Water Act 2003 adds to these requirements and will require applications to describe the steps to be taken for 
minimising the polluting effects of the discharge on any controlled waters and minimising the effects of the discharge on sewerage 
services.
Horizon 
                                                
173 As amended 1990 (SI 1629) and 1992 (SI 339)
174 An "existing substance" is defined as one that is listed in the European Inventory of Existing Commercial Chemical Substances (EINECS).
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Scanning
Legislation: U r b a n  W a s t e  W a t e r  T r e a t m e n t  ( E n g l a n d  a n d  W a l e s )  R e g u l a t i o n s  1 9 9 4 175
Summary of Purpose:  is to ensure that all significant discharges of sewage are treated before they are discharged either to inland surface waters, 
groundwater, estuaries or coastal waters.  The regulations also provide conditions to be followed by those providing waste water treatment facilities.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Classification of 
specific water 
bodies.
Regulations set down various criteria to 
identify sensitive areas.  Schedule 1 
provides elements, which might be 
taken into account when considering 
which nutrient should be reduced by 
further treatment
The criteria are not prescriptive but make 
recommendations as to which types of 
nutrients should be reduced by further 
treatment. With its limited coverage it is 
unlikely that these regulations will extend to 
nanomaterials.
2. Standards 1. Collecting Systems - Sets minimum 
standards for the design, construction, 
operation and maintenance  of 
collecting systems
2. Treatment Facilities – standards in 
design, construction, operation and 
maintenance are required to ensure that 
performance will meet achieve 
compliance of the treatment standards.
The minimum treatment required 
(primary, secondary or tertiary) is 
related to the sensitivity classification.  
Urban waste water entering collecting 
systems is subject to treatment.  
Generally secondary is the most 
common but more stringent treatment is 
required for waters identified as 
"sensitive areas".
1. The standards recommended are based on 
conventional systems and these standards 
may not capture the different level of 
pressures, effects and potential risks 
introduced by nanomaterials.
2. The regulations specify treatment methods 
for specific substances, whether 
nanomaterials are captured by the regulations 
will depend on whether they are included 
within the specified substances due to the 
lack of nanomaterials in waste water are 
unlikely to be captured.
1. To ensure that the standards meet the 
requirements of nanomaterial, information 
on the potential risks  associated with the 
discharge nanomaterials will be required.
2. There are a number of potential 
products containing nanomaterials that will
be disposed into waste water, in particular 
cosmetics, detergents and medicines.
3. Thresholds Discharge concentrations are provided As the regulations provide concentration level There is sufficient scope within the 
                                                
175 Implement Council Directive 91/271/EEC concerning urban waste water treatment.
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for specific substances. for specific substances, nanomaterials will not 
be captured and even if they were captured 
under the regulations, unlikely that the 
concentration levels would be appropriate.
regulations and within the Water 
Resources Act to introduce new 
substances and or conditions including 
concentrations.
4. Conditions 1. Conditions can include the provision 
of apparatus for the purpose of 
measuring or recording the volume, rate 
of flow, nature, composition or 
temperature of any waste water.
2. Other conditions can be attached to
fulfil any duties identified under the 
Water Resources Act^ e.g. discharges 
of biodegradable industrial waste water 
from specified industrial sectors are 
subject to conditions appropriate to the 
nature of the industry.
Given the current uncertainty in relation to the 
potential impacts of nanomaterials on human 
health and/or the environment in relation both 
to the potential effects and the level at which 
these effects might occur, it may not be 
possible to assess the impacts of many 
nanomaterials.  As a consequence it may 
prove difficult to attach appropriate conditions 
to a discharge consent, which will deal with 
any specific considerations arising from the 
presence of nanomaterials.
As above the regulatory framework 
provides for the relevant authority to 
impose conditions, which are appropriate 
for the nature of the industry conducting 
the discharge, therefore scope exists, 
where necessary to include specific 
conditions relating to the discharge of 
nanomaterials in urban waste water – this 
will depend on any practical treatment 
elements to treat nanomaterials.
5. Monitoring Condition on competent authority or 
appropriate body to monitor discharges 
for composition of sludges and to verify 
that discharges are not having a 
negative effect on the environment.
Monitoring is required for specific substances 
of which nanomaterials are not included.   
Even if nanomaterials were included under 
the regulations it is unlikely that the current 
monitoring techniques would capture the 
presence of nanomaterials and therefore 
unlikely that the regulations would be able to 
regulate nanomaterials in waste water.
Linked 
Legislation
Water Industry Act 1991 – The regulations bring into force the requirement under the Act for appropriate authority to secure that 
"collecting systems" are provided by specified dates, and to secure that urban waste water entering collecting systems is subject to 
treatment provided in accordance with the regulations.
Urban Waste Water Treatment Directive 91/271/EEC - is to ensure that all significant discharges of sewage are treated, whether the 
discharge is to inland surface water, groundwaters, estuaries or coastal waters.
Pollution Prevention and Control (England & Wales) Regulations – controls emission levels from certain type of prescribed 
activities.
^ - Water Resources Act 1991 - provides the power to modify discharge consents.
Horizon 
Scanning
Legislation: Water  Environment (Water  Framework Direct ive)  (England and Wales)  Regulat ions 2003
Summary of Purpose: The Regulations require a new strategic planning process to be established for the purposes of managing, protecting and 
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improving the quality of water resources. That process applies to river basin districts and the relevant authority must prepare river basin management plan.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Scope The regulations deal with the 
identification of the pressures on the 
aquatic environment, the monitoring of 
water quality and the means to protect 
and improve the quality of water 
resources in these regulations river 
basins.
Nanomaterials could constitute a pressure on 
the water environment, however it will depend 
on a number of factors including whether 
available techniques exist to measure, 
monitor and capture nanaomaterials and it is 
possible to assess the impact of 
nanomaterials on water quality.
2. Characterisation In England & Wales the Environment 
Agency must conduct a review of the 
impact of human activity on the status 
of surface water and groundwater in 
each river basin district.
Nanomaterials, which have effects on the 
chemical or ecological quality of water could 
be considered a pressure – however in order 
to measure the pressure, standard tests need 
to be applied – current test procedures may 
not capture the different level of pressures 
introduced by nanomaterials.
This analytical and preparatory work must 
then inform the preparation by the Agency 
of proposals for environmental objectives 
and programmes of measures in relation 
to each river basin district.  If the process 
does not capture the pressures from the 
release of nanomaterials subsequent 
actions may fail to address programmes of 
measures.
3. Monitoring 
Techniques
The Environment Agency must 
establish a programme for monitoring 
water status, part of which must cover 
ecological and chemical status.  The 
new system, with five quality classes 
underpinned by monitoring a range of 
biological quality elements, will be 
supported by measurements of physico-
chemistry, hydrology and morphology.
Again it is likely that the current standards for 
monitoring water status will not capture the 
pressures introduced by nanomaterials. 
New monitoring techniques may be 
required with regard to threshold and 
techniques for measuring pressures on 
chemical and ecological quality of water.
4. Programme of 
Measures
A programme of measures must be 
produced for each river basin district.
The programme of measures is linked to the 
analysis identifying pressures, any lack of 
information or gaps at the analysis stage will 
impact on identifying the relevant programme 
of measures in particular those relating to 
prevention or control of the input of pollutants. 
Linked 
Legislation
Horizon 
Scanning
Water Framework Directive - The Directive establishes a new legal framework for the protection, improvement and sustainable use 
of surface waters, transitional waters, coastal waters and groundwater across Europe.  Its aim is to prevent deterioration and enhance 
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status of aquatic ecosystems, including groundwater, promote sustainable water use, reduce pollution and contribute to the mitigation 
of floods and droughts.
Legislation: W a t e r  I n d u s t r y  A c t  1 9 9 1 176 (includes amendments made under Water Act 2003)
Summary of Purpose: occupiers of trade premises may not discharge any trade effluents into a public sewerage unless authorised by the sewerage 
undertaker. An application to discharge should include details of the effluent, quantity to be discharged in any one day, and the highest rate at which it is 
proposed to discharge^.  The Act has been amended by the Water Act 2003.^
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. ‘wholesome’ 
water
1. Secretary of State can prescribe 
specific characteristics of water and 
prescribe specific requirements as to 
the substances that should or should 
not be present in the water*.
2. Water undertaker to ensure that there 
has been no deterioration of water 
quality.
1. Such a provision can enable new 
regulations to be introduced which can extend 
to new substances, processes or products 
and therefore any nanomaterials, which it may 
be considered necessary to classify as a 
prescribed substance could be regulated for 
under new regulations.
2. Due to the current scientific knowledge 
available, any water that may be 
contaminated with nanomaterials that are 
deleterious to the environment or human 
health will not be detected due to the current 
technical standards available for monitoring 
water quality.  
The definition of substances – includes 
micro-organisms, natural or artificial 
substances – to ensure that nanoscale 
substances are captured, the definition 
may need to include reference to the 
nanosize form otherwise it would be open 
to debate.
2. Trade Effluent No effluent can be discharged into the 
sewer which may damage the sewer, 
injure the people working in it or 
1. Definition – the definition of trade effluent is 
sufficiently wide to encompass liquid 
containing nanomaterials produced or used by 
The Act permits the designation of a 
‘special category effluent’ – these are 
substances prescribed under the Act and 
                                                
176 As amended by Water Industry Act 1999 and the Water Act 2003
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interfere with the working of the sewage 
treatment works
industry, as it is confined to trade it excludes 
domestic effluent, which is likely to contain 
disposal of nanomaterials via the sewer.
are present in effluent or within prescribed 
concentrations or derives from a 
prescribed process*.  The provision 
however, will allow, if necessary, new 
regulations to extend to nanomaterials.
3. Trade Effluent 
consents – Water 
Act 2003^
The Water Act introduces a power 
which allows the Secretary of State to 
classify a specified liquid as trade 
effluent.  The Act also requires that 
applications for consent should contain 
the steps to be taken to minimise the 
polluting effects of the discharge and 
the impact of the discharge on 
sewerage services.
While this provision may extend to trade 
effluent containing nanomaterials, at the 
current level of knowledge on the effects of 
nanomaterials it is unlikely that there is 
sufficient available information to fulfil the 
requirements to provide information on the 
impact of the discharge on sewerage services 
or the necessary steps to be taken. 
4. Discharge 1. The Act prohibit disposal to public 
sewers any chemical waste which is 
classed as dangerous, will cause a 
nuisance or is injurious to health 
(s.111).
2. Part III can provide consents to allow 
discharge to public sewers (including 
those regulated under s.111). 
Application to discharge to the sewer 
should include details of the effluent, 
quantity to be discharged in any one 
day and the highest rate at which it is 
proposed to discharge. 
3. In granting a trade effluent consent 
the sewerage undertaker may impose 
conditions such as the volume of 
discharge, composition of the discharge 
(chemical oxygen demand, 
temperature, concentration of 
suspended solids) and the sewer into 
which it may be discharged.
1. Whether nanomaterials will be covered by 
the Act will depend on whether any are 
classed as dangerous and that information is 
available of the likely effects of nanomaterials 
in different circumstances are likely to cause a 
nuisance or be injurious to health.  If, without 
evidence to prove their classification, they are 
not classed as dangerous, there would be no 
prohibition on their disposal to public sewer.
2. Consent applications are open for inclusion 
of nanomaterials to be identified in the 
composition of the trade effluent.  
3. Special conditions may be applied to those 
substances classed as ‘special category 
effluent’ and prohibit disposal where 
necessary or require conditions.  Currently
prescribed substances are unlikely to cover 
nanomaterials at the general level and at the 
specific level only a few applications of 
nanomaterials are likely to be covered if they 
are classed as existing substances177
Applying a precautionary approach, 
nanomaterials which are not supported by 
research findings, should be classed as 
dangerous substances and prohibited 
from disposal to public sewers.
5. Testing The regulations require tests to be 
conducted on the extent and quality of 
the water.
It is likely that the current standards for 
monitoring water status will not capture the 
effects of nanomaterials, if the presence of 
                                                
177 An "existing substance" is defined as one that is listed in the European Inventory of Existing Commercial Chemical Substances (EINECS).
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substances at the nanoscale is likely to affect 
the quality of water.
Linked 
Legislation
^ - Water Act 2003 - adds to these requirements and will require applications to describe the steps to be taken for minimising the 
polluting effects of the discharge on any controlled waters and minimising the effects of the discharge on sewerage services.
* - Trade Effluent (Prescribed Processes and Substances) Regulation 1989 (as amended 1990 & 1992) - apply to companies 
which have, or are seeking, a consent to discharge specified trade effluents under the Water Industry Act.
 Water Supply (Water Fittings) Regulations 1999 – The regulations were made under section 74 of the Water Industry Act to 
prevent the waste, misuse, undue consumption, contamination or erroneous measurement of drinking water. The Regulations set 
requirements for the design, installation and maintenance of plumbing systems and water fittings. They are enforced by water 
companies in their respective areas of supply.
Water Supply (Water Quality) Regulations 2000 (as amended 2001 SI 2885) – Requires water undertaker to identify water supply 
zones for a given year.  Regulations require water to meet ‘wholesomeness’ standards, which requires that micro-organisms and 
substances do not exceed set concentrations.  Water must be monitored and samples taken from supply points and analysed.  No 
substance or product to be introduced into water, which would impact on wholesomeness.  Unlikely due to the prescribed 
concentration levels that nanomaterials will be addressed by these regulations.
Environment Protection Act 1990 - Processes which are regulated under Part I of the Environmental Protection Act 1990 also 
require a trade effluent consent from the sewerage undertaker.
Horizon 
Scanning
Water Framework Directive (Directive 2000/60/EC) – sets out a timetable for implementation of all aspects by 2027 and has key 
aims for improving water quality in the European Union including,  expanding the scope of water protection to all waters, surface 
waters and groundwater, achieving "good status" for all waters by a set deadline, water management based on river basins and 
"combined approach" of emission limit values and quality standards.
Legislation: W a t e r  R e s o u r c e s  A c t  1 9 9 1 178 ( includes amendments made under Water Act 2003)
Summary of Purpose: The Act sets out the responsibilities of the Environment Agency in relation to water pollution, resource management, flood 
defence, fisheries, and in some areas, navigation. It regulates discharges to controlled waters, namely rivers, estuaries, coastal waters, lakes and 
groundwaters. This is distinct from the drainage of water or trade effluent from trade premises into a sewer. Discharge to controlled waters is only permitted 
with the consent of the Environment Agency. An aim of the Act is to ensure that the polluter pays the cost of the consequences of their discharges.  The Act 
has been amended by the Water Act 2003*.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Classification of 
quality of water
Under the Act the Secretary of State 
has the power to introduce regulations 
prescribing a classification system for 
the quality of water.
Classification should consist of specific 
requirements as to substances that are 
present in or absent from the water.  Current 
classifications under this Act has not extended 
to nanomaterials e.g. under the Water 
Nanomaterials, which have effects on the 
chemical or ecological quality of water 
could be considered a pressure on the 
quality, however in order to measure the 
pressure, standard tests need to be 
                                                
178 The Act came into force in 1991 and replaced the corresponding sections of the Water Act 1989 and implements part of the Groundwater Directive 
80/68/EEC
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Environment (Water Framework Directive) 
Regulations.
applied – current test procedures may not
capture the different level of pressures 
introduced by nanomaterials.
2. Monitoring of 
extent of pollution 
in controlled water
A duty is placed on the competent 
authority to monitor the extent of 
pollution in controlled water.
It is likely that the current standards for 
monitoring water status will not capture the 
pressures introduced by nanomaterials, 
therefore the presence of nanomaterials will 
not be captured by the Act or subsequent 
regulations made under the Act unless 
monitoring techniques are capable of 
capturing the relevant data.
3. Offences of 
polluting
1. It is an offence to cause or knowingly 
permits a poisonous, noxious or 
polluting matter to enter any controlled 
water.
2. It is an offence to discharge any 
effluent or matter containing a 
prescribed substance or a prescribed 
concentration
1. Whether the Act covers nanomaterials will 
depend on whether individual nanomaterials 
are classed as poisonous, noxious or polluting 
matter.  Currently, it is unlikely that 
nanomaterials will be covered by the Act as 
under various other regulations they have not 
be classed as dangerous substances unless a 
nanoscale substance is classed as an 
‘existing’ substance179 and therefore 
compared with its macro equivalent, a 
comparison which will not identify the specific 
effects and impacts of the nanoscale form.
2. Only a limited scope of nanomaterials could 
be captured under the existing list of 
prescribed substances and again only if they 
are classed as existing substances (e.g. 
metals).  However, the majority of 
nanomaterials will not be captured and those 
that are, are subject to the limitations of being 
compared to the macro equivalent.
4. Precautions 
against pollution
1. Power to enact regulations to ensure 
that necessary precautions are 
undertaken to prevent or control the 
entry of poisonous, noxious or polluting 
matter into controlled water.
Applying the relevant precaution depends on 
the availability of information on the potential 
effects of a substance in a variety of different 
circumstances.  With the current dearth of 
scientific information on how nanomaterials 
                                                
179 An "existing substance" is defined as one that is listed in the European Inventory of Existing Commercial Chemical Substances (EINECS).
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2. Identification of water protected 
zones – where certain prescribed 
activities are prohibited or restricted.
may react in different environments will limit 
the applicability of introducing the necessary 
precautions to prevent or control entry of 
nanomaterials into controlled waters if they 
are classed as pollutants.  This is also 
applicable to point 2.
5. Consent to 
Discharge**
Conditions may be imposed in any 
consent to discharge for example
relating to nature, origin, composition, 
volume and rate of discharge. 
Provisions for minimising the polluting  
effects, provision for tests and sample 
analysis
Even if nanomaterials qualified as a pollutant 
and triggered conditions on discharge 
consents. Again in order to be able to impose 
conditions, one requires appropriate and 
relevant information to ensure that appropriate 
volumes and rates can be applied.  
At present it is therefore unlikely that 
condition could be complied with to the 
necessary level to ensure the minimisation 
of the polluting effects.
6. Information Pollution Control Register – containing 
information on the samples of analysis.
If nanomaterials are classed as existing 
substances, those that qualify under this 
definition, the information recorded will only 
be that acquired for the macro scale 
substance and as such not necessarily 
appropriate for the particular effects of the 
nanoscale.  Other nanomaterials will not be 
recorded.
This also raises questions in terms of the 
standards used for collecting and 
evaluating samples – as the current test 
procedures may not capture the different 
level of pressures introduced by 
nanomaterials
Linked 
Legislation
The Anti-Pollution Works Regulations 1999 - were enacted into Section 161A of the Act, to enable the Environment Agency to 
serve works notices on polluters or prospective polluters. The purpose of the regulations is to provide the Agency with additional 
powers to prevent water pollution.
* - Water Act 2003 – amends the Water Resources Act and introduced statutory provisions for water companies to produce water 
resources plans.
Water Resources (Environmental Impact Assessment) Regulations 2003 - EIA must be carried out for water management 
projects for agriculture, including irrigation projects, involving the abstraction (taking) or impoundment (storage) of water, which we 
judge could have significant environmental effects
** - Urban Waste Water Treatment (England & Wales) Regulations 1994 -  ensure that all significant discharges of sewage are 
treated before they are discharged either to inland surface waters, groundwater, estuaries or coastal waters
** - Pollution Prevention & Control Regulations – regulates discharges to controlled waters
Horizon 
Scanning
Water Resources Management Regulations – proposed regulations to implement the processes required for water resource 
management plans as required under the Water Act.
Water Framework Directive (Directive 2000/60/EC) – sets out a timetable for implementation of all aspects by 2027 and has key 
aims for improving water quality in the European Union including, expanding the scope of water protection to all waters, surface 
waters and groundwater, achieving "good status" for all waters by a set deadline, water management based on river basins and 
"combined approach" of emission limit values and quality standards.
Legislation: H a z a r d o u s  W a s t e  ( E n g l a n d  &  W a l e s )  R e g u l a t i o n s  2 0 0 5
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Summary of Purpose: The main aim is to define hazardous waste and to ensure it is properly managed and regulated; the regulations control waste 
that can harm human health or the environment.  Producers or consigners are required to register their premises with the Environment Agency, companies 
are required to document the movement of hazardous waste and consignees are required to keep records available for inspection.  A major element of the 
regulations is that there is a general restriction on the mixing of hazardous wastes and where appropriate the separation of wastes is required.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Definition of 
Hazardous Waste* 
The definition of hazardous waste in 
regulation 6 refers to the list of 
hazardous wastes set out in the List of 
Wastes (England) Regulations 2005*.   
For a list of the potential issues relating 
to the definition of hazardous waste –
see the assessment of List of Wastes 
Regulations.
The issue is the identification and 
classification of wastes containing substances 
at the nanosize form.  The main potential gap 
is if waste is not classified as hazardous.
If waste containing nanoparticles is classified 
as non-hazardous? – The waste will be able 
to be mixed with other waste types and 
disposed to non-hazardous landfill* sites –
where it will be mixed with a variety of other 
waste types.  As there is little available 
information on the reaction of nanoparticles 
with other materials – this could lead to both 
damage to human health and the 
environment.
The lack of relevant information on the 
effects of nanosized substances entering 
the waste stream, means that wastes 
classed as non-hazardous will not be 
required to meet the stricter standards 
required for hazardous wastes.  The 
identification of wastes as hazardous 
could lead to a potential increase in 
available data, the Hazardous Waste 
Regulations are linked to the Chemicals 
(Hazard Information and Packaging for 
Supply) Regulations 2002** for the 
determination of dangerous substance –
the use of safety data sheets under these 
regulations could build up a knowledge 
base on disposal options.
2. Consumer 
Products and 
Domestic Waste
The regulations do not extend to 
domestic waste unless it has been 
separately collected.  No direct 
obligations are placed on householders 
under these regulations.
Consequently, with the increase in the 
availability of consumer products containing 
substances at the nanosize form and with little 
information on the effects – there is a potential 
gap relating to the best waste management 
methods.
The existing framework cannot 
accommodate any specific requirements 
to manage domestic waste containing 
products with nanosized substances.
3. Radioactive 
Wastes
Radioactive waste is covered by this 
regulation is being transferred from a 
site under the conditions of an 
Environment Agency authorisation and 
contains other hazardous properties. 
Potential problems may arise in the 
containment of nanomaterials/particles which, 
due to their small size, have the potential to 
disperse far more widely than standard 
radioactive substances. In addition, whilst the 
health risks of radioactive substances are well 
documented, there is little or no information 
on the potential risks posed by radioactive 
nanomaterials, which may have the ability to 
penetrate cell membranes and cause greater 
damage to cells due to their proximity to the 
DNA.
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4. Specific wastes 
to be treated as 
hazardous
The Secretary of State may determine 
in special circumstances that a waste 
may be treated for all purposes as 
hazardous. 
It is recommended that this provision is 
considered in determining the 
classification of substances containing 
nanoparticles.
Linked 
Legislation
* - List of Waste (England) Regulations 2005 – Identifies substances as either ‘Absolute’ or ‘Mirror’ wastes.  Absolute wastes are 
always hazardous, Mirror wastes may be hazardous or non-hazardous dependent on the concentration of dangerous substances.
** - Chemicals (Hazard Information and Packaging for Supply) Regulations 2002 - Dangerous Substance means a substance 
contained in the "Information Approved for the Classification and Labelling of Dangerous Substances and Dangerous Preparations 
(Seventh Edition)” (UK Approved Supply List) or if not on this list is one or more of the categories of danger contained in Schedule 1 of 
this regulation.
Landfill (England & Wales) Regulations 2005 - the classification of waste under the List of Waste will determine, where waste is 
disposed to landfill, the type of landfill to which the waste can be sent.
Pollution Prevention & Control (England & Wales) Regulations 2000 – controls emissions to land, air and water from prescribed 
activities.
Horizon 
Scanning
Regulation (EC) No 166/2006 concerning the establishment of a European Pollutant Release and Transfer Register and amending 
Council Directives 91/689/EEC and 96/61/EC - tool for encouraging improvements in environmental performance, for providing public 
access to information on releases of pollutants and off-site transfers of pollutants and waste, and for use in tracking trends, 
demonstrating progress in pollution reduction, monitoring compliance with certain international agreements, setting priorities and 
evaluating progress achieved through Community and national environmental policies and programmes.  Applies to any chemical 
element and its compounds and applies to any introduction of pollutants into the environment as a result of any human activity, 
whether deliberate or accidental, routine or non-routine, including spilling, emitting, discharging, injecting, disposing or dumping, or 
through sewer systems without final waste-water treatment.  Directive applies to a list of prescribed activities as well as a list of 
prescribed substances with specific thresholds.  It is likely that the thresholds have been set at a level too high to cover the release of 
nanomaterials.
Legislation: L a n d f i l l  ( E n g l a n d  &  W a l e s )  R e g u l a t i o n s  2 0 0 2 180^
Summary of Purpose: Governs the operation of landfill sites and sets out new requirements for the classification and management of these sites. Three 
types of landfill sites are defined – hazardous, non-hazardous and inert. Aims to reduce the amount of waste disposed to landfill by encouraging recycling and 
recovery.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Permits Outline the management procedures for 
operating the landfill, including the types 
and quantity of waste authorised to be 
deposited.  Before permit authorised, 
sites require to be classified into 
hazardous, inert or non-hazardous.
The provisions under this Regulation are such 
that many avenues of wastes containing 
nanoparticles (e.g. from research & 
development) cannot be disposed in landfill 
sites.  It is not foreseen that the existence of 
nanomaterials in waste will result in gaps in 
In general the lack of knowledge relating 
to the effects of nanomaterials within 
waste streams and their different 
properties and characteristics could lead 
to gaps because:
a. They may be misclassified under the 
                                                
180 As amended 2004 (SI 1375) and 2005 (SI 1640)
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the permitting of landfill sites however, 
potential gaps may arise in terms of the types 
of waste disposed to certain landfill sites (see 
box 4 – Waste Sources) or the role of Waste 
Acceptance Criteria (box 2).
List of Waste 
b. As a consequence, if being disposed to 
landfill, sent to the wrong type of landfill
c. Little knowledge on whether the current 
standards are adequate to provide 
sufficient containment from dispersal 
throughout the landfill site and escape into 
water courses.
2. Waste 
Acceptance 
Criteria (WAC)
Waste can only be disposed to landfill if 
it will not result in unacceptable 
emissions to groundwater, surface 
water or surrounding environment; 
jeopardise environmental systems; put 
at risk waste stabilisation processes or 
endanger human health.
These general acceptance criteria are 
supported for additional criteria for each 
of the three independent landfill types 
including being listed on the List of 
Wastes.**
Stable non-reactive hazardous waste 
means hazardous waste, the leaching 
behaviour of which will not change 
adversely in the long-term, under landfill 
design conditions or foreseeable 
1. Non-hazardous Landfill 
Potential gap due to the lack of available data 
in terms of the effects of nanomaterials and 
their potential to travel through the landfill and 
therefore escape.  A number of potential 
wastes particularly consumer products, can 
be disposed to this type of site.
2. Hazardous Landfill*
Stricter standards are required and if 
nanomaterials are classed as hazardous 
waste, there is potential for large volumes to 
be disposed to these sites – wastes will need 
to be treated before disposal and need to 
meet higher WAC standards.  Questions may 
still arise about the ability of nanomaterials to 
escape due to the general lack of available 
data.
3. Inert Landfill
Construction materials containing 
nanoparticles if not coded as hazardous 
waste could be sent to inert landfill where it 
would still be required to meet the criteria 
outlined in box 3.  Inert wastes containing 
nanoparticles may need to be treated prior to 
landfill disposal. 
4. Stable non-reactive hazardous waste – can 
be mixed with non-hazardous waste in the 
same cell.  Only permissible if prescribed 
waste types meet set leaching thresholds –
likely that any nanomaterials would escape 
these values.  There is also a potential gap in 
The availability of data on the impacts of 
nanomaterials will be vital to enable 
wastes containing these substances can 
be disposed safely via the appropriate 
means.
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accidents. scientific knowledge of the long-term impacts 
of nanomaterials and as such they may 
qualify as non-reactive hazardous waste due 
to the lack of information on long-term effects.
3. Waste 
Acceptance 
Procedures
1. Operator to inspect waste at point of 
disposal to confirm waste meets 
description.
2. Detailed data to be held on the 
quantities, characteristics, source and in 
terms of hazardous – its location on the 
site.
1. If waste has been incorrectly classified it is 
unlikely that a visual inspection of wastes 
containing nanoparticles will be detected at 
this stage.
2. The current system should be capable of 
dealing with the disposal of nanomaterials if 
they are correctly classified particularly if 
classified as hazardous – the main concern 
may be the impact of domestic waste.
Domestic waste streams are a source of 
disposal for nanomaterials as many 
consumer products will and do contain 
nanomaterials.  However, it may be 
difficult to separate wastes containing 
nanomaterials from those that do not.  
Current waste management systems for 
domestic waste unlikely to be able to deal 
with segregating out waste products with 
nanoscale particles.
4. Waste Sources Waste arises from a number of different 
generating sources.
1. Domestic Waste
Consumer products containing nanoparticles 
are currently disposed into domestic waste 
streams and therefore disposed to non-
hazardous landfill sites.  With the existing lack 
of knowledge about the impacts of substances 
at the nanosize scale - is there a danger of 
nanoparticles to move through a landfill and 
potentially enter any water supply. There may 
be a potential gap in meeting the waste 
acceptance criteria.  If separately collected 
and hazardous disposed to hazardous landfill 
sites.
2. Research & Development Waste
Banned from landfill disposal – as a 
consequence any nanomaterials generated 
from this sector will not be permitted disposal 
at any landfill.
3. Medical Waste
While hospital and other clinical wastes which 
arise from medical or veterinary 
establishments and which are infectious are 
banned from disposal to landfill there may be 
a number of medical wastes containing 
nanomaterials, which are not infectious and 
More research into the potential impacts is 
required.  Classification and labelling of 
products will be a major step in ensuring 
that wastes containing nanoparticles are 
disposed of in way, which reduces any 
potential damage to human health and the 
environment.
Further research is required on the 
impacts of nanomaterials in landfill and 
whether the current regime, which is 
designed to reduce the escape of
contaminants into the environment, is 
adequate to deal with new nanosized 
substances.
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therefore can be sent to landfill for disposal.    
Due to the lack of data on the effects of 
nanomaterials in waste streams.
Linked 
Legislation
* - Hazardous Waste (England & Wales) Regulations 2005 - Definition of hazardous waste is linked to the List of Waste 
Regulations and after classification as a hazardous waste, these Regulations outline the procedures relating to the movement of 
hazardous waste, the mixture and separation of hazardous wastes.
** - List of Waste (England & Wales) Regulations 2005 - Identifies substances as either ‘Absolute’ or ‘Mirror’ wastes.  Absolute 
wastes are always hazardous, Mirror wastes may be hazardous or non-hazardous dependent on the concentration of dangerous 
substances.
Environmental Protection (Duty of Care) (England) Regulations 1991 – Landfill Regulations altered the Duty of Care by adding a 
requirement to identify the waste by reference to the appropriate category in the European Waste Catalogue, now the List of Wastes
Environment Protection Act 1990 –  Provides the main statutory framework for environmental protection including the management 
of waste, statutory nuisance and contaminated land.
^ - Pollution Prevention & Control (England & Wales) Regulations 2000 – These regulations alter the PPC regime by bringing all 
landfill sites under this regime.  As a result, the PPC system of controlling environmental impacts of industrial operations will apply to 
all landfill sites.  However, regulations based on the current knowledge on the polluting effects of emissions, which may be different in 
terms of the effects of nanomaterials. 
Horizon 
Scanning
Thematic Strategy on the Prevention and Recycling of Waste by the European Commission – seeks to encourage the use of 
waste as a resource and therefore increased recycling.
Regulation (EC) No 166/2006 concerning the establishment of a European Pollutant Release and Transfer Register and 
amending Council Directives 91/689/EEC and 96/61/EC - tool for encouraging improvements in environmental performance, for 
providing public access to information on releases of pollutants and off-site transfers of pollutants and waste, and for use in tracking 
trends, demonstrating progress in pollution reduction, monitoring compliance with certain international agreements, setting priorities 
and evaluating progress achieved through Community and national environmental policies and programmes.  Applies to any 
chemical element and its compounds and applies to any introduction of pollutants into the environment as a result of any human 
activity, whether deliberate or accidental, routine or non-routine, including spilling, emitting, discharging, injecting, disposing or 
dumping, or through sewer systems without final waste-water treatment.  Directive applies to a list of prescribed activities as well as 
a list of prescribed substances with specific thresholds.  It is likely that the thresholds have been set at a level too high to cover the 
release of nanomaterials.
Legislation: L i s t  o f  W a s t e s  ( E n g l a n d )  R e g u l a t i o n s  2 0 0 5 181
Summary of Purpose: The List of Wastes, which replaces the European Waste Catalogue, provides for the classification of wastes and determines 
whether they are hazardous.  The regulation is an integral component of the waste management system in England and Wales.  Classification provides an 
identification of the appropriate waste management process for the coded waste type, it is the first means to ensure that those wastes classified as hazardous 
are treated prior to landfill disposal in a hazardous landfill site.  The codes are an integral part of the waste management system including the duty of care in 
disposal of waste.^
                                                
181 As amended 2005 (SI 1673)
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Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Definition of 
Hazardous Waste
Hazardous wastes are split into 2 
categories ‘Absolute’ meaning the 
waste will always be classed as 
hazardous or ‘Mirror’ which allows for a 
determination as to whether the waste 
will be hazardous or non-hazardous 
depending on their actual composition 
and the concentrations of “dangerous 
substances” within the waste.
1. If waste containing nanoparticles is 
classified as non-hazardous? – The waste will 
be able to be mixed with other waste types 
and disposed to non-hazardous landfill* sites 
– where it will be mixed with a variety of other 
waste types.  As there is little available 
information on the reaction of nanoparticles 
with other materials – this could lead to both 
damage to human health and the 
environment.
2. If waste containing nanoparticles is 
classified as hazardous? – A determination 
will be required on whether waste is an 
absolute or mirror type hazardous waste (see 
Section 3 – Properties & Characteristics of 
Dangerous Substances). 
It is recommended that due to the lack of 
available scientific information on the 
impacts of nanomaterials, wastes resulting 
from the development, manufacture, 
supply and use of nanoparticles are 
classed as hazardous.
2. Dangerous 
Substance **
A substance is classed as dangerous if 
it falls under Reg. 2 of Chemicals 
(Hazard Information & Packaging for 
Supply) Regulations 2002*** –
Schedule 1 of the Regulations outlines 
specific categories of danger.
Currently no existing substance in nanosized 
form has been through the EU system, which 
results in substances being entered onto the 
UK ‘Approved Supply List’. **  The lack of 
data available may mean that substances in 
nanosized form will not be classed as a 
dangerous substance. 
CHIP’s Schedule 1 list of specific 
categories of danger does include 
substances and preparations which in 
very low quantities can cause damage to 
health.  However, as identified in the 
report prepared by the HSE lack of 
available data may result in a failure to 
think through potential health hazards.
3. Properties & 
Characteristics of 
Dangerous 
Substances
Once a waste has been identified as 
possessing dangerous substances it 
must then be assessed as to whether it 
contains dangerous substances in 
concentrations at or above the 
appropriate threshold or a test shows a 
hazardous property.  The thresholds 
applied are H1 to H14 located in the 
Schedule 3 of Hazardous Waste 
Regulations****.
1. If waste containing nanoparticles is 
classified as ‘Absolute’? – Waste will not be 
allowed to be mixed with other waste streams 
and if it has been mixed due to a natural 
consequence of the process – where 
applicable waste should be separated.  
Waste, if to be sent to landfill, must be treated 
prior to disposal and only sent to registered 
hazardous landfill sites.
2. If waste containing nanoparticles is 
classified as ‘Mirror’? -  Determination will 
require to be undertaken as to whether the 
Applying a precautionary approach – all 
nanoparticles should be treated as 
‘Absolute’ hazardous wastes.
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necessary characteristics of danger are 
present.  An assessment of the relevant 
thresholds is necessary to assess whether the 
levels will satisfy an assessment of 
substances at the nanosized form.  If the 
thresholds are not at a  sufficient level, 
substances at this size may not be correctly 
classified.
2(a) If waste classed as hazardous? – Wastes 
will be subject to all of the provisions outlined 
for ‘Absolute’ hazardous waste as in 1 above.
2(b) If waste classed as non-hazardous? –
Waste can be mixed with other waste streams 
and disposed to landfill – due to lack of 
available data on the impact of nanoparticles 
this could result in damage to human health 
and to the environment.
4. Specific Process 
or intended use
Waste types are allocated against an 
identified process or activity or in certain 
circumstances against an intended use.  
When a person is lassifying a waste 
type they are required to code the 
waste according to the source 
generating the waste type.
1. Currently no existing hazardous waste 
codes available within the chapter specifically 
identified for food preparation and production.  
Food wastes containing any nanoparticles or 
nanomaterials, which may be hazardous, will 
have no valid code for classification.  
Producers will have access to codes under 
the manufacture, formulation, supply and use 
of organic and inorganic chemicals.
2. Packaging containing nanoparticles or 
exposed to nanoparticles under the current 
List will only be able to be coded as a ‘Mirror’ 
entry as no ‘Absolute’ code exists.  As a 
consequence the threshold levels may be too 
high to ensure that packaging contaminated 
with nanoparticles is identified with the 
relevant thresholds to be classed as 
hazardous.
3. The allocation of codes to a specific waste 
1. This will not identify that the waste is a 
result of the process of food.  This limits 
available data on the types of waste 
arising from specific sectors.
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is the responsibility of the producer when 
completing Waste Transfer Notes under the 
Duty of Care^ - with the lack of available 
information on nanoparticles, their existence 
in goods, products, resources may not be 
identified – many companies may code 
wastes incorrectly, which could lead to 
incorrect disposal.
5. Up dating the 
List of Wastes
The Regulations contain a provision for 
regular review and up dating of the list 
of wastes.
It is recommended that wastes containing 
nanoparticles are introduced into the List 
of Wastes.
Linked 
Legislation
^ - Environmental Protection (Duty of Care) (England) (Amendment) Regulations 2003 – Requires that a transfer note is a 
document which must be completed and accompany any transfer of waste between different holders.  The document must contain a 
description of the waste in words and also by a code from the List of Wastes.  The identification of the waste under this classification 
will often determine they type of waste management treatment e.g. whether a waste should be disposed to a hazardous or non-
hazardous landfill site.
* - Landfill (England & Wales) Regulations 2002 – the classification of waste under the List of Waste will determine, where waste is 
disposed to landfill, the type of landfill to which the waste can be sent.
**- Chemicals (Hazard Information and Packaging for Supply) Regulations 2002 – Dangerous Substance means a substance 
contained in the "Information Approved for the Classification and Labelling of Dangerous Substances and Dangerous Preparations 
(Seventh Edition)” (UK Approved Supply List) or if not on this list is one or more of the categories of danger contained in Schedule 1 of 
this regulation.
*** - Hazardous Waste (England & Wales) Regulations 2005 –Definition of hazardous waste is linked to the List of Waste
Regulations and after classification as a hazardous waste, these Regulations outline the procedures relating to the movement of 
hazardous waste, the mixture and separation of hazardous wastes. 
End of Life Vehicles Regulations 2003 – ELV wastes coded using List of Waste codes to determine whether waste hazardous and 
therefore containing dangerous substances.
Horizon 
Scanning
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Legislation: W a s t e  I n c i n e r a t i o n  ( E n g l a n d  &  W a l e s )  R e g u l a t i o n s  2 0 0 2 ^
Summary of Purpose: Covers the incineration of both hazardous and non-hazardous waste requiring strict emission limits, based on best available 
techniques, as well as compliance with the IPPC Directive182.  It applies to incineration and co-incineration plants.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Emission Levels Permits are required to operate a waste 
incinerator. Strict emission levels are 
set based on best available techniques.  
The Regulations set down:
a. operating conditions including gas 
temperatures;
b. emission level values for a range of 
substance to air and water including 
dioxins;
c. emission monitoring requirements
1. In general the lack of knowledge relating to 
the effects of nanomaterials within different 
waste streams and their different properties 
and characteristics could lead to gaps in the 
regulation of emission levels.
2. Currently, no limits exist for fine particles, 
which may be a concern in terms of 
nanomaterials and as a consequence result in 
another gap in the control of any emissions 
from the incineration of certain nanomaterials.
3. Present levels reflect current knowledge on 
the polluting effects of emissions, which may 
be different in terms of the effects of 
nanomaterials.
The current levels may not be adequate to 
address any of the potential emissions 
from the incineration of nanomaterials.
2. Waste Types Both hazardous and non-hazardous 
wastes can be disposed via this waste 
management method.
Biomass from e.g. agricultural waste 
exempted from the limits as it is considered 
clean fuel – however the potential application 
of nanomaterials in agriculture may alter this 
assumption.  As a consequence potential gap 
may arise.
                                                
182 Directive 96/61/EC on Integrated Pollution Prevention and Control
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Legislation: W a s t e  M a n a g e m e n t  L i c e n s i n g  R e g u l a t i o n s  1 9 9 4 183
Summary of Purpose:  Implement the requirements provided in Part II of the Environmental Protection Act 1990 and provide the provisions for a waste 
management licensing scheme.
Content for 
Analysis
Summary of regulation Gap or Potential Gap Comment/Impact
1. Information & 
evidence on 
application form
An applicant must supply certain 
information and evidence when making 
an application for a waste management 
licence – (where landfill or lagoon) 
works to prevent or minimise pollution, 
monitoring data of the quality of surface 
water and groundwater
At present the information is likely to be based 
on standard tests and the current test 
procedures may not capture the different level 
of pressures introduced by nanomaterials.
New monitoring techniques may be 
required with regard to threshold and 
techniques for fulfilling this information 
and evidence requirement.
2. Waste Oils Where a licence authorises the 
regeneration of waste oil, conditions 
must be applied to ensure that base oils 
resulting from regeneration do not 
constitute a hazardous waste184.
At present nanomaterials are unlikely to be 
identified as a hazardous waste for a variety 
of reasons.  The first issue is whether they are 
captured under List I or List II of the 
dangerous substances lists as discussed in 
box 3 below.  Secondly, is the numerous 
issues of identifying nanomaterials as 
hazardous waste as discussed in the 
assessment of the List of Waste Regulations.  
Even if identified as hazardous, for many 
wastes a determination has to be made on 
whether the concentration of hazardous 
properties is met and it is unlikely that 
nanomaterials will meet these thresholds and 
therefore may be classed as non-hazardous.
As a consequence it is likely that many 
nanomaterials will not be classed as 
hazardous waste and will therefore not be 
required to meet any of the stricter 
conditions applied to hazardous wastes in 
the various regulations including this 
regulation relating to waste oils.
3. Groundwater* 1. The discharge of List I or List II** 
substances are subject to a prior 
investigation before authorisation of 
licence.
Whether nanomaterials are captured under 
List I or List II substances has been discussed 
under the assessment of Groundwater 
Regulations*.  Of particular concern is 
whether nanomaterials are classed as existing 
or new substances.  If classed as ‘existing’ 
any investigation into potential risks arising 
                                                
183 As amended 1995 (SI 288 & SI 1950), 1996 (SI 1279), 1997 (SI 2203), 1998 (SI 606), 2002 (SI 674), 2003 (SI 595) and Waste Management (England & 
Wales) Regulations 2006.
184 As amended by the Hazardous Waste (England & Wales) Regulations 2005
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2. Conditions
Where the substance is permitted to be 
discharged, conditions may be applied 
including quantity, relevant precautions, 
monitoring and quality of groundwater.  
from the presence of nanomaterials would be 
assessed to the same standards as the macro 
scale, thereby failing to address the particular 
risks and pressures associated with the 
nanoscale.
It is unlikely that due to the lack of available 
scientific data that the relevant precautions 
can be evaluated and this lack of information 
can extend to the maximum quantity of any 
nanoscale substance that may be permitted to 
be discharged.  In addition, if assessed at the 
macro level any quantity conditions will reflect 
the level of pressure arising from the macro 
equivalent and not the nano.
Current technical standards may not 
capture the relevant data related to the 
particular issues and effects that may 
arise from the presence of nanomaterials 
or even detect their presence.
Linked 
Legislation
*- Groundwater Regulations 1998 – nothing in the groundwater regulations apply to any activity for which a waste management 
licence (within the meaning of Part II of the Environmental Protection Act 1990) is required.
** -  List I and List II substances contained in the Dangerous Substances Directive (76/464/EEC), however as part of the ongoing 
restructuring of the Community water policy, the Directive on Dangerous Substances is now integrated in the Water Framework 
Directive (2000/60/EC) which was adopted in September 2000, and Directive 76/464/EEC will be fully repealed in 2013. Directive 
76/464/EEC has been codified as Directive 2006/11/EC on pollution caused by certain dangerous substances discharged into the 
aquatic environment of the Community. 
Waste Management Licensing (Amendment) Regulations 1995 – The amendment introduces conditions for the disposal of scrap 
metal by setting down 7 day limits for the total tonnage of identified metals to be handled by a prescribed activity.
Horizon 
Scanning
